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ABSTRACT OF THE DISSERTATION
Understand and Predict Microbiome and Resistome Dynamics in Response to Perturbations
Across Diverse Populations and Environments
by
Manish Boolchandani
Doctor of Philosophy in Biology and Biomedical Sciences
Computational and Systems Biology
Washington University in St. Louis, 2021
Professor Gautam Dantas, Chair

Complex microbial communities are at the interface of human, animal and environment
interconnected ecosystem, where they can move within and between these entities. These
microbial communities are mostly beneficial, maintaining the host health and homeostatic state.
However, these communities can also serve as reservoirs of antibiotic resistance (AR) genes that
may disseminate to pathogen bacteria, compromising the treatment options. Like other microbial
communities, human gut microbiome is highly dynamic and can get acutely perturbed with the
changes in the habitat, diet, lifestyle and disease. A perturbed gut community structure has
profound impact on the host health and physiology. Use of antibiotics in medical and animal sector,
international travel to high infectious burden regions and occupational exposure at workplace like
dairy farm or swine farm can significantly alter the microbiome structure and function. Thus, in
this thesis, I aim to understand the ecological principles governing the microbiome structure in
different habitats and their response to such perturbations. To accomplish this goal, I first
developed and optimized the computational pipelines (PARFuMS, Resfams (v2), and
xiv

resAnnotator) for high-throughput characterization of antibiotic resistance genes in diverse
habitats. I then employed these methods along with other bioinformatics suites to understand the
dynamics of human gut microbiota and the antibiotic resistant genes that it collectively encodes
(the ‘resistome’) in response to perturbations such as international travel and swine farm
exposures. Additionally, I studied wild and captive baboon populations to understand the impact
of captivity and lifestyle changes associated with human contact on the changes in baboon’s
microbiome and antibiotic resistome.
To determine the impact of international travel and enteric infections on the gut microbial
ecosystem, I have specifically focused on two international travel scenarios. In the first scenario,
travelers from different countries, mainly the US and European nations, travel to one location i.e.
Cusco, Peru, and in the second scenario, travelers from one country, Netherlands, travel to four
different destinations viz. North Africa, East Africa, Southeastern Asia and Southern Asia. In the
first scenario, I investigated the impact of travelers’ diarrhea (TD) on travelers’ gut microbiome
and resistome, and the dynamics of these changes throughout travel and during specific diarrheal
episodes. To this end, we assembled a cohort of 159 travelers visiting the Andean city of Cusco,
Peru and applied next-generation sequencing techniques to 718 longitudinally-collected stool
samples. I found that the gut microbiome composition of all travelers changed significantly during
their stay, but the taxonomic diversity was stable. However, diarrhea disrupts this stability and
results in an increased abundance of antibiotic resistance genes which remains high weeks after
the diarrheal episode. I also identified several taxa that were differentially abundant between
diarrheal and non-diarrheal samples, which were used to develop a classification model that can
distinguish between the two sample types. In addition, we sequenced the genomes of 212
diarrheagenic Escherichia coli isolates, and found that isolates from travelers with diarrhea
xv

encoded more AR genes than those from healthy subjects. In summary, the gut microbiomes of
international travelers’ was found to be surprisingly resilient against dysbiosis; however, they are
susceptible to colonization by antibiotic resistant and multidrug-resistant bacteria, a risk that
becomes more pronounced if they have travelers’ diarrhea.
In the second scenario, I specifically studied the resistome dynamics among travelers to
different high infectious burden regions by comparing their pre- and post-travel samples. The study
showed that the destination shapes the travelers’ resistome, where travelers to a common
destination share similar resistome post-travel compared to their pre-travel resistome. I also found
that Southeastern Asia travelers acquired most AMR gene families compared to other travelers,
and several high-risk AR genes (e.g. mcr-1, blaCTX-M-1) were borne on mobile genetic elements,
highlighting the potential risk of global spread of the locally endemic AR genes.
Indiscriminate use of antimicrobials brings agricultural workers at risk for potential longterm health effects from occupational exposure to AR microbes. To understand how exposure to
such workplaces impact the gut resistome dynamics, I studied metagenomic samples from fourteen
healthy students who visited the confined and controlled swine farms for three consecutive months
and were sampled before-, during and after their visit in China. Longitudinal investigation showed
extensive sharing of AR genes and microorganisms after exposure to the swine farm environment,
along with several evidences of plasmid-associated AR genes that were borne on mobile genetic
elements. The study also showed partial reversal of the microbiome and resistome shift within four
to six-month period post-visit to the swine farms, attributing to the resiliency of the human gut
microbiome.
Although the antibiotics and the defense mechanisms adopted by bacteria to combat them
are ancient, the spread of AR is steadily rising since the introduction of antibiotics in agriculture
xvi

and medicine. To understand the impact of human exposure and how primate microbiota have
changed in the antibiotic era, I investigated the resistome of wild and captive baboon population.
I found expansion of resistome among captive baboons compared to the wild-type counterparts,
and the captivity and lifestyle changes associated with human contact can lead to marked changes
in the ecology of primate gut communities.
In this thesis, I demonstrated the impact of different anthropogenic activities, like
international travel and use of antibiotics in livestock farming on the microbiome and resistome of
the host, and how these activities perturb the gut microbial ecosystem. Although each project
demonstrates the resiliency of the microbiome and its ability to recover from the perturbed state,
there are also long-term, indirect impact on the host physiology especially with the acquisition of
AR genes upon exposure or enteric infections. I believe these studies lay ground with potential
hypothesis that can be further tested with clinical intervention studies.
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Chapter 1: Introduction
The synergistic relationship between human, animals and environment is essential for
sustainable living on our planet1, 2. “We are interconnected” – the message from the One Health
initiative emphasize upon what affects our environment will directly or indirectly affect humans
and animals and vice-versa2. Over the past century, humans have dominated over the planetary
ecosystem using key technological advancements that have increased the rate of industrialization,
globalization and urbanization. While this development path has significantly improved the quality
of life for humans, it has also increasingly made them vulnerable towards global health challenges
such as, risk of emerging infectious diseases like the COVID-19 pandemic that we are living in,
increasing number of non-communicable disease and antimicrobial resistance (AMR) spread1-3.
Antibiotic resistance is a natural feature of microbial system that existed before the advent
of antibiotic era. However, the extensive use of antimicrobial drugs in agriculture and medicine
have triggered the rapid spread of AMR, making it one of the biggest threat to human, animal and
environment. Through the One Health initiative, the scientific community have endeavored to
promote the close cooperation between human, animal and environmental health sciences and to
curb the initiatives that disregard their impact on the animal and environment health4. The
importance of One Health initiative in establishing the society-wide responsibility of improving
health of the ecosystem was recognized and promoted by UN, WHO, G20, and several other
international groups2.

1

1.1 Microbiome at the interface of interconnected
ecosystem
Traditionally, the major focus of One Health associated studies was to examine potential
bacterial and viral “zoonoses” events (transfer of a pathogen from animals to humans). However,
with the increased realization that microbes rarely function in isolation and improved sequencing
methods, the focus has shifted towards capturing the complete assortment of microorganisms i.e.
microbiome4. Each entity (human, animal or environment) has its own complex microbiome which
plays a key role in maintaining its health and homeostatic state. The infants receive their
microbiome from their mother at the time of birth5, 6, which continues to evolve and stabilize
around three years of age7, 8. The healthy human microbiome protects the individual from high risk
of obesity, diabetes, asthma, and allergies9 and produces essential nutrients and vitamins10. Like
humans, animal microbiome also protects them from the adverse effects of diseases and supports
their digestion system11. Similarly, the environment has its own characteristic microbiome, which
significantly vary from location to location. The researchers’ sampling efforts have included
variety of habitats and locations like restrooms and subways12, soil samples from different
locations13, ocean14, 15, and different workplaces, have enriched our knowledge of microbiome
diversity.
The microbiome is at the interface of the human, animal and environment interaction. A
study, published in 2018, investigated the microbiome and genotype information of more than
thousand ethnically diverse individuals who shared relatively common environment. The authors
showed that environment factors can account for about 25% variability in the microbiome and
observed significant similarities in the gut composition of genetically unrelated individuals that
shared the same household 16. This study, along with several others, emphasized upon the role of
2

environment in defining gut microbiome composition and function. Human gut microbiome is
highly dynamic and diverse community of microbes that compete and work together

17

. On one

hand, a stable and healthy microbiome exerts the “protective effect” against the colonization of the
pathogens18, while, on the other, the microbiome can get acutely perturbed with changes in the
environment factors such as diet, lifestyle, occupation, travel, disease (Diarrhea, Irritable bowel
syndrome (IBS), Ulcerative colitis (UC), Crohn’s disease(CD)) and use of medication such as
antimicrobials19-21. Here, I have highlighted the seminal work that investigated the short-term and
long-term impact of these events on the gut microbial dynamics and how these changes impact the
host health and physiology.

Figure 1.1: Schematic representation of One Health concept where microbial communities are at the interface of
humans, animals and environment interactions. These highly dynamic microbial communities that play a key role
in maintaining optimum health are perturbed by multiple biotic and abiotic factors.

3

1.2 Microbiome response to environmental factors
Diet and Lifestyle: Diet can have a significant impact on the human gut
microbiome and can alter gut microbiome composition and stability. Several studies have
investigated the changes in the gut microbial community induced by diet. Short-term dietary
interventions demonstrated significant alterations in the microbiota diversity within 24 – 48
hours20. One study showed that people who moved from meat based diet to plant-based, observed
a significant shift in the gut microbiome composition within 1-2 days of change in their diet22.
However, the effect of these interventions are transient and the gut microbiome composition,
largely defined by the long-term dietary habits, returns to the original structure. A 10-day dietary
intervention study on 10 individuals showed that although there are noticeable changes in the
microbiome within 24 hours of the dietary changes, the enterotype identity remains unchanged
throughout the 10 days, attributing the major compositional features to the long-term dietary
habits23. One study, published in 2018, showed that immigration from Thailand to the US is
associated with loss of microbiome diversity and acquisition of US-associated microbiome and
function. This effect can be observed within few days of arrival and increases with the length of
stay in the US24. This “westernization” of gut microbiota can partially be attributed to change in
diet for these immigrants. The results are consistent with popular belief that urbanization can be
disruptive to a well-established microbiome-host relationship.
Drugs are another major cause of perturbation in the gut microbial community.
Consumption of antimicrobials either as medication or through our food chain, can significantly
disrupt the microbial community. In 2008, Dethlefsen and colleagues showed that use of
ciprofloxacin can significantly alter the abundance of nearly one-third of the gut flora,
4

subsequently decreasing the taxonomic richness and diversity. The study also showed that while
most of the microbes are recovered within four weeks of treatment, certain taxa did not recover
even after six months25. The use of antibiotics within first year of life have also been linked with
slightly increased risk of asthma later in life26. While antibiotics directly exert their effect on the
microbiome community, several other drugs, with no direct link with bacteria, can also affect gut
microbiome composition and function. Metformin, a widely used drug by diabetic patients, has
recently been found to significantly alter the gut microbiome composition27. A recent study
screened 1000 non-antibiotic drugs available in the market against 40 representative gut microbial
species, and showed that about 24% of these drugs inhibits the growth of at least one microbial
strain28. Together, these studies reflect the dynamic nature of the gut microbiome and the influence
of diet and drugs on the gut microbial ecosystem.
International Travel: International travel shares a complex relationship with the human
gut microbiome. On one hand, the globetrotters, knowingly or unknowingly, expose their
microbiome to a new diet and ecologies for a short span of time that can induce significant
perturbation

21

, on the other, the jetlag accompanied with long distance travel can promote

metabolic imbalances that make the gut microbiome glucose intolerant and increases the risk of
obesity29. Travel to high infectious burden regions is also commonly associated with enteric
infections that often leads to travelers’ diarrhea (TD). A healthy and stable microbiome provides
the “protective” effect and resists the colonization of pathogens while a sub-optimal microbiome
is vulnerable to enteric infections. One study has demonstrated the differential susceptibility
towards Campylobacter infection based on the microbiome composition 30. The study examined
the pre- and post-travel microbiome composition of travelers from Sweden to high infectious
burden region and found that there was significant difference in the baseline microbial diversity of
5

travelers who got Campylobacter infection compared to the healthy travelers. The baseline gut
microbial diversity was higher among the healthy travelers 30. There are very few studies that have
investigated the changes in the gut microbiome due to travel. Youmans and colleagues investigated
how TD pathogens alter the gut microbial community by analyzing the post-travel samples and
metadata from 111 individuals who traveled from US to Central America or India, and identified
differences in the microbiome composition of healthy versus travelers with TD

31

. The authors

observed a dysbiotic microbiome signature with high Firmicutes:Bacteroidetes (F:B) ratio among
TD travelers irrespective of the pathogen presence. They also compared their healthy travelers
with healthy subjects of Human Microbiome Project (HMP) and found that the healthy travelers
also have significantly high F:B ratio. The authors did not observe significant change in alphadiversity among travelers 31. This study is one of the first ones to characterize changes in the gut
microbiome in response to travel, however, there are few limitations. The study used 16S rRNA
sequencing that did not offer enough resolution to dive deeper at the bacterial species level to build
significant association with TD. Also, the authors conducted this analysis with single stool sample
from travelers after their return, which could not capture the dynamic changes in the gut
microbiome that occur during travel. These limitations could be addressed by a longitudinal study
that identifies the risk factors, make prediction whether gut microbial structure that can provide
the “protective” effect or predispose individuals towards enteric infection and measure successive
changes in the gut microbiome due to travel, enteric infection and use of antibiotics. In this thesis,
I have endeavored to answer this by investigating longitudinal samples collected from 153
individuals, mainly from US and European nations, who traveled to Peru and quantitatively
evaluated the microbiome and resistome dynamics during travel (Chapter 3).

6

Increasing evidences based on multiple travelers’ population have shown that international
travel to developing regions, in particular regions of Asia, Africa and Latin America is a significant
risk factor for the acquisition and spread multi-drug resistance organisms and genes worldwide 32,
33

. For example, an increase in MDR Enterococcus (MRE) acquisition was found among travelers

and deployed military personnel returning from high infectious disease burden regions, especially
in the tropics, likely owing to poor hygiene and lack of antibiotic stewardship34. Another study
showed high acquisition rate of the extended spectrum β lactamase encoding gene (blaCTX-M) with
rise in their prevalence from 9% in pre-travel samples to 33.6% in post-travel 32. In 2016, Penders
and colleagues investigated the contributing factors that results into acquisition and colonization
of the extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E)

35

. The study

found that antibiotic use, travelers’ diarrhea and pre-existing chronic bowel disease as some of the
key factors that were closely associated with ESBL-E colonization. The median duration of
colonization was 30 days after travel with 12% probability of transmitting ESLB-E to another
household member. Among these groups, many had taken antibiotics and/or had developed
diarrhea during their travel. Together, these studies have raised important concern on global health
and increasing need for actions to limit global spread of antimicrobial resistance genes and
organisms.

1.4 Computational methods to predict microbiota response
to diverse perturbations
A perturbed gut community structure has profound impact on the host health and
physiology. Use of antibiotics, dietary interventions, international travel can significantly alter the
microbiota composition and may provide a niche for pathogen proliferation18. Different habitats
respond differently to the perturbations. Thus, it is important to understand the ecological
7

principles governing the microbiome structure in different habitats and their response to these
perturbations. Studies have identified features (taxa/functions) that are associated with specific
environment or habitat, but our knowledge about their interaction with rest of the microbial
community and their downstream effect on the metabolic level is limited. Computational
predictive models offer a rapid, cost-effective means of capturing these interactions in a timeresolved manner and permits the testing of competing hypotheses that can further be implemented
in animal models. Predictive machine-learning models and microbiome interaction networks (e.g.
deep neural and Bayesian) provides quantitative characterization of the microbial community
associated with the phenotype and models its dynamic structure and interactions with extrinsic
factors over time. Using these models, we can learn about the conserved co-occurrence of these
species across habitats over time and understand their functional interaction. Furthermore, we can
investigate how these key communities respond to perturbations under different habitats to gain
more insights into their mechanisms. Here I have discussed seminal work that implemented these
approaches to build disease predictive model and assess the microbe - phenotype and AR gene phenotype association.

1.4.1 Machine-learning based approach
Numerous studies have explored machine learning algorithms for studying microbial
dynamics and antimicrobial resistance, highlighting their role in predicting phenotype directly
from genotype. Machine learning approaches can be implemented as supervised and unsupervised
learning methods. In supervised learning, the training dataset with outcome of interest can be
utilized the build the predictive model that can further applied to query sequences to predict their
outcome. These predictive models are built upon classification rules that can further be assessed
for their prediction accuracy in an unbiased way
8

36-38

. One study developed the computational

framework to use microbial profiles as input and build a predictive model that distinguish between
healthy and diseased state. Using this framework, the authors performed meta-analysis on eight
different studies and using cross-validation analysis, they showed that their Random forest and
SVM built classifiers achieve close to 85% prediction accuracy for diseases like Cirrhosis,
Colorectal and IBD, and nearly 70% for diabetes and obesity38. However, in the cross-study
analysis, models built on one study were less accurate than the models built from the same study.
The authors also pointed out that combining the healthy cohort from all studies under analyses
improved the prediction capability of the individual model for the associated disease 38. Another
study postulated that the dysbiotic state could be predicted by changes in the abundance of few
microbes, and thus, built a multi-classification model which distinguish healthy microbiome from
following six diseases viz. multiple sclerosis, juvenile idiopathic arthritis, myalgic
encephalomyelitis/chronic fatigue syndrome, acquired immune deficiency syndrome, stroke and
colorectal cancer. The authors further improved their Logit-Boost based prediction model by
selecting best performing taxonomy features using forward selection and backward elimination
approach 39. Recently, a computational toolbox, SIAMCAT R package, was launched by a group
to facilitate building the ML models, performing statistical tests and data visualization using
quantitative microbial abundance profiles. The authors performed meta-analysis on several studies
related to Crohn’s disease and showed the large-scale application of the toolbox in identifying the
functional relationship, making sensible parameter choice and exploring confounding factors40.
Similarly, for resistome predictive model, several studies have used gene
presence/absence or AST outcomes as features to create the ‘training’ set for models. In one study,
a logistic regression approach was used to develop a model based on 14 gene parameters and 3
molecular typing markers that can differentiate between vancomycin-susceptible and vancomycin9

intermediate Staphylococccus aureus, using publicly available genomic data and patient
isolates41. The model performance was tested by a leave-one-out validation method, and it showed
84% classification accuracy. Although this accuracy level does not meet clinical standards, the
approach provides an important proof-of-concept that motivates the development of more
sophisticated models for identifying antimicrobial resistance. Another study evaluated a rulesbased and a machine learning-based approach (i.e., logistic regression) for predicting antimicrobial
resistance profiles and showed that the machine learning-based approach had higher accuracy with
novel variants in known antimicrobial resistance genes compared to the rules-based approach42.
Recent studies and tools utilize k-mers derived from whole genomes of antimicrobial-resistant and
susceptible species along with their AST outcomes to develop prediction models. Mykrobe
predictor43, a fast k-mer screening tool, is used to identify antimicrobial resistance genes and SNPs
in S. aureus and M. tuberculosis. It utilizes the curated genetic information of resistant and
susceptible alleles of the same species to build reference graphs (DBG) of these two categories
and to map k-mers derived from sequencing reads to these graphs. Mykrobe predictor showed
99.1% and 82.6% sensitivity and 99.6% and 98.5% specificity for S. aureus and M. tuberculosis,
respectively, on an independent validation set and provided important insights on potential
antimicrobial resistance elements. By contrast, RAST (Rapid Annotation using Subsystem
Technology)44 is a k-mer-based tool that uses a machine learning classifier (AdaBoost) based on
the PATRIC database to identify target-specific antimicrobial resistance genes in a specific
collection of pathogens. RAST is trained on k-mer data derived from the contigs of each genome.
These k-mer counts were converted to a binary matrix of 1s and 0s to depict whether a particular
k-mer is present in that genome or not. The binary matrix along with AST outcome is then used to
form a classifier model as well as to identify putative k-mers associated with resistance. The RAST
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classifier could identify carbapenem resistance in Acinetobacter baumannii, methicillin resistance
in S. aureus, and β-lactam and co-trimoxazole resistance in Streptococcus pneumoniae with
accuracies

of

88-99%.44

One major shortcoming of any machine learning classifier is its dependency on the training data
or existing knowledge base. To apply machine learning classifiers in clinical diagnostics, a large
data set of curated antimicrobial resistance genes that contain accurate genotypic data linked to
curated AST data will be required to build an effective and robust machine learning-based
classifier for antimicrobial-resistant organisms. In addition to differentiating between an
antimicrobial resistant and susceptible organism, machine learning approaches are currently being
applied to predict antimicrobial resistance genes in metagenomic data. DeepArgs45 is a newly
established tool that applies deep learning46 to identify antimicrobial resistance genes. It utilizes
curated data sets of CARD and ARDB along with Uniprot protein data to build a dissimilarity
matrix between antimicrobial resistance proteins and non-antimicrobial resistance proteins and
used it to train two deep learning model: DeepArg-LS for assembled genes and DeepArg-SS for
short reads. These models can then be used to predict antimicrobial resistance genes in new test
data.

1.4.2 Network-based approach
Microbiome is built from interconnected microbial communities that interact and coevolve
with each other47, 48. These relationships, synergistic or antagonistic, play an important role in
maintaining the health and ecological homeostatis of the host environment. The dynamic nature
and complexity of these interactions can be well represented as networks. Thus, to gain insights
in the small- and large ecological processes, researchers have utilized the universal features of the
network to characterize the intricate relationships. Several methods have been used to construct
11

the ecological network using microbiome data. Correlation based and dissimilarity index based
networks are some of the fastest ways to construct the co-occurrence networks using microbiome
data47. However, the direct application of the correlation based approach on data can lead to
unreliable results because of compositional data of microbes (represented as fractions instead of
absolute abundance)49, 50. In the compositional data, the increase in the abundance of one microbial
group will cause decreases in the fractional abundance of other microbes, thus creating the
compositional artefact. Thus, to avoid the compositional effects, several normalization methods
were introduced to estimate the correlation values between the microbes. One of them is SparCC
(Sparse correlations of Compositional data) that takes correlation between log-transformed
components of microbial abundance to estimate the correlation value49. Another approach, SPIECEASI (Sparse Inverse Covariance Estimation for Ecological Association Inference), uses
GLASSO on the centered log-transformed counts to estimate the correlation between microbial
species51.
Since several microbiome studies evaluate the association of microbial features with
disease and healthy phenotypes, differential co-occurrence patterns can capture important
microbial community characteristics that likely go unnoticed in the individual network. NetShift
is an online tool that facilitates the comparison of two microbiome co-occurrence networks and
quantifies the changes in the connectivity of common microbial species52. Netshift computes the
delta betweenness centrality, a measure of change in connectivity for each node, and NESH
(Neighbor Shift) score, a measure of directional change in the neighboring species, to
prioritize microbial species that undergo maximal changes in connectivity, and nominate them as
“driver taxa”52. Another recently published study introduces a new model called MDiNE
(Microbiome Differential Network Estimation) that estimates changes in the network based on a
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given binary covariate (healthy versus diseased)53. The model takes microbial taxa count in
individual samples and model it through Dirichlet-Multinomial distribution. The authors compared
the model’s performance with SPIEC-EASI and MInt on simulated data and showed improved
AUC values (0.65 – 0.90) for MDiNE model compared to the other two53. To capture the dynamic
changes in the microbial ecosystem using longitudinally collected data, Dynamic Bayesian
Networks (DBN) are appropriate for modeling the time-resolved interactions. One study utilized
the DBNs to model the compositional changes in the infant gut microbiome for 11 weeks 54. Along
with establishing the relationship between microbial taxa, the study also established the effect of
external factors like antibiotic use on gut microbiome development54.

1.5 Scope of thesis
The human gut microbiome is dynamic and liable to changes in response to the change in
habitat, environment, diet and disease. The perturbed gut microbiome can have profound impact
on host health and physiology. In my thesis, I have endeavored to understand the microbiome and
resistome dynamics in response to changes in the environment. In Chapter 2, I have described the
high-throughput pipeline developed to obtain the functionally validated and annotated resistance
genes from functional metagenomics sequencing. These genes were further grouped into families
to build a high precision marker database that can used to quantify the abundance of resistance
genes in metagenomic samples. The pipeline enabled the high-throughput resistome
characterization from metagenomics samples derived from diverse habitats and environments. I
have applied this pipeline across all functional metagenomics studies in this thesis.
International travel is a unique setting where human gut experiences a sudden and
prolonged exposure to new microbial habitat for varied duration. This change significantly alters
the gut composition and function and has been identified as one of the major factor resulting in
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acquisition of resistance genes depending on the new destination. In this thesis, I have specifically
focused on two international travel scenarios. In the first scenario, travelers from different
countries, mainly the US and European nations, travel to one location i.e. Cusco, Peru, and in the
second scenario, travelers from one country, Netherlands, travel to four different destinations viz.
North Africa, East Africa, Southeastern Asia and South Asia. Chapter 3 focuses on the first
scenario where I applied high-throughput experimental methods combined with computational
approaches to study the short-term changes in the gut microbiome during travel and impact of
disease state like diarrhea on the gut composition and function. I specifically focused on the
changes in the microbiome, resistome and diarrheagenic isolates derived from the longitudinal
samples of the travelers in Peru. Through this work, I showed that the baseline microbiome
diversity is important for overall stability of travelers’ microbiome during travel. I also specifically
looked for the short-term and long-term changes associated with diarrhea event. The travelers who
experience diarrhea during their stay, not only experience more divergence from their baseline
sample but also tend to acquire more resistance genes which leads to overall increase in the
resistome in post-diarrhea samples. In the diarrhea samples, the enrichment of resistome was found
to be closely associated with the change in abundance of Enterobacteriaceae family. In Chapter
4, we focused on the second scenario where we studied changes in the resistome of 190 Dutch
travelers when they travel to high infectious burden regions by comparing their pre- and posttravel samples. Using the high-throughput pipeline described in Chapter 2, we characterized the
resistome and showed that travelers acquire significantly large number of AR genes in their posttravel samples. We found that the destination plays a key role in defining the travelers’ resistome,
where travelers to a one location share significantly similar resistome post-travel compared to their
pre-travel state. The study also showed that Southeastern Asia travelers acquired most AMR gene
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families compared to other travelers, and several high-risk AR genes (e.g. mcr-1, blaCTX-M-1) were
borne on mobile genetic elements, highlighting the potential risk of global spread of the locally
endemic AR genes.
Antimicrobials are extensively used for growth promotion and disease protection in
approximately 60 to 80% commercial agricultural livestock raised in the US55. This indiscriminate
use of antimicrobials brings agricultural workers at risk for potential long-term health effects from
occupational exposure to AR microbes. To understand how exposure to such workplaces impact
the gut microbiome composition and function, we studied the microbiome and resistome dynamics
of fourteen healthy students who visited the confined and controlled swine farms for three
consecutive months and were sampled before-, during and after their visit in China in Chapter 5.
Longitudinal investigation showed extensive sharing of AR genes and microorganisms after
exposure to the swine farm environment. The study found several evidences of plasmid-borne AR
genes that were borne on mobile genetic elements, pointing towards potential risk of horizontal
gene transfer events. We also noted that the microbiome and resistome shift observed in students
during their regular visits were partially reversed within four to six-month period post-travel to the
swine farms. Although the antibiotics and the defense mechanisms adopted by bacteria to combat
them are ancient, the spread of AR is steadily rising since the introduction of antibiotics in
agriculture and medicine. To understand the impact of human exposure and how primate
microbiota have changed in the antibiotic era, we investigated the resistome of wild and captive
baboon population in the Chapter 6. We found that there is resistome expansion among captive
baboons compared to the wild-type counterparts. Also, the captivity and lifestyle changes
associated with human contact can lead to marked changes in the ecology of primate gut
communities.
15

In this thesis, I demonstrated the impact of different anthropogenic activities viz.
international travel, livestock farming and animal captivity on the microbiome and resistome of
the host, and how these activities perturb the gut microbial ecosystem.
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Chapter 2: Computational methods and
resources to study antibiotic resistance
Antimicrobial resistance extracts high morbidity, mortality, and economic costs yearly by
rendering bacteria immune to antimicrobials. Identifying and understanding antimicrobial
resistance is imperative for clinical practice to treat resistant infections and for public health efforts
to limit the spread of resistance. Technologies such as next-generation sequencing are expanding
our abilities to detect and study antimicrobial resistance. This Chapter provides a detailed overview
of existing computational resources for antimicrobial resistance genes along with functional
metagenomics approach used to identify and characterize novel resistance genes. The functional
metagenomics method has been extensively implemented in this thesis and outside to understand
the resistome dynamics across different habitats and environment. Here I have discussed the major
outcome we learnt by the implementation of the functional metagenomics approach on two
different perturbation events: international travel and agricultural livestock farms.

2.1 Introduction
Antimicrobials are small molecules that can inhibit or kill bacteria. These small molecules
are commonly used as therapeutics for bacterial infections, but some bacteria can grow and survive
despite antimicrobial pressures. This property is called antimicrobial resistance. In clinical
settings, resistant bacterial infections decrease available treatment options and increase morbidity
and mortality compared with susceptible bacteria56-60. Resistance is observed against nearly all
antimicrobials (Fig. 1A and 1B), including so-called ‘last-resort’ antimicrobials used in lifethreatening multidrug-resistant infections61-65. Bacteria resistant to first-line antimicrobials infect
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2 million people in the United States yearly, and these exact a 20 billion dollar healthcare cost6668

. This problem is not isolated to the United States. In the European Union, antimicrobial

resistance accounted for over 30 thousand deaths and nearly 900 thousand disability-adjusted lifeyears69. In fact, multiple national and global public health organizations categorize antimicrobial
resistance as an imminent danger and uniformly agree that tracking its emergence and prevalence
is critical to minimize the threat to human health69-72. Antimicrobial susceptibility testing (AST)
is the traditional method for assaying antimicrobial resistance in bacteria. These culture-based tests
determine how well bacteria can grow in the presence of antimicrobials. AST is widely used in
hospital clinical microbiology laboratories because it provides actionable phenotypic resistance
data to guide patient treatment decisions. Though culture-based resistance determination can
provide critical information for patient management and resistance gene epidemiology, it has
drawbacks in implementation and information content73. Conducting AST requires microbiology
facilities and trained clinical microbiology personnel for accuracy. Additionally, AST is only
viable for cultivable bacteria, precluding studies on the emergence and spread of antimicrobial
resistance in diverse and complex microbial communities with large fractions of currently
uncultured bacteria74.
Bacterial antimicrobial resistance is usually genetically encoded (Fig. 2.1C). Genetically
encoded antimicrobial resistance can occur through several mechanisms, including overexpression
or duplication of existing genes, point mutations or the acquisition of entirely new genes via
horizontal gene transfer (HGT). Improvements in next-generation sequencing technologies and
computational methods are facilitating rapid antimicrobial resistance gene identification and
characterization in genomes and metagenomes. These developing technologies and methods
complement traditional culture-based methods for clinical and surveillance applications and
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provide opportunities for quick and sensitive resistance determinations in cultivable and
uncultivable bacteria. Large-scale and comparative studies of human, animal, and environmental
samples have provided unprecedented insights into the global distribution of antimicrobial
resistance genes and spread of multidrug-resistant bacteria42, 75-78, resistance exchange networks
79

, and how different habitats and phylogeny affect the evolutionary dynamics of antimicrobial

resistance worldwide80. Understanding and surveying the genetic determinants of resistance using
sequencing data poses unique challenges that are being addressed by improved computational
algorithms that organize genomic data and predict antimicrobial resistance and by improving in
vitro sequencing modalities.
Here we discuss the strengths and weaknesses of current and emerging methods for
studying resistance, including computational strategies and resources for resistance gene
identification in genomic and metagenomic samples. We also describe recent advancements to
mitigate weaknesses in resistance detection methods, and we highlight areas requiring greater
focus.

2.1.1 Sequence-based resistance discovery
Advancements in sequencing technologies have increased bacterial sequence data
availability, and continually decreasing costs have made sequencing a viable antimicrobial
resistance surveillance tool. Several methods and tools have been published in recent years for
detecting genetic determinants of antimicrobial resistance from whole-genome sequencing (WGS)
and whole-metagenome sequencing (WMS) data (Table S2.1). Organizing sequencing data is an
important pre-processing step before antimicrobial resistance gene analysis. Short reads, generated
by technologies such as Illumina, can either be processed using assembly-based methods, whereby
sequencing reads are first assembled into contiguous fragments (contigs) and then annotated by
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comparing with custom or public reference databases, or directly analysed using read-based
methods, where resistance determinants are predicted by mapping reads directly to a reference
database (Fig. 2.1).

Figure 2.1: Antimicrobial targets and resistance mechanisms. a) Antimicrobials are grouped by target site. Drug
classes are in bold, and example drugs from that class are in parentheses below the drug classes. Antimicrobial
resistance mechanisms that act on that class are depicted left of the antimicrobial class according to the layout
shown in part b. b) Mechanisms of antimicrobial resistance are depicted with susceptible organisms represented
on the left and resistant organisms represented on the right. To the left of each labelled mechanism is the legend
annotation position used in part a. c) Genetic underpinnings of antimicrobial resistance are illustrated.
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2.1.1.1 Assembly-based methods
The de novo assembly of WGS of bacterial genomes from short-read data is generally
performed by De Bruijn graph (DBG)-based assemblers such as SPAdes81, Velvet82, ABySS83,
and SOAPdenovo84. In this approach, sequencing reads are divided into shorter overlapping subsequences (called ‘k-mers’) of length k (where k < read length) and are used to form a network
graph. The assemblers then reconstruct the genome sequence by finding an optimum path (Euler’s
path) through the graph that visits each edge once (see Ref85 for more information on DBG-based
assembly). Although the DBG approach is computationally efficient in handling high volume
sequencing data, it is greatly affected by errors introduced during sequencing86. Errors in
sequencing data introduce false k-mers in the graph, resulting in fragmented assemblies. Several
assemblers (e.g., SPAdes and Velvet) heuristically eliminate these errors prior to finding a Euler’s
path in the graph85, 87. Assembling WMS data is more complicated than single-isolate assembly
(Fig. 2.2), since the algorithms need to account for unknown abundances of different organisms
with unknown phylogenetic relationships86. In single-genome assembly, uniform sequencing
coverage across the genome is used by assemblers to correct sequencing errors and to identify
repetitive sequences and plasmids (Several assemblers exploit the higher coverage of plasmids due
to copy number to distinguish between chromosome and plasmid sequences in isolate genomes8891

), but uneven coverage of different organisms in WMS data makes detecting repeats difficult.

Long stretches of identical sequences in unrelated species further complicate assembly by making
it difficult to assign reads to a particular species. Thus, algorithms developed for single-genome
assembly cannot be directly applied to assemble metagenomes. Several metagenome-specific
assemblers have been developed to overcome these challenges either by partitioning or optimizing
the graph for uneven sequencing depths.86 Some notable metagenomic assemblers are IDBA-UD92,
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MEGAHIT93, MetaSPAdes94, and MetaVelvet95 (extensions of SPAdes and Velvet for
metagenomes). The CAMI project96, now starting its second iteration97, seeks to benchmark these
assemblers on highly complex and close to real datasets for users. However, currently there is no
single assembler that stands out as the best one that would accurately reconstruct known genomes
and capture majority of the taxonomic diversity in real datasets. Both biological factors (such as
sample source, microbial community structure) and technical factors (such as library preparation
method, sequencing-depth, sequencing platform choice) affect the ability of an assembler to
generate accurate and larger contigs. Thus, it is recommended to apply multiple assemblers on a
subset of samples to determine the best fit for a given dataset.
Following assembly, genomic or metagenomic contigs are annotated for resistance
determinants by predicting protein-coding regions on contigs and then comparing them against
antimicrobial resistance reference databases using similarity-based search tools (e.g., BLAST98,
USEARCH or DIAMOND99). Although pairwise alignment between the query and antimicrobial
resistance reference sequences is the most commonly applied approach for characterizing the
resistome from contigs, an inherent bias of databases towards human-associated organisms is
reflected in prediction outputs, so choosing the appropriate databases to compare assembled
contigs with reference sequences is imperative100.
Given sufficient coverage, assembly-based methods can construct whole genomes or large
contigs with protein-coding genes, regulatory sequence information, and the complete surrounding
genomic context. This information can be utilized to study co-associated genes and biological
pathways that are involved in resistance determination. Assembly and annotation of WMS data
can identify antimicrobial resistance genes that are more divergent and lack homology to known
sequences in the reference databases. However, the process of de novo assembly and annotation is
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computationally expensive, time-consuming and requires higher genome coverage than referencebased assembly or read mapping based methods, which can be difficult to achieve for all samples,
specifically when dealing with metagenomic samples with high microbial diversity and uneven
taxonomic composition.

2.1.1.2 Read-based methods
Antimicrobial resistance genes in a sample can be detected without genome
assembly, where reads are aligned directly to the reference databases using Bowtie2101 or BWA
and the presence of antimicrobial resistance genes is predicted on the basis of mapping results.
This approach is generally fast and less computationally demanding since it bypasses de novo
assembly, protein-coding gene prediction, and pairwise alignment to public databases. For this
reason, read-based methods have gained traction in recent years, especially in clinical diagnostics
where conducting real-time sequencing-based resistance prediction is crucial.
SRST2102 is one widely used tool that aligns reads to a custom reference database using
Bowtie2 to predict antimicrobial resistance genes in the sample. Alternatively, KmerResistance103
splits reads into k-mers, maps them and counts the co-occurrence of k-mers between reads and
reference database to predict resistance genes and associated species. Both methods can identify
antimicrobial resistance genes even in the presence of contaminants (e.g. background noise in the
raw reads due to the presence of laboratory or host contamination) and in samples for which
insufficient reads are available for de novo assembly, but they cannot predict antimicrobial
resistance conferring single nucleotide polymorphisms (SNPs). By contrast, ARIBA104 uses a
hybrid approach where reference sequences in the database are first clustered using CD-HIT105
and then sequences from each cluster are assembled independently. Resulting contigs are then
compared to the closest reference to identify allelic variants. Additionally, ARIBA provides
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information on whether genes are complete or fragmented and reports sequence variants along
with their potential effects (e.g., missense, nonsense or frameshift mutations and small insertions
and deletions (indels)). Clustering reference sequences and using a representative sequence from
the cluster to map reads considerably reduces ambiguous alignments106, but using a single linear
representative locus masks subtle yet important variation between sub-types and sub-families of
genes within clusters.106, 107 To account for this information loss, GROOT108, a newly established
tool for resistome profiling of metagenomes, builds a variation graph for reference gene sets and
aligns sequence reads to these graphs. Variation graphs are bidirectional acyclic sequence graphs
that represent overall sequence variation within a given population. The alignment of reads against
variation graphs effectively removes reference bias and facilitates accurate annotation of
antimicrobial resistannce genes. Before aligning sequences against a variation graph, traversals
within the graphs are indexed by either Burrows Wheeler transform or hash-map (minHash),
indexing algorithms that significantly improve the mapping rate of large-scale sequencing reads
to the graphs.101, 109
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Figure 2.2: Assembly versus read mapping. a) The process for sequencing data generation for metagenomic and
genomic samples. b) Steps for the read-based and the assembly-based methods of in silico resistance gene
identification are contrasted. c) Examples of analysis that can be conducted on samples after resistance gene
identification. CARD, Comprehensive Antibiotic Resistance Database.

2.1.1.3 Choosing the right approach
Presently, there is no consensus on which sequence analysis approach is better, and
the choice of analysis mainly depends on the type of sequencing (WGS versus WMS), availability
of computational resources and study objective. Both approaches have trade-offs, since assembly
causes information loss compared to direct read analysis110, but allows for identification of protein
coding genes and for investigation of upstream and downstream regulatory elements, whereas
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direct read analysis lacks the positional information required to analyze upstream and downstream
factors of identified resistance genes. New sequencing technologies, such as long-read sequencing
and chromosome conformation capture-derived assays, are helping to alleviate this information
loss by improving assembly fidelity.
The read-based approaches scale well with ever-increasing query sequences and
antimicrobial resistance reference data. More importantly, they allow identification of
antimicrobial resistance genes from low-abundance organisms present in complex communities,
which may be missed by assembly-based methods due to incomplete or poor assemblies. However,
mapping reads directly to large data sets can inflate false-positive predictions, since reads derived
from protein-coding sequences may spuriously align to other genes as a result of local sequence
homology.111 Also, read-based antimicrobial resistance gene detection largely depends on the
completeness and comprehensiveness of the reference databases to which query sequences are
mapped. In read-based methods, resistance genes that are present in the reference databases are
usually detected by exact matching of k-mers (only antimicrobial resistance genes in the reference
databases are detectable). Thus, it is important that the reference databases are comprehensive and
contains all variants of the reference genes. Database choice is especially critical when identifying
antimicrobial resistance genes from large and complex communities such as soil and ocean, as
novel or distant homologues of antimicrobial resistance genes present in under-studied, less
characterized environmental communities may be missed.
Well-studied sample types, such as the human gut, are now extensively characterized, even
for low-abundance microbes, and thus read-based approaches can be more confidently applied.112
However, analysis of diverse samples is confounded by the lack of reference sequences, so the
antimicrobial resistance genes in these environments are likely underestimated. To address this
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problem, ShortBRED (Short, Better Representative Extract Dataset)113, a marker-based method
was developed that enables fast and accurate profiling of the resistome in metagenomic data sets.
ShortBRED first identifies ‘marker’ sequences (short peptide sequences) representative of
antimicrobial resistance protein families from the reference database and then maps reads to these
markers to quantify the relative abundance of the associated antimicrobial resistance protein
families. Several studies have applied this method to quantify the abundance of resistance genes
in large and complex metagenomic data sets, including human79, 114, animal115, and environmental
data sets116. Downstream analysis of resistomes from metagenomic samples can be performed
similar to taxonomic and functional profiling. A comprehensive discussion on processing and
analysing metagenomic samples can be found in Ref.112.

2.1.2 Antimicrobial resistance databases
Both assembly-based and read-based approaches for the computational prediction of
antimicrobial resistance in pathogens and environmental bacteria depend largely on curated
antimicrobial resistance gene databases that link known genetic determinants of resistance to the
antimicrobials they confer phenotypic resistance against (Table 2.2). These databases usually
represent information accumulated from multiple studies that include AST of bacteria harbouring
specific antimicrobial resistance genes.

2.1.2.1 Generalized versus specialized databases
Public databases vary considerably in the scope of resistance mechanisms that they cover
and in the type of information they provide for annotations. Generalized antimicrobial resistance
databases, such as the now archived Antibiotic Resistance Gene Database (ARDB)117, or the active
Antibiotic Resistance Gene Annotation (ARG-ANNOT)118 and Comprehensive Antibiotic
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Resistance Database (CARD)119, cover broad spectrums of antimicrobial resistance genes and
mechanism information, whereas specialized antimicrobial resistance databases provide
comprehensive information for specific gene families or species. For example, targeted databases
such as Lactamase Engineering Database (LacED)120, 121, Lahey database of β-lactamases122, NCBI
β-lactamase Alleles Initiative, and the Comprehensive β-lactamase Molecular Annotation
Resource (CBMAR)123 focus on β-lactamases, a family of antimicrobial resistance enzymes that
facilitate hydrolyzation of the key β-lactam rings in β-lactam antimicrobials, thus protecting the
bacteria from the antimicrobial activity. Resfinder124 is a web-based and standalone tool for
detecting acquired antimicrobial resistance genes from sequenced or partially sequenced bacterial
isolates. Unlike other databases that require contigs as an input, Resfinder124 also accepts short
reads as input for comparison against known acquired resistance genes in bacterial genomes. In
2017, Resfinder124 updated their web-based service to allow identification of chromosomal
mutations using PointFinder125. However, the identification of antimicrobial resistance-conferring
chromosomal mutations is only available for a limited set of pathogenic microbes (Campylobacter,
E. coli, M. tuberculosis, Neisseria gonorrhoeae, Plasmodium falciparum and Salmonella). Similar
to Resfinder124, CARD119 offers its own tool, known as RGI (Resistance Gene Identifier), which
uses curated antimicrobial resistance detection models to predict intrinsic antimicrobial resistance
genes, dedicated resistance genes and acquired resistance from mutations in drug targets. RGI uses
two antimicrobial resistance detection models: Protein Homolog Model for detecting functional
homologues of antimicrobial resistance proteins, and Protein Variant Model for the detection of
mutations conferring antimicrobial resistance in otherwise sensitive targets. ARGs-OAP(v2)126
uses a custom database constructed from ARDB117 and CARD119, called SARG, with a hybrid
UBLAST and BLASTX algorithm, reflecting the critical need for a comprehensive database
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combined with lower identity matching for antimicrobial resistance gene annotation of
metagenomic sequence data.
Species-specific databases exist for pathogenic or model bacteria such as Mycobacterium
tuberculosis (e.g. Tuberculosis Drug Resistance Database127 or MUBII-TB128), and Escherichia
coli. These species-specific databases are invaluable for understanding resistance in these specific
organisms but also highlight the importance of considering antimicrobial resistance genes in their
phylogenetic context, especially as some bacteria can have intrinsic resistance to some
antimicrobials (see Ref.129 for more information).129 Species-centric databases enable rapid and
effective curation of new antimicrobial resistance genes and chromosomal mutations and can offer
quick preliminary screening for characterization. Such screening has proved highly effective for
pathogens such as M. tuberculosis where HGT events are rare and drug resistance originates
mainly from chromosomal mutations.130 The CRyPTIC Consortium and 100,000 genomes project
demonstrated this effectiveness in M. tuberculosis with resistance predictions with over 90%
sensitivity and specificity for all four first-line anti-tuberculosis drug.131
While these tools are all steps in the right direction, a continuously updating and
comprehensive database with extensive gene metadata and ability to find both point mutation
matches and remote homologues is needed.

2.1.2.2 Hidden Markov Model-based databases
One major limitation of these databases is that the antimicrobial resistance genes they
contain are heavily biased towards human pathogens and easily cultivable model organisms,
making it difficult to identify remote homologues or novel resistance sequences present in
fastidious or uncultured bacteria.132 This bias complicates antimicrobial resistance gene
identification across less commonly studied bacteria, a difficulty that is magnified by the diverse
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and complicated mechanisms that cause resistance.133 One potential solution to overcome this bias
is to use hidden Markov model (HMM) databases. Derived from the multiple sequence alignment
of known sequences, an HMM can find sequences with similar function but low sequence
identity.134 Resfams80 is an HMM database of antimicrobial resistance proteins derived from
multiple sequence alignment of manually curated sets of representative antimicrobial resistance
protein sequences obtained from the generalized CARD database, and the specialized LacED121
and Lahey databases122. The authors of the Resfams80 database showed that it can identify a
substantially greater number of novel antimicrobial resistance genes and remote homologues of
known antimicrobial resistance genes in contrast to other databases such as ARDB and CARD that
rely on BLAST-based methods for gene identification. A direct comparison of manually-curated
antimicrobial resistance gene sets showed that Resfams80 identified 64% more antimicrobial
resistance genes in both soil and human gut microbiota compared to the pairwise-alignment
(BLAST)98 based search of CARD and ARDB. This increased sensitivity demonstrates the
HMM’s versatility in annotating sequences from non-clinical samples with sparser representation
in publicly available resistance gene databases. However, HMM-based approaches may have poor
specificity (yield higher number of false positive hits) and may not be able to distinguish between
protein families with closely related functions. This could occur due to the higher probability of
selecting sequences from other subfamilies based on domains common to the family. To mitigate
the lack of specificity, Resfams80 (like the Pfam database) uses curated thresholds (e.g., gathering
threshold) for each profile HMM. These profile-specific gathering threshold values set an
inclusion/exclusion bit score cutoff by comparing it to test datasets containing negative sequences.
Currently, Resfams80 contains 166 profile HMMs that represent major antimicrobial resistance
gene families. HMM-based antimicrobial resistance databases could be valuable in identifying
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large and diverse arrays of resistance determinants in under-studied environmental samples
compared to BLAST-based databases. However, current HMM-based databases do not identify
resistance arising from chromosomal mutations. To further facilitate the detection of antimicrobial
resistance genes in large complex environments, the Functional Antibiotic Resistant Metagenomic
Element (FARME)135 database comprises a curated set of microbial sequences excluded from
current databases but functionally screened to confer resistance in various functional
metagenomics studies of different habitats. Apart from predicted protein-coding antimicrobial
resistance sequences, the FARME database also includes regulatory elements, mobile genetic
elements and predicted proteins flanking antimicrobial resistance genes.
A similar database, the functional resistance database (ResfinderFG)136, was built by
aggregating data from four functional metagenomics studies selected against 23 antimicrobials.
With this database compared to the Resfinder124 database, the authors noted they found different
results by total antimicrobial use; this may represent a difference in how resistance is conferred
when putative resistance determinants are cloned into E. coli as compared to expressed in their
native bacterial host.
The Mustard137 antimicrobial resistance determinants database used an innovative
approach of incorporating three-dimensional protein structure to help predict resistance genes.
When this approach was applied to predicted proteins from metagenomic samples, it predicted
over 6,000 resistance genes compared to 67 by BLASTP and 50 by Resfinder124, suggesting higher
sensitivity.
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2.1.3 Functional metagenomics
In addition to sequence-based metagenomics, functional metagenomics is a powerful,
culture-independent, sequence-unbiased approach for characterizing resistomes138,

139

. In this

method, the metagenomic DNA derived from environmental or fecal samples is isolated, sheared
into the fragment size of 2 – 5 Kb and cloned into an expression vector to generate a metagenomic
library. The library is then transformed into the host strain (e.g. Escherichia coli) to generate
transformants that are grown on the selective media consisting antibiotics. This assay is lethal for
the wild-type host and selects for the recombinant, antibiotic resistant transformants. The selected
inserts from the surviving recombinants, antimicrobial resistant host cells are then sequenced, and
resulting sequences are subsequently assembled and annotated (Fig. 2.3). The complete analysis
for resistome annotation is enabled by combination of custom built pipelines like PARFuMS
(Parallel Annotation and Reassembly of Functional Metagenomics Selection)13, resAnnotator
pipeline and ShortBRED140 (discussed below in Methods section). This approach allows highthroughput analysis of large genomic content (up to 50 Gbp of unique metagenomic DNA
interrogated per library), and antimicrobial resistance phenotypes can be directly associated with
causative genes, obviating the need to culture individual antimicrobial resistance gene carriers.
Functional metagenomics has enabled the discovery of several new antimicrobial resistance
mechanisms and their related genes141. One such example is the recently discovered tetracycline
resistance mechanism by tetracycline destructases142, whereby soil functional metagenomics led
to the discovery of nine genes that confer tetracycline resistance through enzymatic inactivation.
Further analysis and biochemical characterization revealed that these enzymes catalyze
tetracycline oxidation in a FAD-dependent manner, thereby inactivating tetracycline142.
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Figure 2.3: Functional metagenomics to interrogate acquired resistances genes in different environments
and human pathogens. A summary of experimental and computational steps involved in functional
metagenomics. First, sample collection and extraction occur. Metagenomic DNA is isolated from the sample
(for example, soil or faeces). Second, functional selection using an expression vector and the host system is
performed. The metagenomic DNA is sheared to a target size of 2–5 kb, and the fragments are then cloned
into an expression vector and transformed into a host system (for example, Escherichia coli). The
transformants are then selected using antimicrobials at concentrations that are inhibitory to the wild-type
host system. Third, barcoded sequencing of pooled DNA fragments is performed. The resistance-conferring
fragments are PCR amplified, barcoded and pooled together for sequencing. The sequencing reads are
computationally demultiplexed using barcode assembly and quality trimmed to obtain high-quality clean
reads. Fourth, iterative assembly of sequencing reads by sample is performed. The clean reads are assembled
with computational pipeline Parallel Annotation and Reassembly of Functional Metagenomic Selections
(PARFuMS), in which ensemble-based assembly is performed using multiple rounds of a short-read
assembler (Velvet), and intermediate contigs are then used in a long-read assembler (Phrap) to give fulllength contigs. Finally, resistance gene annotation of assembled reads is performed. The annotation of
contigs is accomplished using BL AST-based and Hidden Markov model (HMM)-based databases.

While the preceding study shows the strength and usefulness of functional metagenomics
studies, this approach has certain limitations. For example, a gene has to be functional outside its
native microbial host to be identified by functional metagenomic selections. Many times,
differences between a recombinant expression host such as E. coli and the original host (e.g., some
Gram-positive organisms) do not confer the same phenotype for the same gene. This problem was
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highlighted by studies showing effects of different hosts on the same metagenomic libraries.143, 144
Thus, there is a need to include a phylogenetically diverse group of hosts that can be used for
functional metagenomic selections. Also, genes outside their genomic context, such as syntenic
regulatory elements, may have different phenotypes in the recombinant expression host than the
original host145. Thus, it is important that novel antimicrobial resistance genes identified by
functional metagenomics screens be characterized microbiologically and biochemically.

2.2 Methods
As previously mentioned, the high-throughput characterization of resistome from
functional metagenomics reads is performed by custom built pipelines using PARFuMS,
resAnnotator and ShortBRED. PARFuMS13 takes sequencing reads obtained from functional
metagenomics as input and performs ensemble-based assembly using Velvet82 and Phrap146 to
generate full length contigs. Subsequently, resAnnotator is used to identify and annotate the
resistance genes on the PARFuMS generated contigs. resAnnotator predicts ORFs using genefinding algorithm Prodigal147, and annotate the newly identified genes through hierarchical
comparison with curated resistance gene databases using BLAST and HMM. Together, the newly
identified resistance genes and the curated gene list from resistance databases, are used to create
high precision sequence markers specific to resistance gene families using ShortBRED. These
sequence markers are then manually curated and used to quantify AR gene families in the
metagenomic samples.
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2.2.1 PARFuMS and resAnnotator pipeline to identify novel resistance genes
PARFuMS was first implemented in 2012 to analyze soil microbiome on a small sample
set13, however its adaptation to updated assembly methods, optimization to process large scale
datasets and modularization to generate a complete computational workflow was part of this thesis
work. The pipeline was adapted for high-throughput data processing on the SLURM based
environment with several parameters (originally hard-coded) that are now modifiable by users
based on the dataset under analysis. The pipeline is modularized such that it can be initiated from
five different steps given that interim input files are available. Since assembly programs are
computationally intensive and their failure at any step would require the complete pipeline to run
from the beginning, modularization of the PARFuMS pipeline helped save the associated cost and
enable users to reinitiate the pipeline from the previous drop-off step.
PARFuMS is an ensemble-based assembly approach that was designed to reduce the
number of short-length contigs and generate nearly complete resistance conferring fragment that
can be further characterized for resistance genes13. In this approach, the Illumina paired-end reads
obtained from the functional selections are first de-multiplexed based on their sample-specific
barcode sequence, and are cleaned for the potential adapter and vector sequence. The clean reads
are first assembled into intermediate length contigs using three iterations of Velvet82 program. The
first iteration uses all reads for contig assembly, while the second and third iterations assemble
contigs using reads that were not present in the previously assembled contigs. Following each
round of assembly, redundant contigs are collapsed to one group and a representative contig is
chosen using CD-HIT105 and potential chimeras are removed using FR-HIT148. Subsequently, the
two iterations of long read assembler, Phrap146 assembles the non-redundant intermediate length
contigs to the full length contigs. The first iteration assembles the Velvet output into more complete
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contigs that are linked together if two contigs are bridged by sufficient number of raw reads. The
second iteration then used these linked contigs to provide the nearly complete sequence of
resistance conferring DNA fragment (Figure 2.3). PARFuMS, initially published as in-house
pipeline, is now available at the Github (Github link) and can be used by the scientific community
under the open source license agreement.
PARFuMS regenerates the near complete sequence of resistance conferring DNA
fragments that are filtered based on the contig length (>500 bp) and N50 value. The next step in
the process of generating the resistome profile is to identify and label the resistance conferring
genes in the full-length contig sequences. Several databases (discussed in the Introduction) allow
BLAST-based and HMM-based searches with modifiable parameters that allow characterization
of resistance genes, however, it is important that the database selected for gene characterization is
complete and true representative of the samples under analysis. BLAST-based searches offered by
curated resistance gene databases like CARD149 and Resfinder124 provide high specificity but lacks
sensitivity to capture all potential resistance genes. Also, these databases are enriched for
resistance genes mainly observed in the clinical settings. On the other hand, HMM-based databases
like Resfams80 are specifically designed to capture remote homologues of resistance genes,
however they are limited by their specificity. The HMM-based approach become especially critical
when identifying antimicrobial resistance genes from diverse habitats like soil, ocean and other
environmental samples, as novel and distant homologues of antimicrobial resistance genes from
such samples are understudied and can get easily missed80. Also, characterizing the same set of
contigs through multiple databases, addressing the conflicting annotation and coherently
compiling the resistance gene annotation is cumbersome and error prone task. To address these
issues, we developed a hierarchical approach that first take advantage of the specificity offered by
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BLAST-based search of curated resistance genes databases and annotates the remaining
uncharacterized genes using HMM-based databases that are efficient in identifying the remote
homologues. This process is achieved by resAnnotator pipeline, a linux-based command line
software tool that coordinates a hierarchical search through a suite of curated resistance databases
using BLAST and HMM program. In this approach, the filtered full length contigs from
PARFuMS are first parsed by the gene finding algorithm, Prodigal147 which predicts the potential
open reading frames (ORFs) in the sequence. The complete ORFs, marked by start and stop
codons, are translated into amino acid sequences and compared with the five resistance gene
databases in a hierarchical order. At each step, translated ORFs with significant match are retained
for the final output and the uncharacterized ORFs are forwarded to the next level for comparison
(Fig. 2.4). By default, the e-value threshold of 10-6 was used for each database to filter the
significant hits. The first database in this hierarchical pipeline is the CARD database149, a highly
curated compilation of characterized AR genes, their products and the associated antibiotics. Using
BLAST-based search, translated ORFs were compared with the CARD database and sequences
with >95% sequence identity and >95% coverage (blastp parameters) were retained for the final
output while the uncharacterized ORFs were passed to the ResFinder database. ResFinder124 is
also parsed and compared using the BLAST program using the similar thresholds (blastp
parameters). The significant hits are saved for final output while remaining characterized ORFs
are passed to our third in line AR gene database, NDARO (National Database of Antibiotic
Resistant Organism) (latest version available at NCBI website). NDARO offers a centralized
source of information on antimicrobial resistance pathogenic organisms, which includes a curated
database of AR genes. Using similar BLAST parameters, we compared this database against the
uncharacterized ORFs, retaining the significant matches and forwarding the rest to the first HMM
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based database, NCBI-AMR (latest version available at NCBI website). NCBI-AMR is a curated
database of protein families that are confirmed for antibiotic function and are represented in the
database by the HMM profiles. Using hmm-search enabled by HMMer program, the
uncharacterized ORFs that significantly matches with AMR-HMM profiles are annotated
accordingly, while the unassigned ORFs are passed to the second HMM database, Resfams. Like
NCBI-AMR, Resfams80 is also a curated database of HMM profiles of AR protein sequences.
There are two types of Resfams database – Resfams-core and Resfams-full. Resfams-core HMM
profiles are built using AR protein sequence from the CARD149, the Lactamase Engineering
database121 and Jacoby and Bush’s collection of curated beta-lactamase proteins122. The Resfamscore database is further supplemented with additional profiles HMMs of protein families that
specifically contribute towards resistance genes from Pfam and TIGRFam databases, to form
Resfams-full database. For the resAnnotator pipeline, we used the Resfams-core database HMM
profiles to annotate the unassigned ORFs that significantly matches with the HMM profile. Finally,
the characterized resistance genes from each step are compiled into a single file with the annotation
information and the AR gene database that provided the annotation. The program also generates a
separate fasta file with uncharacterized translated ORFs sequence.

2.2.2 ShortBRED marker database
As mentioned earlier, the main purpose of obtaining the functionally validated resistance
genes is to enable the resistome annotation across all metagenomic samples. To achieve this, we
used the ShortBRED140 program, a pipeline that takes protein sequence as input, group them into
families, build a “marker” database by generating highly specific sequence markers for each family
and use the “marker” database to identify and quantify the abundance of protein families of interest
in the metagenomics samples. In this study, we aimed to build a comprehensive and highly
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inclusive AR gene “marker” database that captures the resistance genes derived from diverse
habitats and non-clinical samples. To this end, we processed sequencing reads derived from
fourteen independent functional metagenomics studies using the PARFuMS and resAnnotator
pipeline.
These studies (listed in Table S2.3) obtained the metagenomic samples from diverse
habitats and environments, ranging from community samples (humans, animals and environmental
samples) from a shantytown in Peru79 to community samples from a swine farm in China150,
samples provided by international travelers with travel destinations in high infectious burden
regions to samples from NICU infants151. Together, these 13 studies provide a wide array of AR
gene families that are observed across different ethnicity, nations, habitats and environment. In
total, we obtained 15,437 AR genes from these studies that were subsequently combined with
CARD and NDARO database to build a comprehensive AR gene database. Further, AR gene
families “marker” database is built from the AR gene database using shortbred_identify.py
program with following changes in the default parameters: -ref: Uniref90.fasta and -clustid 0.95.
The ShortBRED marker list consists 6,594 markers for 2,314 ARG gene families. These marker
gene families were then manually curated based on the following criteria to minimize the number
of false positives in the study. This includes:
1.

genes associated with global gene regulators, two-component system proteins, and

signaling mediators (e.g. blaZ, vanS-vanR, mecI, mepR, gadW, marR),
2.

genes encoding subunits that are part of multiple efflux pumps (e.g. tolC, oprM, opmD),

3.

confers resistance via mutation in genes (e.g. resistance to antifolate drugs via mutations

in dhfr, resistance to rifamycin via mutation in rpoB),
4.

genes conferring resistance by modifying cell wall charge (e.g mprF),
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5.

genes that reduce permeability (omp38, tmrB) or confer resistance through overexpression

(e.g. Thymidylate synthase), and
6.

general efflux pumps that came through functional selections (MFS-type, ABC-type)
The highly precise gene markers from filtered set of 2,314 ARG gene families were then

used to quantify the abundance of ARGs across all metagenomics samples using
“shortbred_quantify.py” with default set of parameters. In my thesis and future studies in the lab,
all subsequent functional metagenomics analyses and resistome quantification were performed
using this AR database.

2.4 Conclusions
The rampant use of antimicrobial in humans, animals and environmental sectors has lead
the global expansion of antibiotic resistance at the unprecedented rate. International travel to high
infectious burden regions, indiscriminate use of antibiotics in agriculture and animal sectors, and
repeated use or occupational exposure at workplace like swine or dairy farm are some of the
exemplary events that have direct and indirect effects on the human health and physiology. In this
thesis, I endeavored to understand the effect of these perturbations on the microbial communities,
such as human gut microbiota and resistome (Chapter 3, 4, and 5), and whether such
anthropogenic perturbations have promoted the evolution and spread of antibiotic resistance
(Chapter 6). Thus, it was imperative to conduct a comprehensive evaluation of changes in the
resistome during these events. To accomplish this goal, I first developed and optimized the
computational pipelines (described above) for comprehensive identification and characterization
of antibiotic resistance genes from 14 independent functional metagenomics studies previously
published from our lab. Then, by incorporating AR sequences from known curated databases
(CARD, NCBI-AMR) and functionally validated AR genes, I built a highly curated custom AR
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“marker” database using ShortBRED and used this database to study the resistome dynamics in
diverse microbial communities. Below is the summary of resistome analyses and findings in this
thesis enabled by the unified pipeline of PARFuMS, resAnnotator and ShortBRED.
International travel is a unique setting where a sudden and prolonged exposure to different
diet, ecology and environment can significantly alter the microbiome and resistome of a traveler21.
Use of antibiotics, traveler’s diarrhea and their interplay with other factors further adds to the
complexity but their impact during the travel is largely unknown. To determine how international
travel to high infectious burden regions and enteric infections during the travel affect the AR
acquisition and abundance, we investigated the AR genes transmission dynamics in two
independent travelers’ cohort. The first cohort is of 190 Dutch travelers who traveled to four
different destinations, viz Northern Africa, Eastern Africa, Southern Asia and Southeastern Asia.
Metagenomic sequencing combined with functional metagenomics analyses of the samples
collected from these travelers before- and after-travel revealed destination specific resistome
signatures among the travelers, suggesting that same travel destinations make travelers resistome
more similar. In this study, we also found that Southeastern Asia travelers acquired most AMR
gene families compared to other travelers, and several high-risk AR genes (e.g. mcr-1, blaCTXM-1) were borne on mobile genetic elements, highlighting the potential risk of global spread of
the locally endemic AR genes (Chapter 4). While the above study defined how travel destinations
converged the gut resistome towards a unique signature, the second study delved into resistome
dynamics when travelers from different nations traveled to a single place. This cohort is comprised
of about 200 individuals who traveled from the US and European countries to a single location,
Cusco, Peru. Longitudinal samples from travelers were collected within two weeks of their arrival
and during the stay at Peru. Many travelers experienced diarrhea episode, referred as “Travelers
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with Diarrhea” (TD), who were treated with antibiotics or oral rehydration therapy, while others
who did not experience diarrhea are referred as “Healthy travelers” (HT) (Chapter 3). Previous
studies as well as our own, points to the significant role of international travel in AR gene
acquisition and their increased abundance among returning travelers, however the risk factors
attributing to this transmission during the travel, like enteric infections, antibiotic use for
prophylaxis or treatment, or baseline gut microbiome composition, are hardly assessed for their
effect on the resistome. The Peru travelers’ cohort enabled us to study these factors in real time
and quantify their effect on the gut resistome of travelers. Diarrhea event and substantial increase
in Enterbacteriaceae family were identified as major factors that were significantly associated
with the gain in unique AR genes and increased abundance. While the AR gene diversity reduces
in the post-diarrheal samples, the overall abundance of the genes remains unchanged, suggesting
a partial recovery from the effect of diarrhea event. Antibiotic use and duration of stay also
significantly affects the overall resistome structure. Overall, we found that diarrhea event and their
associated changes are major contributors of increased AR acquisition during travel.
In commercial agricultural industry, more than 80% of the livestock farms raised in US
land are treated with antimicrobials for growth promotion and disease prevention55. The
indiscriminate use of antimicrobials at these farms provide an ideal niche for emergence of
transmissible AR bacteria that can spread to the workers via occupational exposure152. To
understand how exposure of such workplace impacts the human gut resistome, we investigated the
changes in the gut microbiome of fourteen healthy students who visited the confined and controlled
swine farms for three consecutive months and were sampled before-, during and after their visit in
China150 (Chapter 5). Longitudinal investigation of their gut resistome suggests extensive
remodeling in correlation with the increased exposure to the swine farm environment. Extensive
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network of AR genes were shared between the microbial communities derived from students and
environment. Several of these AR genes were closely associated with mobile genetic elements,
highlighting a potential risk of transfer via horizontal gene transfer events. It is important to note
that these changes also show partial reversal over a 4-6 months period, post-travel to the swine
farm150. Indiscriminate use of antibiotics results in persistent changes in the microbial communities
across habitats and environment. It is likely that the substantial increase to the exposure of
antibiotics have promoted the evolution and transfer of AR genes. Thus, we investigated the
resistomes of wild and captive baboon populations to understand the effect of human exposure and
to understand how the primate microbiota may have been altered during the antibiotic era115. Our
results suggest that there is resistome expansion among captive baboons compared to the wildtype counterparts. Also, the captivity and lifestyle changes associated with human contact can lead
to marked changes in the ecology of primate gut communities (Chapter 6).
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2.6 Supplementary Tables
Table S2.1: Sequencing-based tools for antimicrobial resistance detection

Name

Description

Accessibility

Year

Reference

Tool for detecting acquired AMR genes
from sequenced or partially sequenced
bacterial isolates.

Web
Standalone

2012

Active (PMID:
22782487)

ARGANNOT118

Pairwise comparison of query sequence
with ARG-ANNOT database.

Web

2014

Active (PMID:
24145532)

Resistance
Gene
Identifier149
(RGI)

Pairwise comparison of query sequence
with CARD database. Uses curated AMR
detection models to predict intrinsic
resistome, dedicated resistance genes , and
acquired resistance from mutations in drug
targets

Web

2015

Active (PMID:
23650175)

ARGs-OAP126
(v2)

Online Analysis Pipeline for Anti-biotic
Resistance Genes Detection from Metagenomic Data Using an Integrated
Structured ARG-database

Web
Standalone

2016

Active (PMID:
29408954)

ARIBA

Rapid antimicrobial resistance genotyping
directly from sequencing reads by
comparing with an array of databases

Standalone

2017

Active (PMID:
29177089)

NCBIAMRFinder

Tool for identification of acquired
resistance genes from genomic and protein
sequence data using NCBI's curated AMR
database and curated collection of HMMs

Standalone

2018

Active

SRST2102

Direct mapping of the reads to curated AR
databases

Standalone

2014

Active (PMID:
25422674)

Search Engine
for
Antimicrobial
Resistance106
(SEAR)

A Cloud Compatible Pipeline and Web
Interface
for
Rapidly
Detecting
Antimicrobial Resistance Genes Directly
from Sequence Data

Standalone
(Archived)

2015

Archived (PMID:
26197475)

Resfinder

124

104
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/

/

ShortBRED140

Tool to profile protein families in the
metagenomic data using short peptide
marker sequences

Standalone

2015

Active (PMID:
26682918)

PATRIC153

The Pathosystems Resource Integration
Center as a unique resource for studying
antimicrobial resistance

Web

2016

Active; PMID:
28968762

SSTAR154

AMR identification from WGS data

Standalone

2016

Active (PMID:
27303709)

KmerResistanc
e103

K-mer based algorithm that map raw reads
to multiple databases and resolve for
redundancy

Web

2016

Active (PMID:
27365186)

Graphing
Resistance Out
of
Metagenomes1
08
(GROOT)

Perform resistome profiling by mapping
metagenomic reads to graph representation
of reference gene sets

Standalone

2018

Active (PMID:
29762644)

A deep learning approach for predicting
antibiotic
resistance
genes
from
metagenomic data

Web

2018

Active (PMID:
29391044)

DeepArgs

45

Table S2.2 Summary of antimicrobial resistance reference databases

Database

Description

Reference

Comprehensive
Antibiotic Resistance
Database149 (CARD)

Ontology-based database that provides
comprehensive information of AR genes and their
resistance mechanisms.
Includes curated set of AR-conferring
chromosomal mutations in protein-coding genes

Active; launched in 2013;
updated monthly (PMID:
23650175)

Resfinder

124

Resfams80

2,200 AR gene sequences

Collation of AR genes involved in HGT events

Active; last update in
September, 2018 (PMID:
22782487)

A profile HMM-based curated database
confirmed for AR function

Active; last update in Jan,
2015 (PMID: 25003965)
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Antibiotic Resistance
Genes Database117
(ARDB)

MEGARes155

National Database of
Antibiotic Resistant
Organisms (NDARO)

ARG-ANNOT118

Functional antibiotic
resistance element
database135

 first centralized resources of AR gene
information
 manually curated
 Collation of multiple databases (CARD,
ARG-ANNOT and ResFinder) to avoid
redundancy between entries
 For high-throughput screening and statistical
analysis
Collated and curated data from multiple databases
(CARD, Lahey, Pasteur Institute Beta
Lactamases and ResFinder)
 Collated from scientific literature and online
resources
 Also includes point mutation data for select
AR-associated chromosomal genes

Archived; Last updated in
2009 (PMID: 18832362)
4545 AR sequences

Active; last update in Dec,
2016 (PMID: 27899569)

Active; started in 2016;
4,500 AR protein sequences
Active; last update in May,
2018 (PMID: 24145532)
>1,800 AR sequences

Curated set of microbial sequences functionally
screened to confer resistance in various functional
metagenomics studies of different habitats

Last update on 2017 (PMID:
28077567)

 Hierarchical structured database, derived from
CARD
 Includes AR genes from metagenomes

Cannot access the link (PMID:
29408954)

Lahey list of β Lactamases122

First initiative to compile known β-lactamases
and assign nomenclature to the novel ones

Archived; Last update in 2015
(PMID: 19995920)

β-lactamase database156
(BLDB)

Manually curated database for AMR enzymes
classified by class, family and subfamily

Active; last update in Nov,
2018 (PMID: 28719998)

Lactamase Engineering
Database120, 121 (LacED)

Curated database of TEM and SHV β-lactamases,
including curated set of known TEM and SHV
variants

Archived : last update in
April, 2010 (PMID:
20942904; 19698099)

Comprehensive betalactamase Molecular
Annotation
Resources123 (CBMAR)

Newly established database that identifies and
characterizes novel β-lactamases based on
Ambler classification

Cannot access the link (PMID:
25475113)

MUBII-TB-DB128

Mutations associated with AR in Mycobacterium
tuberculosis

Cannot access the link (PMID:
24731071)

u-CARE157

User-friendly Comprehensive AR repository of
Escherichia coli

Last update on 2016 (PMID:
25935546)

SARG126 (v2)
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Table S2.3: Functionally validated antibiotic resistance gene sequences from previously published cohort used
to build ShortBRED markers database.

StudyID
DLFM01
DLFM02
DLFM03
DLFM04
DLFM05
DLFM06
DLFM07
DLFM08
DLFM10
DLFM11
DLFM12
DLFM13
DLFM14

StudyName
AB95-Soil
Seattle-Tar22
CC_KBS-Soil
TwinStudy
Uncontacted Amerindians
NICU-MKG
ES-Peru
Baboon
NICU-AJG
TD-Cusco
DAIRY-WISCONSIN
COMBAT
GC-Project

# of Library # of Abx # of Slxns Unique AR seqs
1
16
16
54
22
13
169
2536
18
15
219
2527
26
16
195
1383
16
10
52
106
21
11
182
1129
79
16
546
1915
8
9
43
382
22
15
262
1404
21
18
388
2065
9
17
153
2235
21
15
234
1443
17
14
142
323
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Chapter 3: Dynamics of gut microbiotapathogen interactions and acquisition of
antibiotic resistance during travel to high
infectious burden regions

3.1 Introduction
Travelers’ diarrhea is a significant health problem for individuals traveling from highincome countries to low-to-middle-income countries (LMIC)21, 158-160. Travelers’ diarrhea can
disrupt travel plans, necessitate overseas medical treatment, and lead to chronic health
consequences159. Despite improvements to global health, sanitation, and hygiene, the overall
incidence of travelers’ diarrhea remains high with 10 to 40% of travelers experiencing diarrhea161.
Use of antibiotics for prophylaxis or treatment of travelers’ diarrhea is controversial because it
contributes to the expansion and global spread of multidrug-resistant organisms (MRDOs)162.
International travel also alters travelers’ broader gut microbiota, which plays a critical role in
excluding invading enteropathogens (i.e. colonization resistance)18 and acts as a conduit for
transmission of antibiotic resistance genes (ARG) from commensal bacteria to human
pathogens163. For example, nearly 70% of Dutch travelers acquired extended-spectrum betalactamase (ESBL)-producing Enterobacteriaceae when visiting LMICs, and many experienced
persistent colonization up to 12 months or transmitted this MDRO to non-travelling members of
their households35. In addition, the rapid global spread of the carbapenem resistance gene,
blaNDM-1, has been linked to international travel—particularly, by travelers who received
overseas medical care164. Previous studies have documented the acquisition of MDROs and
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changes to the gut microbiota during international travel; however, these focused on select
cultivable MDROs and/or were limited to pre- and post-travel samples35, 163, 165-167. Thus, there is
a lack of understanding about how individuals’ broader gut microbiota responds to infectious
diarrhea and antibiotic use during travel to high infectious burden regions and specific diarrheal
episodes, and how those changes influence MDRO acquisition and ARG carriage. Here, we used
whole metagenome and isolate sequencing on an extensive collection of longitudinally-collected
fecal samples to comprehensively characterize human gut microbiome and resistome dynamics
during travel and travelers’ diarrhea.

3.2 Results
We assembled a cohort of 159 participants (60% female, 40% male; median age 24 years,
range 18-65) visiting the Andean city of Cusco, Peru between June 2012 and July 2016 (Fig. 3.1a).
Participants were from 16 countries (Fig. 3.1a), and their median trip duration was 35 days (IQR:
33 days; Range: 2-173 days). The 113 individuals who experienced at least one diarrheal episode
(defined as one or more semi-liquid or watery stools plus symptoms, Methods) were classified as
“Travelers with Diarrhea” (TD; Fig. 3.1b). The 46 individuals who did not experience diarrhea
were classified as “Healthy Travelers” (HT; Fig. 3.1b). Stool samples were collected upon
enrollment and approximately weekly thereafter, with additional samples collected during
diarrheal events (Fig. 3.1b, Fig. S3.1a). In total, we collected 718 stool samples, composed of 144
diarrheal and 574 non-diarrheal sample types (HT n=212, TD n=362; Fig. 3.1b), with a median of
4 samples per individual (range: 1-22; Fig. S3.1d). Most individuals in the TD group experienced
their first diarrheal episode within 1 month of arrival in Peru (78/113, 69%; Fig. S3.1a). Detailed
demographic data, medical history, and dietary habits were collected from each participant
(Methods, Fig. 3.1b). Cohort characteristics with a summary of metadata features are listed in
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Table S3.1. We observed no significant bias among HT and TD subjects when viewed across age,
gender, trip duration, and other demographic factors, according to univariable logistic regression

Figure 3.1: Study design, assembly and meta-analysis of international travelers’ cohort. a) (top)
The highlighted region in the map shows travelers’ country of residence who visited the Andean city
of Cusco, Peru between June 2012 and July 2016. The major proportion of travelers in the study
traveled either from North America or European subcontinent. (bottom) Circos plot shows the
distribution of samples collected per individual color coded by their country of residence. b) Sampling
strategy and experimental design: Subjects who experienced at least one episode of diarrhea were
classified as Travelers with diarrhea (TD, orange) while the remaining individuals were termed as
Healthy travelers (HT, blue). The collected stool samples were processed to obtain taxonomic,
functional and resistome profile using metagenomics sequencing. A subset of samples were cultured
to obtain suspected diarrheagenic pathogens which were tested for antibiotic susceptibility and
sequenced for their detailed comparative genomic analysis. c) PERMANOVA test quantifying the total
variance explained by the metadata variables in the metagenomic, functional, and resistome profile.
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analyses (Fig. S3.1b, c).
To characterize the gut microbial communities of our travelers, we performed whole
metagenome shotgun sequencing on our 718 stool samples, and then generated three
complementary profiles: taxonomic composition (using MetaPhlAn2168), functional metabolic
capacity (using HUMAnN2169), and antibiotic resistome (using ShortBRED140) (Fig. 3.1b). These
profiles were supplemented with multiplex PCR on 696 stool samples to identify common
diarrheagenic pathogens, whole genome sequencing of 212 diarrheagenic Escherichia coli (DEC)
isolates to evaluate their phylogenetic diversity and AR gene content, antibiotic susceptibility
testing on 169 DEC isolates to determine phenotypic resistance, and the construction of 21
functional metagenomic libraries from 210 stool samples to characterize the antibiotic resistome
in a sequence- and culture-unbiased manner (Fig. 3.1b).
Among all the metadata features, inter-individual variation accounted for the largest
variation (44-52%) across all three metagenomics profiles (Methods). For the other metadata
variables, we observed relatively small (up to 4%) but significant variation associated with stool
grade, sample type, country of residence, and duration of stay (Fig. 3.1c). In addition, pathogen
presence (identified by multiplex PCR) and age were significantly associated with the taxonomic
and functional profiles but not with resistome profile, while sample collection time was
significantly associated with the resistome profile but not the other two (Fig. 3.1c). These
significant features (stool grade, sample type, country of residence, duration of stay, pathogen
presence, age, sample collection time) with systematic effect on the microbial community were
later included in multivariable linear regression models.
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Impact of international travel and diarrhea on the gut microbiota
Our extensive collection of longitudinally-collected metagenomic samples enabled us to
investigate the short- and long-term changes to travelers’ gut microbiomes. Overall, the taxonomic
diversity of participants’ gut microbiota was temporally stable throughout the length of their stay.
The alpha diversity for both HT and TD stool samples, measured by Shannon diversity index (SDI)
and richness, was stable over time and did not significantly differ from each other (Fig. 3.2a).
However, when we compared TD individuals’ diarrheal samples with temporally-matched before
and after TD non-diarrheal samples (collected within 2 weeks pre- and post-diarrhea), we observed
a significant decrease in taxonomic diversity after diarrhea (After TD) (Fig. 3.2b).
While taxonomic diversity remained constant, all participants’ gut microbial communities
underwent significant restructuring throughout the course of their travel abroad. To quantify
divergence from the gut microbial composition at arrival, we compared the beta-diversity,
measured by Bray-Curtis dissimilarity and Jaccard index, of each individuals’ samples to their 1st
week baseline sample, and found that the taxonomic composition of participants in both groups
changed significantly over the length of stay (Fig. 3.2d). This divergence in taxonomic
composition from baseline samples is likely a consequence of travelers living in a country with
different microbial ecologies than their home country. We next compared the beta-diversity of
participants’ consecutive stool samples and found that individuals in the TD group had greater
apparent variation and less stable microbial architecture than those in the HT group (Fig. 3.2c).
Additionally, we observed that individuals with greater taxonomic diversity at baseline were more
resilient to change than individuals with lower baseline diversity, as determined by linear mixed
effect models. This is in-line with previous reports that microbial diversity is an important
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contributor for the overall intra-subject microbial stability and colonization resistance to enteric
pathogens, with a lower pre-travel diversity being significantly associated with increased
susceptibility to infection30. We next evaluated large-scale differences in temporal stability of HT
and TD subjects by searching for microbiome “shift” events. These are defined as events when the
Bray-Curtis dissimilarity between consecutive samples (within a week) from the same individual
is greater than the dissimilarity between individuals (Methods; Fig. S3.3c)170. Using this approach,
we identified 141 shift events (34.5%, 141/408). TD subjects had a significantly higher proportion
of shift events (40.4%, 113/280) than HT subjects (21.9%, 28/128), and the majority of TD
individuals’ shift events occurred during a diarrheal episode (56.7%; 68/120), while only a quarter
occurred outside of a diarrhea event (25%; 33/147) suggesting similar gut microbial stability
pattern in both HT and TD subjects’ except when individual experience a diarrheal episode.
Principal coordinate analysis (PCoA) of temporally-matched before, during, and after TD
samples’ Bray-Curtis dissimilarity showed marked heterogeneity, suggesting that inter-individual
variability among the samples exceeds the effect of the diarrhea-induced changes (Fig. S3.3a).
However, we observed a weak association between samples based on whether they were collected
before, during, or after TD (PERMANOVA R2 = 0.10, P=0.009). Prior studies on infectious
diarrhea among the native population suggests an orderly reversal to the pre-diarrhea state within
1 month of the diarrheal episode171. Since the travelers’ cohort recovers from the diarrhea episode
in a different habitat, we evaluated whether the gut microbial composition returns to the original
before-diarrhea state. To assess the impact of diarrhea, we compared HT and TD individuals’ 1st
week baseline with their non-diarrheal samples collected 1 month later, further differentiating
between TD individuals who experienced diarrhea before 1 month (early TD) or after 1 month
(late TD). We did not observe a significant difference between the Bray-Curtis dissimilarities of
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HT and late TD baseline and 1 month samples, but early TD individuals’ 1 month samples were
significantly more dissimilar than both HT and late TD (Extended Data Fig. 3b). This finding
suggest that the diarrheal episode and/or its combined treatment with antibiotics during travel
further restructures the gut microbiota composition of the traveler that is significantly different
from the before-diarrhea state.
Diarrhea significantly alters the composition of major phyla. Diarrheal samples were
characterized by an enrichment for Proteobacteria and Bacteroidetes, and a depletion of Firmicutes
(Fig. S3.3d), resulting in a lower Firmicutes-to-Bacteroidetes ratio (Fig. S3.3e). This is consistent
with other gastrointestinal diseases and is indicative of a dysbiotic gut microbial architecture31.
However, we observed no significant difference in Firmicutes-to-Bacteroidetes ratio between the
before (Before TD) and after diarrhea samples (After TD) (Fig. S3.3e). This suggests that while
the overall composition is not able to return to the pre-diarrheal state, these phyla are able to
quickly recover. At species-level resolution, we identified 55 differentially abundant species
associated with diarrheal and non-diarrheal samples using multivariable regression models (using
MaAsLin2{201218}) (Fig. 3.2e-f, Fig. S3.4). In diarrheal samples, we found an elevated relative
abundance of known TD-causing pathogens (e.g., E. coli, Campylobacter, and Shigella spp.).
Additionally, we saw an increased abundance of Proteobacteria, including Bilophila spp.,
Sutterella wadsworthensis, Burkholderiales and Parasutterella excrementihominis (Fig. 3.2e).
Previous studies have linked these taxa to host physiology and health outcomes 172-176, such as
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Figure 3.2: Impact of international travel and diarrhea on the gut microbiota. a) The taxonomic diversity
(Shannon index (top), richness (bottom)) of all participants was temporally stable. b) Cross-sectional
comparison of taxonomic diversity (Shannon index (top) and richness (bottom)) between diarrhea and
matched non-diarrhea samples (Before TD and After TD). c) 1-Bray-Curtis dissimilarity (top) and 1Jaccard (bottom) was measured between consecutive samples of each subject and were plotted with their
collection time in Peru (HT:blue and TD: orange). d) Significant divergence in gut microbiota composition
from baseline samples for both HT and TD subjects. 1-Bray-Curtis dissimilarity (top) and 1-Jaccard
(bottom) was measured between each subjects 1st week baseline and subsequent sample. e) Differentially
abundant microbial species enriched or depleted in diarrhea samples compared to non-diarrhea samples
identified using Maaslin2. f) Relative abundance distribution of differentially abundant species in
diarrhea samples compared to non-diarrhea samples from HT and TD subjects.

increased abundance of Bilophila spp. being associated with inflammatory bowel disease173, and
an increased abundance of Suttrella wadsworthensiss impairing intestinal antibacterial immune
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responses, and being linked to ulcerative colitis etiology and FMT treatment failure174-176. We also
observed significant increase in the relative abundance of several taxa within the Bacteroidetes
phylum (e.g., Odoribacter splanchnlcus, Bacteroides fragilis, Bacteroides vulgatus), consistent
with the previous reports on diarrheal diseases177,

178

. Bacteroides are major producers of

sphingolipids that regulate inflammation and immunity in the human gut179, and it is likely that the
bloom of Bacteroidetes species during diarrhea is an effort to restore microbial homeostasis180, 181.
In contrast, several taxa belonging to the Firmicutes phylum were depleted in diarrheal samples
(e.g., Ruminococcus bromii, Eubacterium rectale, Clostridium bartlettii, Coprococcus spp.).
Firmicutes are residents of healthy gut and are known to play key functions, including maintenance
of gut barrier function and digestion of complex polysaccharide by producing short-chain fatty
acids182. Decreased representation of Firmicutes has been associated with other GI diseases,
including ulcerative colitis and Crohn’s diseases183. To understand how individual taxa interact
with each other during diarrhea, we built two unsupervised co-occurrence networks from diarrheal
and non-diarrheal samples using SparCC49 (Fig. S3.5a, b), and compared them using Netshift52
(Fig. S3.5c).
We observed significant change in interactions among several key species during diarrhea
compared to non-diarrheal samples. Netshift identified 14 taxa that showed significant shift in their
interactions in diarrhea compared to non-diarrheal samples (Fig S3.5b, highlighted in red). Among
them, E. coli and Escherichia unclassified, which were enriched during diarrhea, gained
connectivity and were negatively associated with key commensal species like Eubacterium rectale
(Fig. S3.5b). Bacteroidetes species such as B. uniformis and B. caccae were also enriched, gained
interactions, and formed a close sub-network of positive interactions with other Bacteroides
species. This sub-network was positively correlated with other key commensal species, like F.
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prausnitzii (Fig. S3.5a, b; highlighted in orange). Other commensal microbes like F. prausnitzii
and Ruminococcus bromii were depleted during diarrhea and lost their connectivity to other
microbial species. While the gut microbiome underwent major remodeling during diarrhea, a subnetwork built from D. longicatena, D. formicigenerans, E. hallii, R. obeum and R.
sp_5_1_39BFAA, remained conserved with minor shuffling (Fig S3.5a, b; highlighted in blue).
Notably, many of these interconnected and differentially interacting taxa were also found to be
differentially abundant by the linear mixed effect model described above (Fig. 3.2e).
Lastly, we constructed a machine learning classifier that can discriminate between
diarrheal and non-diarrheal samples based on the abundances of key taxa. Using SIAMCAT184,
we implemented three approaches viz. Lasso, Enet and random forest to build a model that
classifies non-diarrheal and diarrhea samples based on key taxa. The random forest model had the
best accuracy (84.2%) and precision-recall (89.4%) (Fig. S3.10). The model identified 32
discriminatory species that distinguish between diarrheal and non-diarrheal samples (Fig. S3.10).
Consistent with the prior observations, 11 out of 32 discriminatory species belonged to Bacteroides
family. The top five species with largest effect size were C. bartlettii, E. coli, P. unclassified, B.
longum and E. rectale. Except E. coli, the other four species are key commensal species that are
depleted during diarrhea.

Temporal dynamics of antibiotic resistance gene diversity and abundance
Having characterized the dynamics of changes to the gut microbiome during travel, we
next sought to determine if similar trends characterize the travelers’ gut resistome. To capture the
complete array of AR genes (ARG) encoded by international travelers’ gut microbiota in a highthroughput, sequence- and culture-unbiased manner, we constructed 21 functional metagenomic
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libraries (representing 89.5 GB) from 210 representative stool samples (Methods). These libraries
were screened against 17 antibiotics, yielding resistance-conferring transformants against all
except for ciprofloxacin and meropenem (Fig. S3.2g). Resistance was most abundant for
trimethoprim and tetracyclines (>3,000 colonies/library), and lowest for colistin and 3rd/4th
generation cephalosporins (<25 colonies/library). The metagenomic inserts from these resistant
transformants were sequenced, assembled, and annotated for AR function using our previously
published pipeline13, 140 (Methods). This yielded 2,065 unique ARG sequences, expanding the
catalog of known ARGs harbored by the gut microbiota. We then built an extensive ShortBRED140
marker database by incorporating ARG sequences from this cohort (n=2065), 14 previous
functional metagenomic studies, and curated ARG databases (CARD185 v2.2.0; NCBI-AMR186
v1.0). This resulted in a database consisting of 6,594 unique marker sequences representing 2,314
ARG families. The relative abundance of ARGs in the sequenced metagenome of each stool
sample was then quantified by mapping the shotgun data to the ShortBRED marker database.
The gut resistome harbored by travelers’ gut microbiota demonstrated temporal stability
during their stays. Similar to the microbiome analysis, the alpha diversity of HT and TD ARGs
(SDI and Richness) showed no significant change over time (Fig. 3a); however, a marginal but
significant increase in cumulative ARG abundance (RPKM) was observed over time (Fig. 3c).
Interestingly, we observed a steady increase in ARG diversity in diarrhea samples collected later
during an individuals’ stay (Fig. 3a). ARG diversity and abundance were significantly higher in
diarrheal samples compared to non-diarrheal samples throughout the study period, and we
observed a marked increase in ARG diversity and abundance among individuals who reported
using antibiotics. When comparing the beta diversity (using Bray-Curtis and Jaccard index) of
individuals’ gut resistomes from consecutive samples, we observed no significant difference
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between HT and TD subjects, and both were similarly stable over the study period (Fig. S3.6a).
However, similar to the microbiome analysis (Fig. 3.2d), when comparing individuals’ later
samples against their 1st week baseline sample, we found significant divergence in both HT and
TD individuals (Fig. S3.6b). This indicates that travelers acquire and/or lose specific ARGs during
the course of their stay, and the enrichment of ARGs in diarrheal samples collected at later time
points may be attributed to the expansion of endogenous and/or acquired resistance. Crosssectional comparison of diarrheal samples with matched before and after non-diarrheal samples
showed an increase in ARG diversity (Shannon and Richness) (Fig. 3.3b) and cumulative ARG
abundance (RPKM) (Fig. 3.3c) during diarrhea. While the ARG diversity recovered to prediarrheal levels (Before TD vs. After TD, P-value > 0.05), the overall ARG abundance remained
significantly higher in After TD samples (Before TD vs. After TD, Supplementary Table 13c).
This increase in relative abundance of ARGs during diarrhea was significantly correlated with a
decrease in microbial diversity at the species level) and increase in relative abundance of
Enterobacteriaceae (Fig. 3.3d). This indicates that the majority of AR determinants in diarrheal
samples are concentrated within Enterobacteriaceae species. Additionally, we observed a
significant negative correlation of ARG abundance with species belonging to Ruminococcaceae,
Eubacteriaceae, Coriobacteriaceae, and Bifidobacteriaceae (Fig. S3.6d). We next sought to
identify specific resistance genes that were differentially abundant in diarrheal samples using
Maaslin2{201218}. Diarrheal samples had an increased abundance of antibiotic efflux pumps, βlactamases (Class A and Class C) and aminoglycoside resistance genes (Fig. 3.3e, f, Fig. S3.6).
Non-diarrheal samples were enriched for tetracycline ribosomal protection genes.
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Figure 3.3: Temporal dynamics of antibiotic resistance gene diversity and abundance. a) Alpha diversity
of ARGs over time in diarrhea (TD:red) and non-diarrhea samples (HT:green, TD: yellow) b) Comparison
of ARG diversity of diarrhea (During TD) with matched non-diarrhea samples (before TD and after TD).
c) Change in cumulative abundance of ARGs (log 10 scale) over time and during diarrheal episode. d)
Increase in cumulative abundance of ARGs is associated with decrease in microbial diversity (at species
level) and increase in relative abundance of Enterobacteriaceae. e) Differential abundance analysis shows
ARGs that are enriched (red) or depleted (green) in diarrhea samples compared to non-diarrhea samples.
f) Relative abundance distribution of differentially abundant ARGs in diarrhea samples of TD subjects
(red density plot), non-diarrhea samples of TD subjects (yellow density plot) and non-diarrhea samples of
HT subjects (blue density plot), normalized by the median relative abundance of non-diarrhea HT samples.
Fraction of samples below detection limit are plotted in the barplot on the left.

60

Phenotypic and phylogenetic analyses of diarrheagenic pathogens
As bacterial etiologies are the predominant cause of TD187, we evaluated both diarrheal
and non-diarrheal stool samples for the presence of common diarrheagenic pathogens. We
performed multiplex PCR on 696 stool samples to detect Campylobacter spp., Shigella spp.,
Norovirus (GI, GII), and six strains of diarrheagenic Escherichia coli (DEC) (Methods, Table
S3.2). At least one diarrheagenic pathogen was detected in 217 samples (31.2% overall; 62/142,
43.7% diarrheal; 155/554, 28.0% non-diarrheal). No pathogen was detected in 80/144 (55.6%)
diarrheal samples, consistent with previous reports. DEC was the most common pathogen detected
(193/217, 88.9%), followed by Norovirus (29/217, 13.4%), Campylobacter spp. (18/217, 8.3%),
and Shigella spp. (3/217, 1.4%). Of the samples positive for DECs, enteropathogenic E. coli
(EPEC; 49/217, 22.6%), enterotoxigenic E. coli (ETEC; 42/217, 19.4%), and enteroaggregative
E.coli (EAEC; 45/217, 20.7%) were most commonly isolated. Less frequently detected were
diffusively adherent E.coli (DAEC; 31/217, 14.3%), Shiga toxin-producing E.coli (STEC; 20/217,
9.2%) and enteroinvasive E.coli (EIEC; 6/217, 2.8%). Simultaneous detection of ≥2
enteropathogens was observed (24/217, 11.1%), predominantly co-detection of different DEC
strain types (19/217, 8.8%; Fig. 3.4a). Consistent with the prior studies188, we observed
significantly higher detection rate of ETEC (OR: 3.4; 95% CI: 1.7-6.9; p-value < 0.001),
Campylobacter (OR: 13.9; 95% CI: 3.6-54.5; p-value < 0.001) and Norovirus (OR: 2.7; 95% CI:
1.1-6.4; p-value: 0.03) in diarrheal samples compared to non-diarrheal samples.
To assess the phenotypic resistance of our DEC isolates, we performed antimicrobial
susceptibility testing on 169 DEC isolates cultured from stool, evaluating resistance against 20
antibiotics belonging to 12 antimicrobial classes (Fig. 3.4b). The majority of DEC isolates (66.9%,
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n=113) were multidrug-resistant (MDR; defined as resistance to ≥1 antimicrobial agent in ≥3
antimicrobial classes; Fig. S3.4b). Rates of MDR were most common among DAEC pathotypes
(89.3%, 25/28), followed by EAEC (75%, 33/44) and EPEC (65.9%, 29/45) but less frequent in
ETEC (59.5%, 22/37) and STEC (30.8%, 4/13). No resistance was detected against imipenem,
ceftazidime, cefotaxime-clavulanate, nitrofurans and amikacin (Fig. 3.4b). In contrast, high rates
of resistance were detected against erythromycin (ERY; 95.9%, n=162), ampicillin (AMP; 65.7%,
n=111), ticarcillin (TIC; 60.9%, n=103), tetracycline (TET; 58.0%, n=98) and trimethoprimsulfamethoxazole (SXT; 53.3%, n=90). Resistance to gentamycin (GEN; 3.6%, n=6), and 3rdgeneration cephalosporins (CRO; 1.8% n=3; FEP; 0.6%, n=1) was detected, but relatively
infrequent. We observed moderate rates of resistance to azithromycin (AZM; 23.7%, n=40) and
ciprofloxacin (CIP; 7.7%, n=20), two antibiotics recommended for the treatment of acute
diarrhea187. Interestingly, resistance against these drugs was particularly enriched for in DAEC
isolates (Fig. 3.4b).
We sequenced the genomes of 212 suspected DEC isolates (carrying DEC specific
virulence determinants detected by multiplex PCR) from 195 fecal samples to investigate the
genomic diversity, ARG content and virulence potential of enteropathogens in our cohort. This
included 157 isolates 149 non-diarrheal samples, and 55 isolates DI from 46 diarrheal samples.
The draft assemblies of these isolates were quality filtered, and 23 isolates with poor assembly
metrics were excluded (Methods, Fig. S3.2d-f). The average genome size—representing both
chromosomal and plasmid DNA—of the remaining 189 DEC isolates (non-diarrheal=139,
diarrheal=50) was 5.1 Mb (range, 4.6-5.8 Mb) with a median N50 of 128 Kb. We analyzed the
population structure of these isolate genomes, along with 40 publicly available E. coli genomes of
diverse pathotypes, by constructing a core genome (2,216 genes, ≥95% identity) maximum
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Figure 3.4: Phenotypic and phylogenetic analyses of diarrheagenic pathogens. a) Frequency of
diarrheagenic pathogens that were detected using multiplex PCR in non-diarrhea (green) and
diarrhea samples (red). b) Antibiotic susceptibility testing of diarrheagenic E.coli isolates against 20
antibiotics. c) Phylogenetic tree inferred from core-genome alignment of 189 E.coli isolates (this
study) and 40 published E.coli reference genomes. The phylogroups are depicted in the inner circle
as A (green), B1 (red), B2 (orange), D (purple), E (yellow), F (blue). The reference strains within
each phylogroup are marked by asterisk signs. The gray barplot denotes the number of ARGs in each
isolate and the inner ring indicates the pathotypes. Strains of same pathotype are coded by same
color and color annotation is shown in the top left legend. The outer barplot (in black) shows
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virulence factor count in each strain, and the outermost ring shows asymptomatic (A:green) and
diarrheal (D:red) samples.

likelihood phylogenetic tree (using Roary and RAxML). The phylogenetic clusters were
independently confirmed independently by using BAPS. In line with the literature, our DEC
isolates grouped into 6 distinct clusters corresponding to phylogroups A, B1, B2, D, E and F (Fig.
3.4c). The majority of our isolates belonged to Clade A (106/189; 56.1%) and Clade B1 (56/189;
29.6%). Together, all other phylogroups (Clade B2: 8/189, Clade D: 11/189, Clade E: 5/189) and
Clade F: 3/189) accounted for less than 15% (n=27) (Fig. 3.4c). No significant association between
phylogroups and source sample type (diarrhea vs. non-diarrhea) was observed (Fisher’s exact, P =
0.3), except for those belonging to Clade B2 and Clade F which were isolated only from nondiarrheal samples. The MLST profiles of these isolates represented 74 unique sequence types (STs)
with ST10 (22.2%; 42/189) being the most common in Clade A, and ST21 (7.9%; 15/189) in Clade
B1.
Among 189 sequenced DEC isolates, only ETEC (OR: 3.65; CI: 1.5-8.7; p-value=0.002)
was significantly associated with diarrheal samples. No significant association was detected in
other DEC types. In line with AST profiles, DAEC and EAEC isolates carried more unique ARGs
whereas ETEC and STEC isolates that were more frequently associated with diarrheal samples
had lower counts of unique ARGs. To further explore the diversity and distribution of AR
determinants harbored by isolates among travelers, we screened the draft genomes for known AR
genes, point mutations that confer resistance (e.g., gyrA, parC, parE, and pmrB). In total, we
identified 60 unique AR determinants, including 21 core (present in ≥95% of isolates) and 39
accessory resistance determinants. Consistent with previous findings, the core resistome of DEC
isolates include genes that mediate resistance to multiple drugs via efflux pumps. The accessory
resistome, however, was widely variable, with no clear association with phylogroups or source
sample type (Fig. S3.8a). The most common accessory AR genes were emrE efflux pumps (115
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isolates, 60.9%), alleles of sul mediating resistance to sulfonamides in (sul1, sul2, sul3, 88 isolates,
46.6%), blaTEM (blaTEM-148, blaTEM-206, 82 isolates, 43.4%), trimethoprim resistance genes dhfr
genes (76 isolates, 40.2%), and aminoglycoside resistance genes aph6-Id and aph3” (66 isolates,
34.9%). In addition, we detected point mutations in gyrA (S83L: 30, S83A: 14, D87N: 8, D87Y:
4, 48 isolates, 25.4%), parC (S80I: 9, A56T: 4, E84G: 2, E84V: 2, S57T: 2, 13 isolates, 6.9%),
and parE (I355T: 3, I529L: 2, L416F: 2, S458A: 2, 9 isolates, 4.8%) quinolone resistance
determining region (QRDR) genes. The frequency of these prevalent accessory AR genotypes
(present in ≥10% of isolates) were similar in DEC strains isolated from diarrheal and non-diarrheal
samples (Fig. S3.8c).
However, DEC strains isolated from non-diarrheal samples in TD subjects encoded for
more AR genes than isolates from HT subjects (Fig. 3.5a) (non-diarrheal HT vs. non-diarrheal TD,
p-value=0.01). These isolates were significantly enriched for blaTEM-148, sul2, aph6, and tetA genes
(Fig. S3.9d). Notably, several DEC strains isolated from TD subjects also carried other MDR genes
including, ESBL genes (blaCTX-M, n=7; blaOXA, n=3), AmpC (blaCMY, n=1), and mcr-1 (n=1).
Colonization of TD individuals by MDR DEC strains could have long-term consequences both
during their travel and when they return to their home counties. At the community level, these
MDR pathobionts could spread to new hosts during and after travel (e.g., household members,
healthcare facilities). At the individual level, infection by the pathobiont or horizontal transfer of
its MDR gene to another pathogen could lead to treatment failure or longer hospitalization.

65

Figure 3.5: High prevalence of antibiotic resistance genes linked to mobile elements in TD subjects. a) (top) The
boxplot shows the distribution of total unique ARGs carried by the DEC strains extracted from HT and TD
subjects. The colored circles represent different DEC strain types. (bottom) Prevalence of ARGs in DEC isolates
from asymptomatic HT and asymptomatic TD samples. The annotated genes (blaTEM-148, sul2, aph6, and tetA)
were significantly associated with TD subjects after FDR correction. b) Co-occurrence network of ARGs and
mobile elements among E.coli isolates. Nodes represent ARGs (circle) and mobile elements (triangle). The
connection between two nodes representd correlation of genes occuring together with mobile elements in the
same contig (within 5kb). The solid line represents significant relationships after FDR correction. The shadded
regions represent subnetwork. c) Examples of arrangement of ARGs and mobile elements identified on the same
contigs from isolates.

We observed several AR gene clusters associated with plasmids. Pairwise co-occurrence
comparison of accessory AR determinants revealed highly interconnected groups of AR genes
(Fig. S3.9) circulating among DEC isolates. The most common cluster of AR genes frequently
66

detected together (blaTEM-148, sul2, aph6, aph3, emrE, and tetA) were also found to be significantly
associated with plasmids (49%; 25/51; FDR < 0.05; Fisher’s exact test). Several other ARGs were
also found in plasmid sequences but could not be evaluated because of their overall low frequency
in the dataset. We next analyzed the genomic context of these ARGs to assess transmission risk.
We identified mobile genetic elements (MGEs) (unit and composite transposons, insertion
sequence) within 5 kb of the resistance genes using MGEfinder (Fig. S3.10), suggesting the ability
to transfer horizontally. We then built the co-occurrence network of the observed ARGs with
MGEs and identified clusters that were more frequently observed together in the isolates. We
identified four major clusters that include ARGs conferring resistance via different mechanisms
(Fig. 3.5b). The genes sul2, aph6, aph3 and blaTEM-148 were the most common group observed,
occurring in 60 isolates (39.1%). These genes were often observed with the IS26 insertion element
(n=12) and Tn2 unit transposon (n=12). We also observed these genes frequently occurring with
dfrA8/dfrA14 genes (n=20) and other mobile elements like IS903. Co-occurrence and co-transfer
of these resistance genes raises concerns over their potential expansion.
We identified instances of both temporary and persistent colonization by DEC isolates, as
well as co-colonization of multiple DEC strain types. For individuals with >2 DEC isolates
collected from their longitudinal stool samples, we compared the phylogenetic relatedness of those
isolates using StrainSifter189 (Fig. S3.11). The single nucleotide variation (SNV) per megabase of
isolates from the same individual was highly variable, ranging from 0 to 16,833 SNVs. For
example, DEC isolates from HT-P041 on day 33, 39 and 45 had zero SNVs, suggesting a single
strain of E. coli had persisted in that individuals gut throughout the two week period (highlighted
yellow). In contrast, isolates cultured from the diarrheal sample of TD-P004 collected on day 77
differed by 9,187 SNVs per megabase, suggesting simultaneous colonization by distinct DEC
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strain types (highlighted blue). In most cases, these isolates also showed distinct resistome profiles.
Co-existence of multiple DEC strains with distinct resistome profiles in a diarrheal sample can
potentially affect the ability to treat diarrhea by antibiotic therapy. Just as the gut microbiota of
HT subjects was more temporally-stable compared to the TD subjects, a similar stability pattern
exists for DEC isolates. We calculated the pairwise SNV count from isolates collected
longitudinally from the same subjects, and observed increased stability in HT (HT median pairwise
SNV count = 5,218; TD median SNV count = 8.922; P=0.02, t-test).

3.3 Conclusions
Here, we report the first large-cohort longitudinal interrogation of host microbiotapathogen interactions and acquisition of MDRO during travel to high-infectious burden regions.
We observed travelers’ gut microbiome and resistome compositions diverging significantly from
their baseline gut microbial architecture, with the greatest change occurring during the first month
of stay. This is likely explained by living in a non-native environment with different microbial
ecologies and changes in diet. The microbiomes of HT subjects showed remarkable temporal
stability, while those of TD subjects were less stable and had greater variation. The overall
temporal stability of traveler’s gut microbiomes was attributed to higher baseline microbial
diversity. During diarrheal episodes we observed a dysbiotic microbial architecture marked by the
enrichment of Bacteroidetes and Proteobacteria, and depletion of Firmicutes, similar to what has
been shown previously31. Unlike native population studies171, the microbiomes of our non-native
travelers did not return of pre-diarrheal state even after 1 month of diarrheal episode, suggesting
metagenomic scars that could lead to health consequences. We also identified several taxa that
were differentially abundant between non-diarrheal and diarrheal samples, which were used to
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develop a classification model that can distinguish diarrheal from non-diarrheal samples. This
underscores the ability of microbiome-based biomarkers to differentiate between disease and
health, but more mechanistic studies with model systems like gnotobiotic animals would be needed
to elucidate the role of these species in inhibition or proliferation of intestinal pathogens.
By complementing metagenomic sequencing with functional metagenomics, we
comprehensively assessed the ARGs harbored by traveler’s gut microbiota. In contrast to other
studies, we found that travelers’ resistomes are temporally stable throughout their stay, with
marginal increases in ARG abundance over time. This difference can be partially attributed to
different travel destinations, as the country and region visited can have profounds effect on ARG
acquisition. On the other hand, we found that diarrheal events significantly altered the travelers
resistome, resulting in the enrichment of ARGs—particularly those encoded by Enterobacteriaceae
species. This observation was corroborated by quantitative analysis of diarrheagenic E. coli
isolates (a key member of Enterobacteriaceae family). We found isolates from TD subjects
encoded more resistance genes than isolates from HT subjects, even during asymptomatic periods.
We further identified ARGs strongly associated with TD subjects and found a small cluster of
plasmid-borne, resistance-conferring genes (blaTEM-148, sul2, aph6, and tetA) likely able to be
mobilized through horizontal gene transfer (HGT). Collectively, these observations suggest that
travelers’ diarrhea is a significant risk factor for increased carriage of MDRO E. coli. The
acquisition of these MDRO strains can have long term consequences for the traveler, such as HGT
of ARGs to another pathogen causing to treatment failure or longer hospitalization, and public
health systems, as they can spread to new host upon return.
Although we identified antibiotic use for prophylaxis or treatment during travel as a
significant risk factor for increased ARG carriage, we were unable to separate the effect of specific
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antibiotics. Controlled intervention studies focused on the impacts of specific antibiotic treatments
and/or prophylaxes (e.g., prebiotics, probiotics, synbiotics) on the gut microbiome and resistome
could further inform best practices to mitigate the collateral damage from antibiotic use during
travel. It is unlikely that our conclusions about specific taxa and ARGs can be translated for travel
to other countries with different infectious diseases burdens and ARG abundances, but our more
broad conclusions about microbiome and resistome dynamics and acquisition of MDROs could be
generalizable. Further multi-cohort travelers’ studies to countries with different infectious disease
burden are warranted to best inform treatments and mitigation strategies that minimize microbial
disruption and MDRO acquisition during travel, TD and antibiotic use.

3.4 Methods
Study design and cohort overview: For this study, we recruited international travelers
who traveled to Cusco, Peru, mainly from US and European countries, to study foreign language
at Amanita Spanish School in Cusco, Peru. Study doctors explained the purpose and procedure of
the study to students as soon as they arrive in Cusco, Peru, and were invited to participate. Upon
agreement, written consent form and a standardized questionnaire that collects demographic and
medical history data is obtained from the participants. This includes the information about
participant’s background, their stay in Cusco, medical history, recent travel history, prior
vaccination etc. (Form A in Supplemental Information). Our inclusion criteria included individuals
who are 18 years or older, have proficiency in the English language and filled out the consent
form. After enrollment, each subject was asked to provide a baseline stool sample with their next
bowl movement. Each subject then received the stool collection kit and guidelines describing how
to use it. We also provided detailed explanation of diarrhea episode as defined by the study (one
or more semi-liquid or watery stool accompanied with symptoms like abdominal pain, cramping
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and nausea), so that the study subjects can collect the samples before taking any medication,
particularly antibiotics. Subjects were then asked to provide samples on the weekly basis,
irrespective of whether they had diarrhea or not, throughout their stay. These samples were
delivered to the study site within 24 hours or placed in the designated refrigerator by the subject
In case of diarrhea episode, the subject collected the stool sample and reported to the study
physician within 24 hours of illness. The subjects were then interviewed daily to document their
symptoms and signs on each day of the diarrheal episode. The study physician also took the vital
signs and symptoms of the subject’s illness and filled the form that addressed specific questions
related to the diarrheal event (Form B in Supplemental Information). Two consecutive diarrhea
episodes were treated as independent events if they are lapsed by at least seven days of full
recovered period. Subjects were de-identified and were classified as Healthy Travelers (HT) and
Travelers with Diarrhea (TD) based on whether the participant had diarrhea episode during their
stay or not. Samples were also marked as Asymptomatic (A) and Diarrhea (D) based on whether
they were collected during a diarrheal episode or not. All samples collected in Cusco, Peru were
shipped overnight on dry ice from Peru to the U.S., and stored in a -80C freezer in the U.S.
Empirical selection of diarrhea samples: Diarrhea is a complex clinical infection and selfreported diarrhea events can be misleading. Prior diarrheal studies have collected rich
epidemiological and clinical data and developed scoring schemes to distinguish mild-to-moderate
events from the severe diarrhea cases. This includes Vesikari score specifically designed to
identify endpoint for rotavirus clinical trials, MAL-ED score, designed to evaluate diarrhea in
newborns during their first two years of life, and ADSS regression model to distinguish between
mild and severe case of diarrhea (requiring hospitalization) among adults. In this study, we
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implemented a multi-factor selection procedure using epidemiological and clinical aspects of
diarrhea to minimize the number of false positive diarrhea episodes.
To analyze the changes at the microbiome and resistome level during diarrhea episode, we
performed pairwise comparison between diarrhea samples with the before- and after-diarrhea,
collected within two weeks of the diarrhea event. In total, 144 diarrhea events were reported among
113 TD subjects, but we limited our analysis to the first diarrhea episode experienced by the
individual. Among them, five diarrhea samples were filtered out because of their low read count
(< 3.0 million reads), while remaining samples were filtered based on the metadata information
collected during diarrhea episodes. Diarrhea samples collected within the onset date and recovery
date were included for analysis. If the recovery date is missing, only those diarrhea samples
collected within two days of the onset date were included. In case, both the onset and recovery
dates are missing, only those diarrhea samples that have stool consistency of 3 or 4 (semi-liquid to
liquid) were included in the analysis. The filtered diarrhea samples were further evaluated using a
modified scoring strategy based on diarrheal symptoms reported by individuals (stool frequency,
nausea, vomiting etc) and macroscopic data collected in the lab (stool consistency), referred as TD
score. There are six scoring parameters in the TD score and each parameter is further divided into
thirds and assigns equal points based on severity of the symptom (1 point: bottom-third, 2 point:
middle-third, and 3 point: upper-third). These six parameters include stool frequency (in last 24
hours) and consistency, duration of diarrhea, participant-reported dehydration, presence of
behavioral signs like nausea, fatigue, headache, bloating, anorexia and presence of clinical
symptoms like fever (temperature > 38C), Pulse rate (> 100), blood in stool (Yes/No). We
analyzed the TD score validity by comparing it with individual factors such as stool grade,
maximum stool frequency in 24 hrs and duration of diarrhea (in days). While the individual factors
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do not necessarily correlate with each other, the TD score was significantly correlated with the
given etiological factors. Diarrheal samples with TD score greater than 1.5 were included in the
analysis. In total, we obtained 102 diarrhea samples after the above filtering procedure. We further
obtained the non-diarrheal samples collected within two weeks of the diarrhea event (before- and
after-diarrhea) and included only those participants that have at least two samples included after
filtering. These samples were analyzed for their changes in the alpha diversity (measured by
Richness and Shannon Index) and resistome (measured by Richness, Shannon index and Total
RPKM) during diarrhea episode.
Stool specimen processing: Collected fecal samples were brought to the lab and were stored at 80 °C after an aliquot was placed on Cary Blaire medium for bacteria and parasite analyses. These
samples were examined macroscopically for consistency and appearance, microscopically for
parasite detection and fecal leukocytes, and underwent routine stool culture followed by
antimicrobial sensitivity testing. Cary Blaire specimen of stool samples were cultured for bacterial
enteropathogens like Campylobacter, Escherichia coli, Salmonella, Shigella, Aeromonas, Vibrio
and Plesiomonas by conventional microbiological methods. Antibiotic sensitivity testing against
17 antibiotics (amoxicillin-clavulanate, ampicillin, azithromycin, ceftriaxone, chloramphenicol,
cephalothin, cefepime, ciprofloxacin, rifaximin, amikacin, gentamicin, imepenem, tetracycline,
and trimethoprim-sulfamethoxazole, ticarcillin, ticarcillin/clav, furazolidone) was performed by
disk diffusion method according to the Clinical and Laboratory Standards Institute (CLSI)
guidelines.
To fully assess the burden of disease due to bacterial enteropathogens, real time
florescence-based multiplex PCR was used to detect six types of diarrheagenic E. coli, Shigella
and Campylobacter. For diarrheagenic E. coli, we used eight different primers specific to different
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virulence genes in the same reaction. The target genes were aggR gene for enteroaggregative E.
coli (AggEC), st1a or st1b and it gene for enterotoxigenic E. coli (ETEC), eaeA gene for
enteropathogenic E. coli (EPEC), stx1 and stx2 gene for Shiga toxin-producing E. coli (STEC),
ipaH gene for enteroinvasive E. coli (EIEC), and daaD gene for diffusely adherent E. coli (DAEC)
(Guion, Ochoa et al. 2008). Shigella was detected through virulent gene specific PCR where
primers specific to ipaH virulence gene were used for amplification. Similarly, Campylobacter
was identified using ipxA virulence gene specific PCR. For the PCR reactions, nucleic acid was
extracted from the stool samples using Qiagen DNA stool extraction kit. Samples stored at -80 °C
were shipped to Washington University in St. Louis, MO where the samples were stored at -80 °C
until DNA extraction
DNA extraction and whole metagenome shotgun sequencing: Metagenomic DNA was
extracted from 400 – 600 mg stool samples using phenol – choloroform bead beating protocol as
described previously. DNA was then quantified using Qubit florometer dsDNA HS assay
(Invitrogen) and was stored at -20C. Metagenomic DNA was sheared to 300-400 bp length and
the shotgun sequencing was performed on Illumina HiSeq or NextSeq with 2 x 150 paired reads
at The Edison Center of Genome Sciences at Washington University in St Louis Raw sequencing
reads were demultiplexed and trimmed using Trimmomatic. Human contaminating reads were
identified and removed using Decon-seq. Post-cleaning, the average sequencing depth was 6.2
million reads per samples where samples with at least 3.0 million reads (Sample count: 710) were
used for downstream analysis.
Taxonomic and Functional profiling: The filtered metagenomes were taxonomically profiled
using Metaphlan2 with the default parameters. Species were removed if their relative abundance
was less than 0.01% in more than 90 percent of samples. Finally, 143 species were filtered in for
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downstream analyses. We further used HUMAnN2 in Uniref90 mode for functional profiling of
the metagenomes. HUMAnN2 builds a sample-specific pangenome of Metaphlan2 detected
species, quantifies the gene presence by mapping reads against pangenomes and generates
abundance profiles of gene families, categorized by the contributing species
Functional metagenomics library preparation, sequencing and analysis:

Functional

metagenomic library were prepared and sequenced as per the protocol previously described in
Boolchandani et al., 2017. Briefly, we constructed 21 functional metagenomics libararies from 210
stool samples by pooling 9-10 randomly selected metagenomics samples in each library.
Metagenomic DNA was extracted, sheared into 2 – 3 kb fragments and inserted in the pZE21
MCS-1 vector to create the metagenomics library. These libraries were then transformed into E.
coli cells, and selected on kanamycin resistant media plate for E. coli transformants. Each library
was then screened for antibiotic resistance genes against 15 antibiotics (ceftazidime,
chloramphenicol,

ciprofloxacin,

colistin,

cefotaxime,

cefepime,

cefoxitin,

gentamicin,

meropenem, nitrofurantoin, piperacillin, trimethoprim-sulfamethoxazole, tetracycline, tigecycline,
piperacillin-tazobactam). The resistance conferring E. coli transformants were then pooled, and
metagenomic inserts were amplified using vector-specific primers for PCR. The PCR product is
then isolated by purification, barcoded uniquely for each antibiotic selection and sequenced at
Illumina HiSeq 200 platform for 2 x 101 paired end reads at the Edison Center for Genome
Sciences and System Biology at Washington University in St Louis. Raw reads from the
sequencing platform were then demultiplexed by their barcodes, and were assembled into contigs
using PARFuMS (Parallel Annotation and Reassembly of Functional Metagenomic Selection), an
in-house pipeline specifically designed for high-throughput assembly and annotation of the
resistance conferring DNA fragments, and were annotated using AMR gene annotator pipeline
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called ResAnnotator (Github link). ResAnnotator filters assembled contigs based on their length
(default: > 500bp), predicts ORFs in the contigs using Prodigal and sequentially searches putative
amino acid sequences against known ARG databases viz. CARD, ResFinder, Resfams and NCBIAMR, using BLAST and HMM and assigns annotation with the confidence score. Using this
approach, 15,437 complete gene sequence were identified and were marked as resistance
determinants from this study.
ARG quantification in metagenomic samples: To quantify relative abundance of ARGs in the
metagenomic samples, we used ShortBRED113 to create high precision markers and quantify
ARGs presence based on these markers. We first built a comprehensive database of resistance
genes by combining resistance determinants from this study and 14 independent functional
metagenomics studies. We obtained the curated list of ARGs from these 14 studies using
ResAnnotator pipeline, combined them with curated ARGs from CARD and NCBI-AMR database
and resistance determinants from this study, and filtered the complete set based on sequence
identity to keep only unique ARGs. In total, we obtained a comprehensive set of 14,857 unique
ARGs which were then used to build marker families using “shortbred_identify.py” with the
following changes in the default parameters : -ref : Uniref90.fasta and -clustid 0.95.
The ShortBRED113 marker list consists 6,594 markers for 2,314 ARG gene families. These
marker gene families were then manually curated based on the following criteria to minimize the
number of false positives in the study. This includes:
1. genes associated with global gene regulators, two-component system proteins, and
signaling mediators (e.g. blaZ, vanS-vanR, mecI, mepR, gadW, marR),
2. genes encoding subunits that are part of multiple efflux pumps (e.g. tolC, oprM, opmD),
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3. confers resistance via mutation in genes (e.g. resistance to antifolate drugs via mutations
in dhfr, resistance to rifamycin via mutation in rpoB),
4. genes conferring resistance by modifying cell wall charge (e.g mprF),
5. genes that reduce permeability (omp38, tmrB) or confer resistance through overexpression
(e.g. Thymidylate synthase), and
6. general efflux pumps that came through functional selections (MFS-type, ABC-type)
The gene markers from filtered set of 2,314 ARG gene families were then used to quantify the
abundance of ARGs across all metagenomics samples using “shortbred_quantify.py” with default
set of parameters.
Metadata analysis: Demographic factors, medical history and dietary habits were evaluated for
their association with diarrheal outcome of the participant (HT/TD) using univariate logistic
regression model.
Microbiome Network Construction: The unsupervised microbiome co-occurrence network was
created for both the diarrhea and the non-diarrheal samples using species level relative abundance
of the microbes using SparCC algorithm. To account for significant difference in diarrheal and
non-diarrheal sample count, both sample sets were filtered. The non-diarrheal samples were
filtered to include the samples that were taken within first two weeks of arrival of the travelers
Likewise, diarrhea samples were filtered to include samples that correspond to first diarrhea event
in the TD travelers. SparCC calculates the correlations between the microbial species while taking
into account the sparsity and inherent compositionality in the microbe relative abundance data. For
the given diarrhea and non-diarrhea dataset, the true correlation values between different species
were obtained using “sparcc.py” with the default parameters. The “MakeBootStrap.py” was then
applied to generate 100 bootstrap tables from the raw microbe relative abundance table, which
77

were again used to calculate the SparCC correlation values using “sparcc.py”. Finally, the
correlation values from bootstrapped tables were used to obtain two-tailed p-value using
“PseudoPvals.py” command with the default set of parameters. We then selected only those
microbe-microbe relations that have p-value less than 0.05. The co-occurrence network of diarrhea
and non-diarrhea samples were drawn using igraph R package and compared using NetShift.
NetShift takes two co-occurrence networks as input and quantifies the changes in the interactions
of the individual node to identify the “driver taxa”. The key parameters for identifying the driver
taxa are NESH score, Jacard index and delta betweenness centrality.
Identification of covariates: To identify the metadata variables that significantly affects the
taxonomic profile, functional profile and resistome profile, we calculated the variance explained
by metadata variables using PERMANOVA with the adonis function of R package “vegan”. The
total variance contribution of each variable is calculated independent from other variables. The
significance value for metadata variables was determined using 1,000 permutations. To account
for repeated measurement in metadata variables that change over time (e.g. stool consistency,
sample type etc.), permutations were limited within the subjects. All p-values were corrected for
the multiple hypothesis testing using FDR correction. These metadata variables were included as
covariates in the downstream analyses.
Microbiome shift events: The temporal stability of the individual’s microbiome was assessed by
characterizing the microbiome “shift” events. Price et al., 2019 described the microbiome “shift”
occurrence when the Bray-Curtis dissimilarity index of two consecutive samples of an individual
was more likely to come from the distribution of Bray-Curtis dissimilarity index derived from
samples of different individuals. Based on this definition, we first obtained the distribution of
Bray-Curtis dissimilarity index between samples from different individuals of HT cohort and
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Bray-Curtis dissimilarity index between samples from same individuals of HT cohort at the
different ranges of time difference. The point at which inter-individual dissimilarity estimate
exceeds the intra-individual dissimilarity estimate is chosen as the threshold to define the
microbiome “shift” event (Bray-Curtis dissimilarity: 0.52). Further, we calculated the Bray-Curtis
dissimilarity between all consecutive samples for both the HT and TD subjects, and identified the
microbiome “shift” event based on the threshold value.
Differential Abundance Analysis: To gain insights into which microbial species are closely
associated with the diarrhea samples, we performed the multivariate association analysis
usingMaaslin2, a generalized additive linear mixed effect model that quantitatively captures the
effect of a single variable of interest, and removes the confounding effect of other metadata
variables. In this case, we used relative abundance of microbial species as our variable of interest
and added significantly associated metadata variables identified from PERMANOVA as
covariates. The effect of covariates, such as Age, Gender, and Region, were added as fixed
variables, was “subtracted out” and the calculated estimates only captures the contribution of the
given microbial species relative abundance. To account for the repeated measurements from same
individual, the subject ID was added as a random effect
Diarrheagenic E. coli isolate sequencing, assembly and annotation: The E. coli isolates frozen
in 15% glycerol were inoculated in 1.5 ml tryptic soy broth (TSB) and was grown overnight at 37
°C with shaking. Genomic DNA was extracted using Biostic Bactermia DNA isolation kit
following the manufacturer’s protocol. The DNA was quantified using Qubit florometer and was
stored at -20C. Isolate sequencing libraries were prepared as per the protocol previously described
in Bayme et al, 2015, and were sequenced on the Illumina NextSeq platform at the Edison Centre
of Genome Science at Washington University in St Louis. Total 207 isolate samples were
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sequenced with 2 x 150 paired end reads with >100x coverage. Raw reads from sequencing were
binned by the index sequence assigned to each sample. Adapter and index sequence trimming was
performed using Trimmomatic. Human contamination reads were removed by DeconSeq. Reads
were assembled using SPAdes using the following parameters Contigs with less than 500 bp were
removed from the downstream analysis. Assembly quality was assessed by CheckM. Genomes
were annotated using Prokka with default parameters. Multilocus sequence types were determined
using in silico MLST (https://github.com/tseemann/mlst). Species assignments were determined
by querying assemblies against a RefSeq sketch using Mash.
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3.6 Supplementary Figures and Tables

Figure S3.1: a) Timeline of sample collection and diarrheal episode among healthy travelers (HT, bottom)
and travelers with diarrhea (TD, top). The non-diarrhea samples are represented in green and diarrhea
samples are indicated in red with diarrhea duration indicated in pink color bars. b-d) Distribution of Age,
duration of stay, number of processed samples per subject in HT and TD subjects. e) Relationship as
measured by Spearman correlation between measurements (Stool frequency per day, diarrhea duration,
and stool grade) collected during diarrheal episode and ADSS. The ADSS threshold was used in
filtering/selection of diarrhea sample for analysis f) Distribution of number of antibiotics to which
diarrheagenic E.coli (DEC) isolates were resistant.
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Figure S3.2: Summary of shotgun metagenomics, isolates sequencing and functional metagenomics: a) Distribution
of unprocessed (yellow) and quality-filtered trimmed reads (blue) in metagenomics samples (n=718), b)
Distribution of cleaned reads (in millions) where samples with less than 3M cleaned reads were discarded. c)
Pairwise comparison of cleaned read counts across sample types from HT and TD subjects d) Total number of
contigs in each isolate assembly (highlighted in yellow) and the filtered contigs with length greater than 500bp
(highlighted in blue) e) Line plot depicting the completeness and contamination of isolate assemblies. Isolate
assemblies with > 90% completeness and < 5% contamination were included in the analysis (represented by green
bar on x-axis) while the remaining were excluded (red bar on the x-axis) f) N50 distribution against total length
for isolate assembly. The assemblies are color coded based on whether they were included or excluded based on
previously described criteria, and the shape represents the species: E. coli (circle) and Campylobacter (triangle).
g) Heatmap shows the number of resistant colonies observed while screening functional metagenomics libraries
(n=21) against 17 antibiotics.
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Figure S3.3: a) Principal Component Analysis (PCA) of samples collected before-(green), during-(red) and after(yellow) diarrhea episode b) Boxplot representing distribution of Bray Curtis distance calculated between HT
baseline sample and after one month sample (green), TD baseline sample and after one month sample given that
TD subject experienced diarrhea within a month of their arrival (red), and TD baseline sample and after one
month sample given the TD subject did not experience during this one month period (yellow). c) Distribution of
Bray–Curtis dissimilarity between the consecutive samples from the same subject (represented by blue curve)
versus those from different individuals (represented by red curve) to calculate Bray Curtis threshold (represented
by green line) that is used to define the “microbiome shift” event (Bray-Curtis threshold > 0.52). d) Relative
abundance of five major phyla in before- , during- and after-diarrhea samples. e) Distribution of
log(Firmicutes:Bacteroidetes ratio) in before-, during- and after-diarrhea samples. f) Top 12 species that were
repeatedly found to be significantly altered during the microbiome shift events. The first column is Non-diarrheal
– Non-diarrheal (ND-ND) shift events reported in both the HT and TD subjects, the second column is Nondiarrheal - Diarrhea (ND-D) shift events observed in TD subjects and third column is Diarrhea – Diarrhea (DD) events reported in TD subjects
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Figure S3.4: Relative abundance distribution of different species belonging to 4 different phyla in
diarrhea samples of TD subjects (red density plot), non-diarrhea samples of TD subjects (yellow density
plot) and non-diarrhea samples of HT subjects (blue density plot), normalized by the median relative
abundance of non-diarrhea HT samples. Thus, the x-axis on each plot is log10(abundance relative to
the median of non-diarrhea HT samples). Fraction of samples below detection limit are plotted in the
barplot on the left.
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Figure S3.5: a) Co-occurrence network of non-diarrhea (top) and diarrhea (bottom) samples. The size of the
node are proportional to relative abundance of the species. The edges between two nodes represents significant
correlation (green: positive; red: negative) between the two species. The orange highlighted region shows
Bacteroidetes that are enriched in diarrhea (right) compared to non-diarrhea (left) network. The blue highlighted
region shows conserved relationship among Firmicutes in both the networks. b) Common sub-network species
between diarrhea and healthy sample network. Nodes size is proportional to their scaled NESH score and species
that gained connectivity in diarrhea network compared to the healthy network are colored red. Connectivity
changes between the common sub-network are represented by connections between these species. c) Accuracy of
machine learning classifiers: Random Forest, Lasso and Enet. d) Heatmap shows the relative abundance of most
discriminatory taxa between diarrhea and non-diarrhea samples using Random forest model.

85

Figure S3.6: a) ARG compositional stability over time in HT(blue) and TD(orange) subjects measured by BrayCurtis index and Jacard index b) Comparison of 1-Bray-Curtis dissimilarity and 1-Jacard index between baseline
samples with subsequent samples from each subjects c) Change in prevalence of different types of antibiotic
resistance genes over their stay in Peru in weeks d) Increase in antibiotic resistance gene abundance is associated
with decrease in microbial diversity (at species level) of Ruminococcaceae, Eubacteriaceae, Coriabacteriaceae,
and Bifidobacteriaceae e) ARGs that showed significant change in cumulative abundance (RPKM in log scale)
during diarrheal episode.
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Figure S3.7: Distribution of relative abundance (RPKM) of ARGs in diarrhea samples of TD subjects (red density
plot), non-diarrhea samples of TD subjects (yellow density plot) and non-diarrhea samples of HT subjects (blue
density plot), normalized by the median relative abundance of non-diarrhea HT samples. The x-axis on each plot
is log10(RPKM relative to the median of non-diarrhea HT samples). Fraction of samples below detection limit are
plotted in the barplot on the left.
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Figure S3.8: a, b) The frequency of antibiotic resistance and virulent gene families identified in the genomes of
DEC strains isolated from asymptomatic (green) and diarrheal (red) samples. c, d) Prevalence of antibiotic
resistance and virulence genes in DEC isolates from diarrhea or asymptomatic samples.
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Figure S3.9: Co-occurrence matrix of accessory ARGs in isolates. The number within each cell represents the
total number of isolates that had both the pair of ARGs. ARGs that were significantly associated with plasmid
are marked with black squares ().
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Figure S3.10: Examples of arrangement of antibiotic reisstance gene (ARG) and mobile
genetic elements that are identified (within 5kb of ARG) on the same contig of DEC
isolates.
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Figure S3.11: Phylogenetic relatedness of DEC isolates assessed by Strainsifter, Average nucleotide identity,
Antibiotic resistance genes, and Virulence factors of DEC isolates from subjects that had >=2 DEC isolates.
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Table S3.1: Travelers cohort description and assessment of the risk factors associated with TD
Characteristics
Demographic factors
Gender
Female
Male
Age
Lodging in cusco
Other
Host Family
School Lodging
Missing
Country
Others†
Canada
Germany
Netherlands
Switzerland
United Kingdom
United States
Previous travel to
developing country
No
Yes
Missing
Previous travel in last 1
year
No
Yes
Total trip duration
(days)
Preventative measures
Typhoid vaccine
No
Yes
HepatitisA vaccine
No
Yes
Missing
Cholera vaccine
No
Yes
Missing

Total

All, N = 159

HT, N = 46

TD, N = 113

OR

95% CI

P-value

96 (60%)
63 (40%)
24 (20, 29)

30 (65%)
16 (35%)
23 (19, 28)

66 (58%)
47 (42%)
24 (21, 29)

--1.34
1.02

--0.66, 2.77
0.99, 1.06

0.427
0.214

14 (8.9%)
52 (33%)
91 (58%)
2

4 (8.9%)
16 (36%)
25 (56%)
1

10 (8.9%)
36 (32%)
66 (59%)
1

--0.9
1.06

--0.22, 3.15
0.27, 3.48

0.874
0.932

25 (16%)
10 (6.3%)
21 (13%)
17 (11%)
19 (12%)
14 (8.8%)
53 (33%)

7 (15%)
4 (8.7%)
8 (17%)
4 (8.7%)
7 (15%)
3 (6.5%)
13 (28%)

18 (16%)
6 (5.3%)
13 (12%)
13 (12%)
12 (11%)
11 (9.7%)
40 (35%)

--0.58
0.63
1.26
0.67
1.43
1.2

--0.12, 2.86
0.18, 2.19
0.31, 5.67
0.18, 2.41
0.32, 7.69
0.39, 3.45

0.492
0.468
0.747
0.534
0.653
0.743

1.13

0.54, 2.42

0.751

107 (68%)
51 (32%)
1

32 (70%)
14 (30%)
0

75 (67%)
37 (33%)
1
0.8

0.35, 1.72

0.571

1

0.99, 1.01

0.712

0.73

0.35, 1.49

0.396

0.44

0.07, 1.78

0.308

2.82

0.96, 10.4

0.08

159

159
157

159

158

159

159

43 (27%)
116 (73%)

11 (24%)
35 (76%)

32 (28%)
81 (72%)

35 (21, 54)

35 (23, 52)

35 (21, 54)

159
60 (38%)
99 (62%)

15 (33%)
31 (67%)

45 (40%)
68 (60%)

144
12 (8.3%)
132 (92%)
15

2 (4.7%)
41 (95%)
3

10 (9.9%)
91 (90%)
12

79 (75%)
27 (25%)
53

26 (87%)
4 (13%)
16

53 (70%)
23 (30%)
37

106
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Received any
preventative medicine
info
No
Yes
Health history
Pre-existing bowel
disease†
No
Yes
GERD or Dyspepsia†
No
Yes
Lactose intolerant
No
Yes
Other disease†
No
Yes
Diarrhea in last 2 weeks
No
Yes
Missing
Antibiotics at
enrollment
No
Yes
Dietary habits at
enrollment
Raw fruits or vegetables
Rarely or Never
Sometimes
Almost Always or
Always
Tap water or unbottled
beverages
Rarely or Never
Sometimes
Almost Always or
Always
Under cooked meat
Rarely or Never
Sometimes
Almost Always or
Always
Add sauces to food

159
29 (18%)
130 (82%)

9 (20%)
37 (80%)

43 (93%)
3 (6.5%)

139 (87%)
20 (13%)

44 (96%)
2 (4.3%)

95 (84%)
18 (16%)

146 (92%)
13 (8.2%)

40 (87%)
6 (13%)

106 (94%)
7 (6.2%)

143 (90%)
16 (10%)

43 (93%)
3 (6.5%)

100 (88%)
13 (12%)

109 (69%)
49 (31%)
1

33 (72%)
13 (28%)
0

76 (68%)
36 (32%)
1

159

159

158

159
40 (87%)
6 (13%)

107 (67%)
37 (23%)

30 (65%)
11 (24%)

77 (68%)
26 (23%)

15 (9.4%)

5 (11%)

10 (8.8%)

159
135 (85%)
15 (9.4%)

36 (78%)
8 (17%)

99 (88%)
7 (6.2%)

9 (5.7%)

2 (4.3%)

7 (6.2%)

159
120 (75%)
35 (22%)

34 (74%)
11 (24%)

86 (76%)
24 (21%)

4 (2.5%)

1 (2.2%)

3 (2.7%)
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1.55

0.46, 7.08

0.52

4.17

1.14, 26.9

0.063

0.44

0.14, 1.44

0.162

1.86

0.57, 8.42

0.35

1.2

0.57, 2.62

0.632

0.37

0.11, 1.26

0.105

0.89

0.54, 1.52

0.668

0.78

0.42, 1.48

0.418

0.93

0.48, 1.90

0.844

1.25

0.76, 2.08

0.372

107 (95%)
6 (5.3%)

159

159

0.782

102 (90%)
11 (9.7%)

159

147 (92%)
12 (7.5%)

0.45, 2.65

20 (18%)
93 (82%)

159
145 (91%)
14 (8.8%)

1.13

Rarely or Never
Sometimes
Almost Always or
Always
Wash hands before
eating
Rarely or Never
Sometimes
Almost Always or
Always
Dietary habits at
completion
While in peru did you
eat raw fruits or
vegetables
Rarely or Never
Sometimes
Almost Always or
Always
While in peru did you
drink local water
Rarely or Never
Sometimes
Almost Always or
Always
Missing
While in peru did you
drink unbottled
beverages or with ice
Rarely or Never
Sometimes
Almost Always or
Always
Missing
While in peru did you
eat raw undercooked
meat
Rarely or Never
Sometime
Missing
While in peru did you
add sauces to food
Rarely or Never
Sometimes
Almost Always or
Always
Missing

41 (26%)
82 (52%)

16 (35%)
19 (41%)

25 (22%)
63 (56%)

36 (23%)

11 (24%)

25 (22%)

18 (11%)
45 (28%)

6 (13%)
12 (26%)

12 (11%)
33 (29%)

96 (60%)

28 (61%)

68 (60%)

128 (81%)
25 (16%)

34 (74%)
10 (22%)

94 (83%)
15 (13%)

6 (3.8%)

2 (4.3%)

4 (3.5%)

159

159

125
112 (90%)
8 (6.4%)

32 (86%)
2 (5.4%)

80 (91%)
6 (6.8%)

5 (4.0%)
34

3 (8.1%)
9

2 (2.3%)
25

126
70 (56%)
47 (37%)

20 (54%)
16 (43%)

50 (56%)
31 (35%)

9 (7.1%)
33

1 (2.7%)
9

8 (9.0%)
24

105 (87%)
16 (13%)
38

30 (86%)
5 (14%)
11

75 (87%)
11 (13%)
27

121

121
38 (31%)
53 (44%)

10 (29%)
16 (46%)

28 (33%)
37 (43%)

30 (25%)
38

9 (26%)
11

21 (24%)
27

95

1.04

0.62, 1.69

0.886

0.69

0.36, 1.34

0.257

0.63

0.28, 1.44

0.256

1.11

0.61, 2.11

0.734

0.88

0.29, 2.99

0.826

0.91

0.54, 1.54

0.724

While in peru did you
wash hands before
eating
Rarely or Never
Sometimes
Almost Always or
Always
Missing

121

0.81
9 (7.4%)
34 (28%)

3 (8.6%)
7 (20%)

6 (7.0%)
27 (31%)

78 (64%)
38

25 (71%)
11

53 (62%)
27

0.40, 1.51

0.515

Statistics presented: Median (IQR) for 'Age' and 'Total duration in days' ; n (%) for all other categorial variables
p-value = Estimated by univariate logistic regression
q-value = False discovery rate correction for multiple testing
OR = Odds Ratio, CI =Confidence Interval
HT = Healthy Travelers
TD = Travelers Diarrhea
GERD† = Gastroesophageal reflux disease
Pre-existing bowel disease† = ‘Diarrhea-predominant IBS’, ‘Constipation-predominant IBS’, ‘Functional diarrhea’, ‘Functional Constipation’
Other countries† = 'Australia', 'Austria', 'Brazil', 'Belgium', 'France', 'Hong Kong', 'Israel', 'Italy', 'Norway', 'Sweden'
Other diseases† = ‘Asthma’, ‘Insomnia’, ‘Narclepsy’, ‘Migranes’, ‘Hypothyrodism’, ‘Osteoarthritis’

Table S3.2: Summary of enteric pathogens detected using multiplex PCR and their association analysis with
diarrhea outcome
Overall, N
= 718

Characteristic
N
Diarrheagenic E.coli (DEC)
EAEC
696 47 (6.9%)
EPEC
696 48 (7.1%)
ETEC
696 39 (5.8%)
DAEC
696 33 (4.9%)
STEC
696 18 (2.7%)
EIEC
696
4 (0.6%)
Other bacterial pathogens
Campylobacter
Shigella
Viral pathogens
Norovirus
Infection type
No pathogen
detected
Mixed
pathogens
detected
Any pathogen
detected

Nondiarrhea, N
= 574

Diarrhea,
N = 144

OR

95% CI

p-value

q-value

40 (7.4%)
38 (7.0%)
22 (4.1%)
26 (4.8%)
12 (2.2%)
3 (0.6%)

7 (5.2%)
10 (7.4%)
17 (13%)
7 (5.2%)
6 (4.4%)
1 (0.7%)

0.69
1.06
3.42
1.09
2.05
1.34

0.30, 1.57
0.51, 2.19
1.70, 6.88
0.46, 2.56
0.76, 5.58
0.14, 13.0

0.372
0.872
<0.001
0.851
0.158
0.8

0.496
0.872
0.002
0.872
0.237
0.872

696
696

18 (2.6%)
3 (0.4%)

7 (1.3%)
1 (0.2%)

11 (7.7%)
2 (1.4%)

6.57
7.91

2.50, 17.3
0.71, 87.9

<0.001
0.092

0.002
0.158

696

29 (4.2%)

18 (3.2%)

11 (7.7%)

2.51

1.16, 5.43

0.02

0.04

696

479 (69%)

399 (72%)

80 (56%)

0.5

0.34, 0.74

<0.001

0.002

696

20 (2.8%)

11 (1.9%)

9 (6.2%)

3.41

1.39, 8.40

0.008

0.018

696

217 (31%)

155 (28%)

62 (44%)

2

1.35, 2.96

<0.001

0.002
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Chapter 4: Destination shapes antibiotic
resistance gene acquisition, abundance
increases, and diversity changes in Dutch
travelers
Antimicrobial resistant bacteria and their antimicrobial resistance (AMR) genes can spread
by hitchhiking in human guts. International travel can exacerbate this public health threat when
travelers acquire AMR genes endemic to their destinations and bring them back to their home
countries. We prospectively investigated the abundance, diversity, function, and context of AMR
genes in the fecal microbiomes of 190 Dutch individuals, before and after travel to diverse
international locations. Through a powerful combination of whole metagenome shotgun
sequencing, functional metagenomics, and statistical modeling, we found that travel markedly
increases the abundance and α-diversity of AMR genes in the travelers’ gut resistomes. We also
determined distinct geographical destination correlations to these gut resistome changes. Finally,
we identified and detailed specific acquisition events of high-risk AMR genes (e.g., mcr-1,
blaCTX-M-1) borne on mobile genetic elements. These results highlight the putative risks that
international travel poses to public health by gut resistome perturbation and the global spread of
locally endemic AMR genes.

4.1 Introduction
Antimicrobial resistance (AMR) is a major global public health threat with a high mortality
cost56-60,

190

. AMR bacterial infections now frequently render antibiotics ineffective and limit
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clinicians’ antibiotic treatment options. This trend threatens 70 years of progress in treating
bacterial infectious diseases.
AMR is rising worldwide, but there are large geographic differences in the prevalence and
type of resistant bacteria and their AMR genes143, 191. Low- and middle-income countries generally
have higher endemic AMR than high income countries, mainly driven by the overuse of antibiotics
in humans and animals143, 190-193. International travel can facilitate transfer of resistant bacteria and
AMR genes from their endemic regions to other locations around the globe32, 35, 75, 194-198.
An AMR gene’s ability to spread via international travel is context dependent64, 75, 145.
Context includes the AMR gene’s prevalence in the endemic region, the specific bacteria harboring
the AMR gene, and the other genetic elements colocalized with the gene. AMR genes such as
extended spectrum β-lactamases (ESBLs), qnr, and mcr-1 are often associated with mobile
genetics elements like plasmids, and are of particularly high concern due to their ease of spread75,
143, 199-201

.

Returning travelers are rarely tested for resistant bacteria or AMR genes unless they
manifest clinical symptoms, so the magnitude of AMR gene acquisition risk from international
travel remains underdetermined. Using microbial culture, studies have shown significant
acquisition rates of opportunistic pathogens, such as ESBL-producing Enterobacteriaceae197, 198,
202, 203

. These studies identified specific pathogenic bacteria acquired during international travel,

and several identified specific AMR genes acquired during travel197, 204, 205. But the effect of
international travel on AMR is most likely not limited to opportunistic pathogens such as E. coli
or to ESBL-encoding resistance genes. A broader risk assessment must include acquired
commensals and their potential horizontal transfer of AMR genes with host microbiomes.
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Rapid advancements in sequencing technology, bioinformatics, and database curation
facilitate quantitative insight into the human microbiome’s role as an AMR reservoir in a broader
context and how this role might be influenced by international travel143, 206. We can sequence all
extracted DNA using shotgun metagenomic sequencing143, 206, 207, and we can directly identify
AMR genes in these shotgun metagenomes by mapping reads to curated AMR gene databases143,
206

. Though AMR gene databases and identification techniques have made significant

advancements in recent years, they still rely heavily on traditional microbiological culture that
excludes many bacteria206. Functional metagenomics is a powerful complementary method to
more broadly survey AMR determinants without a reliance on culturing resistant bacteria143, 206,
208

. Instead functional metagenomics uses a cultivable indicator bacterium to identify functional

AMR determinants from metagenomic samples via recombinant gene expression and phenotypic
selection208.
Here we combine next-generation sequencing, functional metagenomics, and statistical
modeling to investigate the abundance, diversity, function, context, and acquisition of AMR genes
in a group of international travelers. Our results demonstrate that international travel is a significant
perturbation to the gut resistome and reveal destination specific changes to travelers’ resistomes
including AMR gene acquisitions against last resort antibiotics and AMR gene colocalization with
mobile genetic elements. These findings further our understanding of the role of travelers as
potential reservoirs and spreaders of AMR.
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4.2 Results
4.2.1. Cohort description and generation of a functional metagenomics
augmented resistance marker database
To understand the effects of travel on the human gut resistome, we whole shotgun
metagenomic sequenced and analyzed fecal samples from 190 Dutch individuals collected
immediately before and after they traveled internationally to 4 different geographic regions (Fig.
4.1). Our cohort visited Northern Africa (n=43), Eastern Africa (n=44), Southern Asia (n=51), and
Southeastern Asia (n=52), yielding 380 samples (190 before travel and 190 after travel). 174 study
participants denied using antibiotics during the observation period while 10 participants claimed
antibiotic use (6 participants answered unknown).

Figure 4.1: Study design and sample collection. Destinations for Dutch travelers:
190 Dutch individuals’ gut microbiomes were samples before and after traveling
(380 total samples) to 4 different sub regions (Northern Africa, Eastern Africa,
Southern Asia, and Southeastern Asia)

The majority (n=170) were traveling on holiday, with a minority traveling for business
(n=6), to visit relatives (n=4), and for religious purposes (n=10). Participants were adults with a
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median age of 50.7 (IQR 32.5–59.2) years. To improve on AMR gene detection offered by
conventional AMR databases, we pooled our cohort stool samples within travel destination to
make 21 functional metagenomics libraries, which we screened against 15 antibiotics (Fig. S4.1)13,
208

. These libraries yielded resistant transformants for every antibiotic screened except meropenem.

By combining sequences from known AMR gene databases (CARD185, NCBI-AMRFinder186) and
from our functionally selected AMR genes, we generated a custom ShortBRED140 database with
6,585 marker sequences corresponding to 2,331 AMR gene families.

4.2.2. Travel increases AMR gene abundance and a-diversity but decreases bdiversity.
We used our custom ShortBRED database to profile the gut resistome in our 380 Dutch
traveler samples. We then compared the pre- and post-travel samples for AMR gene abundance
and diversity. AMR gene abundance in the gut microbiome was significantly higher (p=1.8e-5
[paired sample t-test]) in the post-travel compared to the pre-travel samples (Fig. 4.2A), indicating
that travel may enrich the microbiome for AMR determinants. This increase in abundance was
matched by increased α-diversity (Fig. 4.2B) measured by unique AMR genes (p<2e-16 [paired
sample t-test]) and by evenness of AMR genes in the resistome (p<3e-12 [paired sample t-test]).
These results suggest that travelers are acquiring new AMR genes abroad.
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Figure 4.2: AMR gene abundance and alpha-diversity increase with travel and AMR gene beta-diversity
decreases. A) The left panel shows AMR gene abundance in RPKM. Each point is a sample and the boxes are the
medians with interquartile ranges for the pre-travel samples in blue and the post-travel samples in red. The p-value
(paired sample t-test) for the comparison is given at the top of the panel. The right panel shows the difference
between the bootstrapped distributions of the post- and pre-travel samples. The red line gives the 95% confidence
interval for the difference and the point gives the estimate. B) AMR gene alpha-diversity measured by richness (top
left panel) and Shannon Index (bottom left panel) is compared between the pre-travel (blue) and post-travel (red)
samples. Each point corresponds to a given sample and each box gives the median and interquartile range for the
distribution. The p-value (paired sample t-test) for the comparison is given at the top of each panel. The panels to
the right of the boxplots show the difference between the bootstrapped distributions of the post- and pre-travel
samples. The red line gives the 95% confidence interval for the difference and the point gives the estimate. C) AMR
gene beta-diversity measured by Bray-Curtis dissimilarity is compared between the pre-travel (blue) and posttravel (red) samples. Each point is a comparison between two samples within the same timepoint group. The
distributions are shown to the right of the points and boxplots showing the median and interquartile ranges are
overlaid on top of the points. The p-value by paired wilcoxon test for the comparison is shown near the top. In the
right panel lines show the 95% confidence intervals and points show the mean values for the pre- (blue) and posttravel (red) Bray-Curtis dissimilarity distributions.

Linear mixed-effects modeling of AMR gene abundance and α-diversity showed that while
the two measurements are significantly related (p<0.001), pre- or post-travel state significantly
impacts AMR α-diversity (p<0.001) even when AMR gene abundance is accounted for. Timepoint
also has a much larger effect size, indicating that travel is the major driver behind increases in αdiversity of the gut resistome.
While AMR gene α-diversity increased following travel, resistome β-diversity between
samples decreased (p<2e-16 [paired wilcoxon test]) (Fig. 4.2C). These results suggest that the
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pressure of travel on the resistome may increase resistome similarity between individuals despite
their different destinations. This finding could result from acquisition of similar AMR genes.

4.2.3. Unsupervised clustering separated pre- and post-travel samples into
distinct subclusters, suggesting composition differences.
Dirichlet multinomial mixture models209, an unsupervised method for clustering and
modeling metagenomics data, revealed significant bias for samples from the same collection
timepoint to group in the same metaresistome (p=1.36e-137 [Fisher’s exact test]) (Fig. 4.3A). Each
metaresistome is a multinomial parameter probability vector, fit from a Dirichlet prior, over the
resistance genes detected in our cohort. Together, the metaresistomes are the set of possible
probability distributions that could result in our 380 samples using multinomial random draws.
Thus, samples associated with the same metaresistome can be thought of as being drawn from the
same underlying probability distribution.
Of the 8 metaresistomes in the best fit mixture model, 6 showed a significant bias to either
the pre-travel (n=3) or post-travel (n=3) timepoint (Fig. 4.3B). Since each subject has two samples,
we determined if an individual’s pre- and post-travel samples grouped in the same metaresistome.
Instead we observed 150 travelers (79%) switched metaresistomes, indicating a travel-specific
effect in addition to subject random effects. Since we have underlying AMR gene probability
distributions for each metaresistome in our final mixture model, we can directly compare the
models together. The post-travel biased metaresistomes were characterized by higher α-diversity
and lower β-diversity (Fig. S4.2), mirroring the results we observed for the samples considered
individually.
Prior studies of non-travel resistome perturbations150,

151, 210

have used supervised

clustering from Bray-Curtis dissimilarity to determine group significance to resistome
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composition. Supervised clustering of our Dutch traveler resistomes also revealed significant
separation (p=2e-4 [permanova]) between the pre-travel and post-travel samples (Fig. S4.3A).
However, the 8 optimal metaresistomes from the Dirichlet multinomial mixtures and the

Figure 4.3: Travel outweighs subject effects in shaping resistome architecture. A) 95% confidence interval (red
line segment), odds ratio (red point), and p-value calculated by Fisher’s exact test for samples with the same
timepoint being drawn from the same metaresistome. The black vertical line at 1 shows the expected result under
the null. B) Each row in this plot corresponds to a metaresistome (m1-m8) in a Dirichlet Multinomial Mixture
Model of all traveler samples. The pie charts on the left are proportional in size to the number of samples in
each metaresistome. The fill of the chart corresponds to the number of individuals in the timepoint (pre-travel
in blue and post-travel in red). The network shows the number of individuals that transition from any model into
any other model following their return from abroad. The black lines indicate staying within the same model and
the green line indicate transition from one model to another model. The thickness and opacity of the lines
correspond to the number of people following that transition path. Node label sizes correspond to the number
of individuals in the model from the timepoint. Nodes filled in blue are significantly enriched in pre-travel
samples and nodes in red are significantly enriched in post-travel samples. The right panel shows the estimates
(points) and 95% confidence intervals (lines) for binomial tests of bias for pre- or post-travel samples. P-values
for the comparison (fdr corrected binomial test) are given above the lines. The expected estimate under the null
model is given by the dark black line at 0.5
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differences in the AMR gene diversity between metaresistomes suggest subclusters exist within
the pre-travel and post-travel timepoints.

4.2.4. Destination specific resistome signatures explain metaresistome
subclustering.
Though all four destinations had increased AMR gene abundance (Fig. 4.4A) and diversity (Fig. 4.4B), the magnitude of these differences varied and broadly agree with clinical
isolate resistance data published by the Center for Disease Dynamics, Economics, and Policy.
Resistome -diversity was significantly higher for individuals returning from Southeastern Asia
than from the other three destinations (Fig. S4.4). Individuals traveling to the same subregion also
had decreased interindividual resistome -diversity (p=0.016 [unpaired wilcoxon test]), suggesting
that having the same travel destination makes traveler resistomes more similar (Fig. S4.5). These
-diversity decreases were significantly larger in travelers returning from Southeastern Asia and
Eastern Africa than Northern Africa and Southern Asia (Fig. 4C).
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Figure 4.4: Travelers to different destinations cluster separately by resistome composition but show similar trends
by abundance and diversity metrics. A) The bottom panel shows the comparisons of AMR gene abundance before
and after travel to the four subregions in this study. Points correspond to samples and boxes give the median and
interquartile ranges. pre-travel is shown in blue and post-travel is shown in red. The p-values (fdr corrected paired
Wilcoxon tests) for comparisons within region between the pre- and post-travel samples are shown above each
comparison. The top panel shows the difference between the bootstrapped distributions of the post- and pre-travel
samples. The red line gives the 95% confidence interval for the difference and the point gives the estimate. B) AMR
gene α-diversity measured by Richness (left) and Shannon Index (right) is compared by region between the pretravel (blue) and post-travel (red) samples. Each point corresponds to a given sample and each box gives the
median and interquartile range for the distribution. The p-value (fdr corrected paired wilcoxon test) above each
comparison. The panels above show the difference between the bootstrapped distributions of the post- and pretravel samples for each destination. C) The left panel compares β-diversity for pre-travel (blue) and post-travel
(red) collections for the four travel destinations. The points are pairwise Bray-Curtis dissimilarity between two
samples and the boxes represent the median and interquartile ranges of the distributions. P-values (paired wilcoxon
test) are given above each comparison. The right panel shows the difference between the bootstrapped
dissimilarities of the pre- and post-travel groups.
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Thus, individuals returning from Southeastern Asia and Eastern Africa had more similar AMR
profiles to other travelers to the same destination than individuals returning from Northern Africa
and Southern Asia.
To interrogate these region-specific effects, we rebuilt Dirichlet multinomial mixture
models after separating the pre-travel and post-travel samples. Separating the timepoints removes
possible random effects due to subject identity allowing narrower focus on destination. This
analysis yielded 9 metaresistomes (4 in the pre-travel samples and 5 in the post-travel samples).
Though the pre-travel metaresistomes did not show significant bias by destination (p=0.485
[Fisher’s exact test]), the post-travel metaresistomes had strong regional bias (p=1.21e-23
[Fisher’s exact test]) (Fig. 4.5A). These results also appeared in supervised clustering where
destination significantly distinguished samples (Fig. S4.3B - S4.4C) after travel (p=4e-4
[permanova]) but not before travel (p=0.7021 [permanova]). This demonstrates that individuals
traveling to the same destination are far more likely to have their post-travel samples cluster in the
same metaresistome than their pre-travel samples.
Considering these destination signatures, we wanted to determine if the travelers’
resistomes looked similar to resident gut resistomes in their travel destinations. We used shotgun
metagenomic reads from a recently published cohort of fecal microbiomes from the Indian
subcontinent211. After profiling the Indian resistomes using our ShortBRED AMR protein marker
database, we found that the Dutch subjects returning from Southern Asia (which includes India)
had resistomes that were more similar to the Indian resistomes compared to subjects returning from
the other three subregions (Northern Africa p=2.2e-10; Eastern Africa p=2.1e-19; Southeastern
Asia p=1.4e-61 [unpaired Wilcoxon test]) (Fig. S4.6).
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The grouping effect of destination was strongest for Eastern Africa and Southeastern Asia
(Fig. 4.5B). This finding matches the previous results (Fig. 4.4C) where interindividual resistome
-diversity was lower in subjects returning from these two destinations. We can see from these

Figure 4.5: Travelers’ resistomes group significantly by region after travel and Southeastern Asia and Eastern
Africa have the strongest signature. A) 95% confidence intervals, odds ratios, and p-values for samples with the
same destination being drawn from the same metaresistome. Fisher’s exact tests were done for this comparison
within timepoint (y-axis). The black vertical line at 1 shows the expected result under the null. B) The left of this
Sankey diagram has models built from the pre-travel samples and the right has models built from the post-travel
samples. Each model has a pie-chart that shows the number of samples in the model (total of 190 for each timepoint)
and these pies are divided by destination. The lines connecting the pre- and post-travel models are colored
according to region (Dark blue is Northern Africa, light blue is Eastern Africa, orange is Southern Asia, and red
is Southeastern Asia) and their thickness is proportional to the number of samples that follow that path.
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analyses that the destination-specific effects result in individuals returning from the same
destination having similar post-travel resistome states despite diverse pre-travel states.

4.2.5. AMR gene abundance increases and acquisitions during travel are
concentrated in several AMR gene families and resistance mechanisms
We found a positive correlation between prevalence and abundance (p=1.23e-22) for AMR
genes in our Dutch traveler cohort (Fig. S4.7), but this correlation varies by AMR mechanism.
Efflux (p=6.73e-5), inactivation (p=2.76e-4), and target protection (p=7.87e-8) all had significant
positive correlations and the trend for antibiotic target alteration was also positive. In contrast, the
trend for antibiotic target replacement is nearly flat. This suggests that abundance of specific target
replacement AMR genes in the gut resistome is nearly independent of their spread.
We next assessed if abundance of these mechanisms changed following travel (Fig. 4.6A).
The abundance of genes encoding for target replacement (p=1.1e-9), efflux (p=3.4e-3), and
inactivation (p=8.0e-8) of antibiotics all significantly increased after travel. This indicates that at
the level of AMR mechanisms there is a significant effect of travel in structuring the gut resistome.
By further classifying the AMR genes families into gene classes defined by CARD ontology, we
observed that 11 of 20 detected classes had increased abundance in the post-travel samples
compared to the pre-travel samples (Fig. 4.6B). These data demonstrate that travel related
resistance gene increases are not limited to those identified by culture-based analysis. The
strongest effect was seen in the class A β-lactamases which inactivate several clinically important
antibiotics, though we did not observe class A carbapenemases. This is consistent with the lack of
resistant transformants observed against meropenem in our functional metagenomic libraries.
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We detected 56 AMR genes with significant evidence of acquisition after travel, compared
to only 4 showing significant loss following travel (Fig. 4.6C and Fig. S4.8), highlighting the heavy
bias of AMR gene acquisition in the post-travel samples. AMR genes for antibiotic efflux
(p=2.78e-6 [permutation test]) and for antibiotic target replacement (p=0.0295 [permutation test])
were both highly enriched in the significantly acquired set of genes. In contrast, AMR genes for
antibiotic target protection (p=8.29e-6 [permutation test]) were completely absent in the
significantly acquired genes (far less than predicted under a null model).

Figure 4.6: AMR gene abundance changes and acquisitions are unequal across AMR mechanisms. A) AMR
mechanism abundance is compared between pre-travel (blue) and post-travel (red) samples. Each point is a sample
and the boxes represent the median and interquartile range. P-values (fdr corrected paired wilcoxon test) for the
comparisons are given near the top of the panel. The top panel shows the difference between the bootstrapped
distributions of the post- and pre-travel samples. AMR classes where the 95% confidence interval does not cross 0
are red. B) AMR class abundance is compared between pre-travel (blue) and post-travel (red) samples. Each point
is a sample and the boxes represent the median and interquartile range. P-values (fdr corrected paired wilcoxon
test) for the comparisons are given near the top of the panel. AMR classes where the 95% confidence interval does
not cross 0 are red. C) AMR gene acquisitions or losses after travel. Each point is a AMR gene and points are filled
in according to their AMR mechanism. The red shaded region spans significantly acquired AMR genes, the blue
shaded region spans significantly lost AMR genes, and the gray shaded regions spans genes that were not
significantly acquired or lost. The diagonal line is the null of equal losses and gains for AMR gene. The inset panel
shows which AMR mechanisms were significantly acquired during travel by permutation testing. The colored
histograms show the expected distribution according to 10000 permutations and the black vertical lines show the
observed value (points in the red shaded region of the main plot).
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The diversity of AMR genes with significantly increased abundance and acquisition posttravel demonstrates the importance of expanding AMR analysis beyond ESBLs to the entire gut
resistome. For example, we detected two variants of tetX, an antibiotic-inactivating
monooxygenase which confers resistance against all clinically relevant tetracyclines, including last
resort antibiotics like tigecycline, eravacycline, and omadacycline212, 213. Tetracycline inactivation
AMR genes increased in abundance after travel (Fig. 4.6B), but acquisition was only significant
for one of two tetX variants (Fig. S4.8). The variant of tetX encoded in NCBI-AMR was not
significantly acquired during travel (0.59 CI [0.406-0.763], p=0.523 [binomial test]), while the
variant of tetX discovered in our functional selections was significantly acquired during travel
(0.75 CI [0.551-0.893], p=0.0247 [binomial test]).
AMR gene acquisitions were also significant when accounting for gene abundance. Models
with taxonomic covariates (Fig. S4.9) built at both the broad AMR gene classification level (Fig.
S4.10 - S4.12) and at the detailed single gene level all showed more AMR determinants associated
with the post-travel timepoint. Travel duration had a weak but significant effect on AMR gene
acquisition (Fig. S4.13).
A study by Langelier et al. in 2019 reported on the resistome in 10 travelers to Asia or
Africa165. Eight of these travelers went to Nepal, one went to Nigeria, and one went to Uganda.
The authors sampled the subjects once before travel and thrice after travel; they found increased
AMR genes against multiple antibiotic classes, including β-lactams, quinolones, and anti-folates.
This increase in AMR genes after travel mirrors our results and many of the AMR genes they
identified were also detected in our study. Interestingly, in contrast to the results in Langelier et
al., we saw increases in some tetracycline resistance genes and aminoglycoside resistance genes
after travel. For the tetracycline resistance genes, this may be explained by our more detailed
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consideration of resistance mechanism. We observed that while tetracycline inactivation
mechanisms significantly increased in abundance after travel, tetracycline ribosomal protection
mechanisms did not. In fact, none of the tetracycline ribosomal protection resistance genes were
significantly acquired during travel. Our study-specific functional metagenomic selection database
also provides higher sensitivity to detect AMR genes that may be underrepresented in conventional
AMR databases. Indeed, 51 of the 121 (42.1%) AMR genes detected and compared in our analysis
were from functional selections. The AMR genes identified in Langelier et al. are often found in
commonly cultured clinical isolates and thus are well represented in conventional AMR databases.
An individual’s gut resistome response to travel perturbation may parallel the response
from other non-travel gut perturbations, including hospitalization and antimicrobial treatment214,
215

. In a 2017 study of healthy patients compared to antibiotic treated patients hospitalized in an

ICU in the Netherlands, Buelow et al. found that healthy patients had enriched tetW and catA215;
both of these genes were also more likely to be found in our pre-travel than post-travel samples.
In contrast, the antibiotic treated ICU patient resistomes in the Buelow et al. study were enriched
for AMR genes such as erm and an aac(6') family gene, both of which were also acquired and
increased in our post-travel samples. In the case of antibiotic perturbation, the effects on the gut
resistome can vary based on the spectrum of the antibiotic114, 151, 210. However, there is commonly
an increase observed in the resistome α-diversity and a decrease in β-diversity210. This is similar
to our observations in response to travel perturbation. Additionally, some of these studies show a
time dependence for AMR gene acquisitions and abundance increases151, 210. This also parallels
the weak time dependence we show in our results. There are conflicting results on if these
antibiotic perturbations return to the initial state or leave persistent scars151, 216. Even if the travel
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related resistome changes revert to baseline, it is possible that the AMR genes will be disseminated
in the resident country before they are lost in the host.

4.2.6. Travelers to Southeast Asia had the most AMR gene acquisition and
Southeast Asian functional selections had high mobile genetic element burden.
Every destination showed significant AMR gene acquisition (Fig. 4.7A), with travelers to
Southeastern Asia having the highest AMR gene acquisition (0.73 CI [0.71-0.75], p=1.54e-85) and
those visiting Northern Africa having the lowest AMR gene acquisition (0.67 CI [0.65-0.70],
p=4.64e-35). Six of the 56 significantly acquired AMR genes identified in Fig. 4.6C were
significantly associated with travel destination (Fig. 4.7B and Fig. 4.7C). Travelers to Southeastern
Asia had the most acquisitions normalized by the number of subjects traveling to the region, for
all six genes. Three of these AMR genes were dfrA1 variants, which confer resistance against
trimethoprim. Each dfrA1 variant had a fold change increase between 3.62 and 3.92 in prevalence
in post-travel samples. Increases we saw in trimethoprim-sulfamethoxazole resistance genes (Fig.
4.6B and Fig. 4.7C) parallel results from Blyth et al. 2016 where 42% of post-travel E. coli isolates
had new resistance against trimethoprim-sulfamethoxazole196.
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There was a bias for aminoglycoside resistance gene ant3 to be acquired in Southeastern
Asia, and a bias for the macrolide resistance gene mphA to be acquired in Southeastern and
Southern Asia. tetA was the only AMR gene of these six with more acquisition events from Eastern
Africa than from Southern Asia though Southeastern Asia still had the highest acquisition rate.

Figure 4.7: AMR gene acquisitions and mobile genetic elements differed by travel destination. A) Significance of
AMR gene acquisitions by travel destination. Lines show the 95% confidence intervals and points show the
estimates of binomial tests for bias. Binomial tests were conducted by region for number of acquired AMR genes
and number of lost AMR genes. Both acquisitions and losses were normalized by the number of individuals traveling
to the region. P-values (fdr corrected) from this test are show just below the dotted line at 0.5 indicating the null.
Numbers lower than 0.5 indicate AMR gene loss and numbers greater than 0.5 indicate AMR gene gain. B) Genes
that showed significant region-specific bias following multinomial testing. Points indicate their number of
acquisitions normalized by number of travel subjects and p-values are given in the top left. C) Sankey diagram of
AMR gene acquisitions by travel region. Black nodes are when the gene was not found, and bright red nodes
indicate the gene was present. The width of all lines is proportional to the number of individuals following that
path. D, E) The number of MGE elements detected from the functional metagenomic libraries are plotted on the yaxis and the number of input (D) libraries and (E) reads are on the x-axis. P-values calculated by the fdr corrected
multinomial test are in the bottom left of each panel.
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Genomic context like colocalized mobile genetic elements impact AMR gene spread64, 75,
145, 217

. To search for AMR gene context, we assembled contigs from our travelers’ metagenomic

samples and searched for putative mobile genetic element annotations adjacent to AMR genes. In
these AMR containing contigs, we detected a higher burden of putative mobile genetic elements
in post-travel samples than in pre-travel samples (p=1.4e-10 [paired wilcoxon test]) (Fig. S4.14A).
This difference was significant across all regions (Fig. S4.14B), but not between travel destinations
(Fig. S4.15).
Destination differences did appear when we counted the number of mobile genetic element
associated annotations on contigs with AMR genes from our functional metagenomics data. We
split these counts based on sample destination for the inputs to the functional metagenomics
selections, and we found significant association between subregion and number of mobile genetic
element annotations. This was true when we normalized by the number of input reads (Fig. 4.7D)
or by the number of input libraries (Fig. 4.7E). Travelers to Southeastern Asia had the most mobile
genetic element associated annotations despite having fewer input reads and fewer input libraries.
Though travelers to Southeastern Asia had the highest number of mobile genetic elements adjacent
to AMR genes, travelers to Southern Asia and Eastern Africa also had comparable numbers.
Travelers to Northern Africa had far fewer AMR gene associated mobile genetic element
annotations than the other three regions. This is concordant with our findings showing that
travelers to Northern Africa also had lower AMR gene abundance and acquisition than other
destinations.
Our results suggest that the colocalization of mobile genetic elements with AMR genes
correlates with destination specific resistance gene acquisition and demonstrate the importance of
functional metagenomics data in detecting these differences. This fact is highlighted for subregion
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by the contrast between the lack of association with travel destination for MGE annotation counts
across all assemblies (not necessarily colocalized with AMR genes) as presented in Fig. S4.15 and
the strong association with travel destination in Fig.s 4.7D-4.7E showing annotations in the
functional selections where the mobile genetic elements are adjacent to AMR genes. The number
of mobile genetics elements adjacent to AMR genes may contribute to increases in AMR gene
burden post-travel.

Figure 4.8: Quinolone resista
-lactam resistance
genes had destination specific acquisition. A) AMR genes acquired or lost after travel detected by qPCR. Each
point is a AMR gene. The x-axis is the number of individuals that had the gene in the pre-travel timepoint, but not
in the post-travel timepoint. The y-axis is the number of individuals that had the gene in the post-travel timepoint,
but not in the pre-travel timepoint. Significant acquired AMR genes are in red. The number of significant genes is
tabulated in the top right. Non-significant genes are in black. The diagonal line is the null of equal losses and gains
for a AMR gene. The inset panel gives results from binomial tests of bias for AMR gene acquisition for the posttravel timepoint. Lines are 95% confidence intervals and points are estimates. P-values (fdr corrected binomial
test) are given at the bottom of the plot for each gene. The dotted line is the expected value under the null. Lines
and points are red if significantly acquired. B) Sankey diagrams of significant gene acquisitions by travel region
detected by qPCR. Black nodes are when the gene was not found, and bright red nodes indicate the gene was
present. Ribbon colors correspond to the destination countries (dark blue is Northern Africa, light blue is Eastern
Africa, orange is Southern Asia, and red is Southeastern Asia). The width of all lines is proportional to the number
of individuals following that path.
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4.2.7. qPCR detected high-risk AMR genes acquired by Dutch travelers
Concurrent with our comprehensive metagenomic resistome analysis, we specifically
targeted 16 clinically important AMR genes in our samples by qPCR. Of these 16, four genes
(tetM, tetQ, ermB, and mefAE) were present in all of the samples and two genes (qnrA and mcr-2)
were not present in any samples. We conducted acquisition analysis and destination bias analysis
for the remaining 10 genes.
Acquisition analysis showed that 6 of the 10 AMR genes that were present in at least 1
sample were significantly associated with the post-travel timepoint (Fig. 4.8A). Notably, mcr-1, a
high risk, plasmid borne, colistin resistance gene was found only in post-travel samples.
Quinolone resistance genes qnrB and qnrS were acquired in high proportion following
travel to all four subregions (Fig. 4.8B), but blaCTX-M-1, blaCTX-M-9, and mcr-1 had strong regionspecific effects (Fig. 4.8B and Fig. 4.9A). Over 80% of blaCTX-M-1 and blaCTX-M-9 -lactamase
acquisitions were in travelers to Asia. blaCTX-M-1 was predominantly acquired in Southern Asia
(61.8%) and blaCTX-M-9 was predominantly acquired in Southeastern Asia (82.1%). Uniquely, mcr1 was only acquired by travelers to Southeastern Asia (Fig. 4.9A).
These high-risk gene acquisitions are concordant with qPCR-based research of endemic
antibiotic resistance in our cohort’s travel destinations. A 2019 study from Bich et al. demonstrated
qnr endemicity in Vietnam. 100% carriage of qnr by qPCR of fecal samples from 93 Vietnamese
residents of the Ha Nam province218. This same study also found carriage of blaCTX-M-1 (38%) and
blaCTX-M-9 (61%). These results match well with the high acquisition rate we saw for these genes
in individuals traveling to Southeastern Asia and are also concordant with predominance we saw
of blaCTX-M-9 in travelers returning from Southeastern Asia.
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4.2.8. Dutch travelers to Southeastern Asia acquired mcr-1
We also observed that AMR genes in our cohort were often colocalized with mobile genetic
elements. mcr-1, a plasmid borne colistin resistance gene, was one of the most concerning genes
we detected. 18 of the 52 Dutch travelers to Southeastern Asia (34.6%) acquired mcr-1 during our
study. These acquisitions are consistent with Bich et al. where 88% of tested Vietnamese residents
carried mcr-1218. In comparison, a culture-based study219 by Arcilla et al. of ESBL-producing E.
coli isolates from 2001 participants (540 to Southeastern Asia) detected mcr-1 in 6 E. coli isolates,
indicating higher detection sensitivity for mcr-1 using qPCR directly from stool. These results are
also comparable to another culture based isolate study205 where 20 of 412 returning U.S. travelers
yielded mcr harboring E. coli.
To further investigate the high-risk mcr-1 colistin resistance gene, we assembled contigs
using the raw shotgun reads from the samples that were mcr-1 positive by qPCR and annotated
these contigs for mcr-1. One contig assembled from subject S032, a traveler returning from
Vietnam, was positive (Fig. 4.9). Plasmidfinder 2.0 identified subject S032’s mcr-1 containing
contig as an IncI2 type plasmid (100% identity and 100% template length using the
Enterobacteriaceae database)220, 221. A follow up study222 of the 6 isolates from Arcilla et al.219
demonstrated that one ESBL-producing E. coli from a traveler returning from Vietnam also
harbored mcr-1 on an IncI2 type plasmid.
We searched NCBI for the best BLAST match of subject S032’s mcr-1 containing contig
and the top hit (99.9% identity with 100% query coverage) was to a plasmid from a gastroenteritis
causing E. coli (Fig. 4.9B) isolated in Chiang Mai, Thailand (data from BioSample
SAMN10531954
Reference

[https://www.ncbi.nlm.nih.gov/biosample/SAMN10531954]
Sequence
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and

NCBI

NZ_CP034405.1

[https://www.ncbi.nlm.nih.gov/nuccore/NZ_CP034405.1]). In both plasmids (Fig. 4.9C), mcr-1 is
flanked by a tra cluster of conjugon transfer genes and mcr-1 is also colocalized with a virB cluster
type IV secretion system (T4SS). T4SS have known involvement in horizontal gene transfer223227

. There are prior reports of mcr-1 colocalization with T4SS in plasmids64, 228, though in those

studies mcr-1 was on different plasmid incompatibility types than IncI2.

Figure 4.9: mcr-1 containing contig from a Dutch traveler matched a plasmid sequenced from a gastroenteritis
patient in the destination region. A Sankey Network showing region specific acquisition for mcr-1. B Map showing
where the reference genome was isolated from a gastroenteritis patient. C Alignment between a plasmid from an
E. coli isolated from a gastroenteritis patient in Chiang Mai and a contig assembled from a Dutch traveler’s gut
microbiome.

In 2018, Wang et al. analyzed mcr-1 containing plasmids across a number of different
bacterial isolates from around the globe75. China and Vietnam were the two countries with the
most isolates harboring mcr-1 plasmids, which corresponds to our detection of mcr-1 in travelers
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to Southeastern Asia. The authors found that mcr-1 initially mobilized to plasmids through an
ISApl1 transposon. This is consistent with the reference plasmid in Fig. 4.9C.
Our mcr-1 results advocate for a combined approach of AMR gene detection. Short-read
shotgun metagenomic sequencing provided us with excellent data for understanding gut resistome
composition changes, diversity changes, and AMR gene acquisitions due to travel, but only 1 of
18 (5.6%) mcr-1 qPCR positive stool samples we assembled yielded an mcr-1 contig. However,
we show that AMR gene contig assembly yields important genomic context surrounding resistance
genes that could have implications for understanding and modeling AMR gene spread. Contig
assembly using short-read shotgun metagenomic sequencing may differ by AMR gene. For
example, we successfully assembled tetX in 56 of 143 (39.2%) ShortBRED positive samples.
Future studies may employ chromosome conformation capture or long-read sequencing in concert
with short-read sequencing to improve metagenomic assembly and give even more detailed
genomic context to resistance gene detection directly from stool206.

4.3 Conclusions
Global AMR spread threatens decades of success in treating bacterial infections with
antibiotics190, 193, 229-231. This problem is exacerbated by antibiotic resistant bacteria and AMR
genes spread worldwide by international travelers143,

232

. Our investigation of 190 Dutch

individuals’ gut resistomes before and after travel indicates international travel is a significant gut
resistome perturbation and highlights the extent of AMR gene acquisition. We found acquisition
of previously unknown AMR genes, increased AMR gene abundance, and increased resistome diversity in the post-travel samples. We also observed AMR gene colocalization with mobile
genetic elements and identified travel destination specific resistome signatures.
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Our study design was optimized to understand acquisition within travelers, and we do not
have samples from travelers’ contacts while abroad. Future investigation into travelers’ contacts
may resolve AMR gene transmission networks. We observed that grouping samples by subregion
better explain sample composition than grouping by continent. It is possible that we are missing
even more granular effects that would be found at the country or even city level79, 233.
Despite these limitations, our study illuminates novel insights regarding the effect of
international travel to low- and middle-income regions on the gut resistome of travelers from a
high-income country. We show that such travelers act as interactive biological units who acquire
and carry AMR genes, and we have detailed that these AMR genes include both known clinicallyrelevant AMR genes that are common in pathogens (e.g., mcr-1) and novel AMR genes with no
known homologs in current databases that we identified through functional metagenomics. We
also show AMR gene acquisition and carriage in the gut resistome is travel destination specific
with compositional signatures lasting at least until the traveler returns home. Importantly, the
spread of AMR genes and resistant bacteria is likely bi-directional. Pre-travel samples for our
Dutch cohort still contained resistant bacteria and AMR genes. Since the gut microbiota has
frequent contact with the outside environment, these bacteria and genes may also transfer from the
traveler to the destination region. Unfortunately, the spread of AMR may act combinatorically;
once AMR is established in a new locale, that locale becomes an acquisition risk for new incoming
travelers. However, these results are also a reason for hope; interventions and resources used in
low- and middle-income countries with current high endemic AMR burdens may have a
disproportionately positive effect on curbing the rise of AMR worldwide. Together, our results
show that global health concerns surrounding international travel as a vector for AMR spread are
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warranted, and they provide a template for future surveillance measures to consider the entire gut
resistome.

4.4 Materials and Methods
4.4.1 Sample collection and DNA extraction
Samples for this project were selected from a subset of the broader COMBAT study234, 235.
The methods for sample collection are described in detail Arcilla et al. 2014 and Arcilla et al. 2017.
Briefly, travelers were given fecal swab kits that included instructions, a modified Carey Blair
transport medium with an associated swab (Fecal Swab®; Copan, Brescia, Italy), and paid postage.
Before leaving for and immediately after returning from travel, subjects took samples from their
stool using the fecal swab kits and mailed them to the lab.
We limited selection to travelers to Southeastern Asia, South Asia, North Africa, and Eastern
Africa to have sufficient numbers per subregion. Travelers were excluded if they visited multiple
subregions or consumed antibiotics in the three months before travel. Selections were made by
stratified random sampling using SPSS.
Metagenomic DNA was extracted from stool samples using repeated bead-beating (RBB)
combined with column-based purification according to protocol Q (IHMS_SOP 06 V2 http://www.microbiome-standards.org/index.php?id=253)

of

the

International

Human

Microbiome Standards consortium236. Bead-beating was done using the FastPrep™ Instrument
(MP Biomedicals, Santa Ana (CA), USA) with 0.1 mm zirconium-silica beads (BioSpec Products,
Bartlesville (OK), USA) to homogenize feces. DNA was finally purified by adapting to QIAamp
DNA Stool Mini kit columns (Qiagen, Hilden, Germany). A Qubit® fluorometer dsDNA HS
Assay (Invitrogen) was used to quantify extracted DNA and this DNA was stored at -20°C.
122

Extracted metagenomic DNA was diluted to 0.5 ng/L and prepared for sequencing with a Nextera
DNA Library Prep Kit (Illumina) using a modified Nextera protocol237. Libraries were purified
using the Agencourt AMPure XP system (Beckman Coulter) and quantified using the Quant-iT
PicoGreen dsDNA assay (Invitrogen). For each sequencing lane, 10 nM of approximately 96
samples were pooled three independent times. These pools were quantified using the Qubit®
dsDNA BR Assay and combined in an equimolar fashion. Samples were submitted for 2x150 bp
paired-end sequencing on an Illumina NextSeq High-Output platform with a target sequencing
depth of 5 million reads per sample.

4.4.2 Functional metagenomics
Samples were pooled according to destination for the functional metagenomics pipeline.
Functional metagenomics was conducted using the protocol outlined in Boolchandani et al.
2017208. Briefly, 190 post-travel samples were divided based on four different travel regions, and
up to ten random samples from each region were pooled together to form each metagenomic library
(Fig. S4.1). We constructed 21 metagenomic libraries where 4 to 6 libraries represent each region,
and each library was selected for functional resistance against 15 antibiotics (ceftazidime,
chloramphenicol,

ciprofloxacin,

colistin,

cefotaxime,

cefepime,

cefoxitin,

gentamicin,

meropenem, nitrofurantoin, piperacillin, trimethoprim-sulfamethoxazole, tetracycline, tigecycline,
piperacillin-tazobactam).
The surviving colonies for each selection were pooled. Metagenomic inserts from each pool were
isolated via PCR with vector-specific primers, barcoded, and sequenced in parallel with the
Illumina HiSeq 2000 (2x101 or 2x150bp reads). Reads were demultiplexed by barcode, assembled
into contigs with PARFuMS13. Selections were excluded if the number of contigs were 10 times
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more than the total number of pooled colonies or if more than 350 contigs are assembled. Contigs
were also filtered based on length (> 500 bp).
Total number of contigs obtained were 7,020 and in total, 16,334 open reading frame (ORF) were
predicted in these contigs using gene finding algorithm Prodigal147. These ORFs were then
annotated using an in-house AMR gene annotator called resAnnotator.py, a pipeline that searches
amino acid sequence against known ARG specific databases sequentially and assigns annotation
using BLAST and HMM approach. Overall, 1233 complete sequences were assigned using
resAnnotator. Percentage identity of 1233 ARGs were examined via a BlastP query against both
the NCBI protein Non-Redundant (NR) database (retrieved 10 Jan 2020) and a combined database
of all ARG proteins from CARD, NDARO to identify the top local alignment. The best hit
identified using BlastP was then used for a global alignment using the needle program with the
following non-default parameters: -gapopen-10 -gapextend=0.5. 22 AMR genes did not have any
homologues in known AMR sequence databases.

4.4.3 Sequence quality filtering
Trimmomatic v0.36238 was used to trim nextera adapter sequences and to quality filter
sequenced reads with the following parameters:
Adapter = nextera
Illuminaclip = 2:30:10:1:TRUE
Leading = 10
Traling = 10
Sliding Window =4:15
Min Length = 60

Deconseq v0.4.3 was used to remove human read contamination239.
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4.4.4 Resistome and metagenome profiling
AMR gene relative abundance was quantified using ShortBRED113 v0.9.4. Marker
sequences were built using the Comprehensive Antibiotic Resistance Database (CARD)119, 185, the
NCBI-AMR database186, and our functional selections with shortbread_identify.py. Default
parameters were used with exception for -clustid 0.95. Uniref90240 was the reference masking
protein database. Genes with annotations “Efflux Regulator”, “Operon Regulator”, and “Other”
(e.g. genes that reduce permeability or cause resistance through overexpression) were removed
from analysis consideration due to their lower specificity to antimicrobial resistance compared to
other genes in the database. ShortBRED hits were filtered out if they had counts lower than 2 or a
mean RPKM lower than 0.001. Microbial taxa relative abundance was calculated using
MetaPhlAn2241 (repository tag 2.6.0).
Contig assembly was done using the de-novo assembler SPAdes v3.14.081. Assemblies
were annotated using our in-house AMR gene annotator called resAnnotator.py which includes
CARD119, 185, Resfinder124, NCBI-AMR186, and Resfams80. Assemblies were also annotated with
Prokka242. The BLAST+ command line tool (blastn)243 was used to compare the mcr-1 plasmid to
our contig containing mcr-1. FastANI244 v1.3 was used for average nucleotide identity
comparisons

between

assembly

GCA_004135815.1

[https://www.ncbi.nlm.nih.gov/assembly/GCA_004135815.1] and our draft genome assembly and
for comparisons between our assembled mcr-1 containing plasmid and NCBI Reference Sequence
NZ_CP034405.1 [https://www.ncbi.nlm.nih.gov/nuccore/NZ_CP034405.1].

4.4.5 MGE element profiling
Annotations with the following keywords were pulled from the functional metagenomic
assemblies: transposase, transposon, integrase, integron, conjugative, conjugal, recombinase,
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recombination, mobilization, and phage. These elements were counted as putative mobile genetic
elements. The same keywords were used in the analysis of putative mobile genetic elements from
whole metagenome assemblies.

4.4.6 Comparisons to other published data
The cohort of Indian residents we compared to was published by Dhakan et al. in 2019211.
The

data

from

this

study

can

be

accessed

from

BioProject

PRJNA397112

[https://www.ncbi.nlm.nih.gov/bioproject/PRJNA397112].
The mcr-1 containing reference isolate and plasmid we compared to can be accessed from
BioSample SAMN10531954 [https://www.ncbi.nlm.nih.gov/biosample/SAMN10531954] and
NCBI

Reference

Sequence

NZ_CP034405.1

[https://www.ncbi.nlm.nih.gov/nuccore/NZ_CP034405.1].

4.4.7 Statistical analysis and data visualization
Statistical analysis was conducted in R24523278 version 3.6.2. Visualizations were made
using ggplot224623379 version 3.1.0, ggpubr24723480 version 0.2.5, and cowplot24823581 version 1.0.0.
Fig 4.1 and Fig. 4.9B were made using sf24923682 version 0.1.8 and spData25023783 version 0.3.3 with
post processing in Adobe Illustrator25123884 version CC 2020 (24.0.2). Sankey networks were
generated using networkD325223985 version 0.4 with the sankeyNetwork function. Alignment
visualization for mcr-1 in Fig. 4.9C was made using genoPlotR253. Dirichlet Multinomial Mixture
Models209 were made using DirichletMultinomial25424188 version 1.26.0. Linear mixed-effects
models were implemented with lme425524289 version 1.1-21 (lmer function). Models were assessed
using report25624390 version 0.1.0 and performance25724491 version 0.4.4. Vegan: Community
Ecology Package25824592 version 2.5.6 was used for canonical analysis of principal
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coordinates25924693 (capscale function), - and -diversity calculations (diversity and vegdist
functions), and PERMANOVA tests (anova.cca function). Dabestr260 version 0.2.3 was used for
bootstrapping samples and calculating confidence intervals from bootstrapped samples. Linear
models were implemented with lme425524289 version 1.1.21 (lmer function). MaAsLin2
[https://github.com/biobakery/Maaslin2] was used for modeling resistome data with metadata and
taxonomic variables26124895. Confidence intervals for non-bootstrapped samples were calculated
using Rmisc26224996 version 1.5 (group.CI function). Multinomial tests were calculated using the
multinomial.test function from EMT26325097 version 1.1. Stats (base R) version 3.6.2 was used for
statistical calculations. The wilcox.test function was applied with paired=T/F as appropriate. The
fisher.test function was for Fisher’s exact comparisons. The binom.test function was for binomial
tests. The p.adjust function was applied where appropriate to correct for multiple hypothesis
testing with method=“fdr” (Benjamini--Hochberg26425198). The aov function was used for analysis
of variance and the TukeyHSD function was used for analysis of variance significance testing. The
sqrt function was used for square root transformations. Log-transformation was implemented
using a custom log function.
LOG <- function(x) {y <- replace(x, x == 0, min(x[x>0]) / 2); return(log10(y))}
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4.6 Supplementary Figures

Figure S4.1: Functional Metagenomics Workflow: 21 functional metagenomics libraries were built using cohort
samples with selections against 15 antibiotics. The resultant reads were assembled and annotated. AMR genes were
then used to build a ShortBRED marker database.

Figure S4.2: The top panel shows beta-diversity (Shannon Index) measurements for the 8 metaresistomes defined
in Figure 3. Boxes are filled according to which timepoint metaresistomes were significantly associated with (blue
for pre-travel, red for post-travel, and black for neither). The bottom panel shows the Bray-Curtis dissimilarity
between metaresistomes. The columns (x-axis) gives the reference group and the colored text on the plot gives the
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comparison group. The y-axis position gives the β-diversity between the reference and comparison groups. All text
is colored according to timepoint association (blue for pre-travel, red for post-travel, and black for neither).

Figure S4.2: A) Tukey’s range test of post-travel resistome richness by travel destination showing 95% family-wise
confidence level (lines) and mean difference (points) for all pairwise destination comparisons. Multiple hypothesis
corrected p-values are given in line with each comparison. Significant comparisons are highlighted in red. B) Posttravel resistome richness for all travel destinations where each point is an individual sample. Boxes give the median
and interquartile ranges.
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Figure S4.3: β-diversity comparisons between A) Africa (blue) and Asia (red-orange), B) same continent (gray) or
different continents (green), C) same destination subregion (gray) or different destination subregions (green). Each
point is a pairwise Bray-Curtis dissimilarity between two post-travel samples and the boxes represent the median
and interquartile ranges. The distributions are visualized to the right of the points. P-values (unpaired wilcoxon
test) are given near the top of each plot.

Figure S4.4: A) Difference in Bray-Curtis dissimilarity between post- and pre-travel samples by region. Each point
is the difference of two pairwise comparisons between a Dutch traveler and an Indian resident. The boxplots give
the median and interquartile range for each distribution and the shaded region gives depicts the distribution
density. P-values by fdr corrected unpaired wilcoxon test are given above. B) The lines are the 95% confidence
intervals and points are the estimates for the distributions shown in panel A. The dotted black line shows the null
hypothesis of no change.
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Figure S4.5: The top left panel shows the relationship between AMR gene prevalence (x-axis) and AMR gene
abundance (y-axis). The colors of the points correspond to the mechanism of AMR for the gene represented by the
point. The exploded panels on the bottom right show this same relationship for the AMR mechanisms considered
individually. In these panels, the colors further subdivide the AMR mechanisms into AMR class. In all panels, the
black line is the best fit linear trendline through the points and the gray shaded region is the 95% confidence
interval for this trendline. The fdr corrected p-value for the relationship is given in the top right of each panel.
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Figure S4.6: The results from binomial tests of bias for AMR gene ShortBRED ID acquisition for the post-travel
timepoint. Lines are 95% confidence intervals and points are estimates. P-values (fdr corrected binomial test) are
given at the bottom of the plot for each gene. The dotted line is the expected value under the null. Lines and points
are red if significantly acquired and blue if significantly lost.
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Chapter 5: Characterization of Wild and
Captive Baboon Gut Microbiota and Their
Antibiotic Resistomes
Environmental microbes have harbored the capacity for antibiotic production for millions
of years, spanning the evolution of humans and other vertebrates. However, the industrial-scale
use of antibiotics in clinical and agricultural practice over the past century has led to a substantial
increase in exposure of these agents to human and environmental microbiota. This perturbation is
predicted to alter the ecology of microbial communities and promote the evolution and transfer of
antibiotic resistance (AR) genes. We studied wild and captive baboon populations to understand
the effects of exposure to humans and human activities (e.g. antibiotic therapy) on the composition
of the primate fecal microbiota and the antibiotic resistant genes that it collectively encodes (the
‘resistome’). Using a culture-independent metagenomic approach, we identified functional
antibiotic resistance genes in the gut microbiota of wild and captive baboon groups and saw
marked variation in microbiota architecture and resistomes across habitats and lifestyles. Our
results support the view that antibiotic resistance is an ancient feature of gut microbial
communities, and that sharing habitat with humans may have important effects on the structure
and function of the primate microbiota.

Importance
Antibiotic exposure results in acute and persistent shifts in the composition and function
of microbial communities associated with vertebrate hosts. However, little is known about the state
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of these communities before the wide-spread introduction of antibiotics into clinical and
agricultural practice. We characterized the fecal microbiota and antibiotic resistomes of wild and
captive baboon populations to understand the effect of human exposure and to understand how the
primate microbiota may have been altered during the antibiotic era. We used culture-independent
and bioinformatics methods to identify functional resistance genes in the guts of wild and captive
baboons and show that exposure to humans is associated with changes in microbiota composition
and resistome expansion compared to wild baboon groups. Our results suggest that captivity and
lifestyle changes associated with human contact can lead to marked changes in the ecology of
primate gut communities.

5.1 Introduction
Antibiotic use in medicine and agriculture has steadily increased in recent decades. This
has led to acute and persistent perturbations in bacterial communities in virtually all humanassociated environments, including the evolution of multidrug-resistant pathogens that
compromise our ability to treat infectious disease

193, 265

. In contrast to the recent emergence of

clinical resistance in response to antibiotic use, resistance in environmental bacteria is an ancient
and prevalent feature of natural ecosystems266-269. This is explained by the estimation that
environmental microbes have harbored antibiotic production capacities for millions of years, and
thereby required antibiotic resistance mechanisms to be evolved on the same time-scale to enable
self-protection

270

. Accordingly, antibiotic-producer microbes are likely both the evolutionary

progenitor of modern resistance genes, and also provided selection pressure for their neighbors to
evolve or acquire resistance genes

271

. By extension, the microbiota of humans and other

vertebrates have likely been exposed to antibiotics naturally-produced by environmental bacteria
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269

, and concomitantly their antibiotic resistance genes, before the era of anthropogenic antibiotic

use

266, 272

. Importantly, the gut microbiota has been shown to be a rich reservoir of AR genes

which may be exchanged with pathogens 79, 273, 274.
We were interested in the question of how the primate gut microbiota and mobility of its
encoded resistome may have differed from before the era of anthropogenic antibiotic use compared
to modern times. One approach to answer this question is to analyze the microbiota and resistome
of isolated human populations that have never been exposed to industrially-produced antibiotics
and compare them to the microbiota of humans living in modern societies where antibiotics are
commonly used. A few recent studies on remote, hunter-gatherer populations have indeed shown
that their microbiota is more diverse compared to industrialized humans and encodes resistance
genes to clinically relevant antibiotics 275-277. However, validation and replication of these results
is exceptionally difficult because of the decreasing likelihood of finding such remote human
populations. A complementary strategy is to investigate the microbiota of non-human primates
living in the wild 278-280 compared to groups living in captivity 281-283, as well as to modern human
populations. Access to samples from wild baboons in Zambia, captive baboons in the USA, and
published metagenomic datasets from humans and baboons allowed us to test the hypothesis that
human contact is correlated with substantial shifts in microbiota composition, function, and
resistome profiles compared to ‘naïve’ baboon gut microbiota.
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5.2 Results
5.2.1 Comparison of the human and baboon gut microbiome
We performed sequencing of the 16S rRNA V4 region to survey the fecal microbiota of
wild baboons (n=71) from two sites in Zambia (Fig. 5.1) and captive baboons (n=9) from the
Southwest National Primate Research Center (SNPRC, Texas, USA).

Figure 5.1: Location of the study sites at the Kafue National Park, Zambia

We analyzed our 16S dataset along with data from a study of the microbiota of human
adults living in urban areas in the USA (n=253) and rural communities in Malawi (n=30) and
Venezuela (n=60) 7. Principal coordinates analysis (PCoA) of unweighted UniFrac distances
indicates that composition of the baboon gut microbiota is highly divergent from the two
previously observed human microbiota clusters (urban vs. rural) (Fig. 5.2A; ANOSIM R=0.91,
p=0.001). The phylogenetic diversity (Faith’s PD) of the baboon microbiota was higher than USA
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individuals (t-test, p<0.0001) and lower than the Malawi / Venezuela population (t-test, p=0.0045,
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Fig. 5.2B).

Figure 5.2: Taxonomic composition of the baboon and human gut microbiota. (A) Principal coordinates
(PCoA) plot of 16S-based profiles from individual baboon fecal samples (red) and human samples
(US=green, Venezuela=gray, Malawi=blue). (B) Alpha diversity (Faith’s PD index) in baboons and
humans at a rarefaction depth of 13000 sequences using a de novo OTU picking strategy. (C) Relative
abundances of major bacterial phyla across individuals, sorted by decreasing abundance of
Actinobacteria. (D) Phylogenetic tree of bacterial taxa identified in human and baboon 16S datasets.
Clades significantly enriched (LEfSe, LDA log-score >4.0, p=0.05) in baboon (red nodes) and human
(green nodes) communities are indicated. Yellow nodes denote clades not enriched in either group.
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Like the human microbiota, baboon microbial communities display high inter-individual
variation in the relative abundances of bacterial phyla (Fig. 5.2C, Fig. S5.1A)7, 284. The Firmicutes
phylum was the most abundant across all samples (Fig. 5.2C, Fig. S5.1A). However, at the order
level, linear discriminant analysis (LDA) using LEfSe285 indicates that the baboon gut microbiota
was enriched for Lactobacillales (families Streptococcaceae and Lactobacillaceae) (Fig 5.2D),
unlike humans where members of the Clostridiales (families Lachnospiraceae and
Ruminococcaceae) were enriched. Also, members of the Bacteroidetes and the Proteobacteria, two
bacterial phyla prominent in the healthy human gut, were greatly reduced in baboon communities.
Actinobacterial species of the families Bifidobacteriaceae and Coriobacteriaceae were enriched in
the wild baboon microbiota, reaching relative abundances as high as 80% in some individuals.
Comparison of the fecal microbiota of wild kinda baboon populations from Kafue National
Park to captive olive baboons from SNPRC shows that the composition of their microbiota varies
by site (ANOSIM R=0.76, p=0.001) (Fig 5.3A), with lower species diversity in the wild group
(Fig S5.1B, Fig S5.1C). Relative abundance of Actinobacteria species in captive baboons was the
lowest among all sampled animals (Fig S5.1A). As in humans, the microbiota of the captive
baboons were enriched in lactic acid bacteria of the order Lactobacillales (Fig 5.3B). 16S rRNA
profiles did not cluster significantly based on age class (ANOSIM R=0.04, p=0.273) or sex
(R=0.005, p=0.397), but we observed significant clustering by social group membership (R=0.52,
p=0.001) (Fig S5.2), as reported previously for wild baboon and chimpanzee populations280, 286.
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Figure 5.3: SNPRC baboons harbor a unique microbiota composition. (A) PCoA plot of Kafue (North, red circles,
n=55; South, blue circles, n=16) and SNPRC (green circles, n=9) baboon fecal communities. (B) Phylogenetic
tree of bacterial taxa (kingdom, phylum, class, order, family) identified in wild and captive baboon datasets. Clades
significantly enriched (LDA log-score > 4, p=0.05) in all Kafue (red nodes) and SNPRC (green nodes) communities
are indicated. Yellow nodes denote clades not enriched in either group.
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5.2.2 Functional selections and whole metagenome surveys of AR genes
suggest overlapping resistomes in humans and captive baboons
We sought to identify AR genes in the baboon gut microbiota using two complementary
methods: (i) functional metagenomic selections to discover genes that confer phenotypic resistance
in E. coli expression libraries, and (ii) surveying whole-metagenomes for AR genes present in
curated databases.
Due to the limited amount of fecal material available from individual animals to create
expression libraries, we pooled metagenomic DNA in sets of three animals to create a total of eight
pooled-DNA libraries. Pools corresponded to the six sampled baboon social groups: NG and DE
for South Kafue (low human contact); CC1, CC2, CH, CS for North Kafue (medium contact); and
S1, S2 for SNPRC (high contact) (Fig. S5.3). Libraries were screened against 12 natural and
synthetic antibiotics from six different classes. Sequencing and assembly of resistance-conferring
fragments using PARFuMs13 resulted in 155 DNA contigs (mean length: 2.0 ± 1.3 kb) across all
samples, of which 128 are unique (99% nucleotide identity clustering). No phenotypic resistance
was observed for ciprofloxacin (a synthetic fluoroquinolone), meropenem (a late-generation
carbapenem), tigecycline (a semi-synthetic derivative of tetracycline), and colistin (a polymixin)
in any of the sampled baboon metagenomic libraries. Annotation of resistance contigs with
Resfams80 revealed that 49 (38%) contained AR genes that could be annotated with high
confidence to a specific gene category and function (e.g. class A and C β-lactamases,
chloramphenicol acetyltransferase, TetA efflux pump, TetM/W/O/S family of ribosomal
protection factor, etc.) Ten of these predicted proteins were novel (<70% amino acid identity to
any protein in NCBI nr, Fig. 5.4A): six chloramphenicol acetyltransferases and four 16S rRNA
methyltransferases. Assembly of regions flanking AR genes enabled the annotation of mobile
genetic elements (MGEs; e.g. integrases, transposases, phage recombinases) in 15 (11.7%) contigs
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from CH, CS (North Kafue, medium contact), and S1/S2 (SNPRC, high contact) libraries. Four of
these MGEs were syntenic with class A β-lactamases and the TetO ribosomal protection protein.

Figure 5.4: The antibiotic resistomes of baboons and comparison to human resistomes. (A) Identity % of the 43
unique AR genes found in functional metagenomics selections of baboon libraries against the NCBI nr protein
sequence database. (B) Resistome diversity per metagenome, based on markers generated from functional
selections and the CARD resistance database. (C) Sum of all-marker abundances per metagenome, in RPKM. (D)
PCoA plots of Sørensen-Dice similarity matrices from ShortBRED results. Kafue (wild) and SNPRC (captive)
baboon metagenomes represent pooled libraries containing 18 and 6 individual baboons, respectively.

No putative MGEs were identified in resistance contigs from South Kafue (low contact) baboon
metagenomes.
We performed shotgun metagenomic sequencing on the same eight pooled samples to
further characterize their resistomes and analyze them in the context of published metagenomes
from baboon and human cohorts. ShortBRED113 was used to conduct a metagenome-wide survey
of AR gene composition and abundance. First, we created unique protein markers from a
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combination of 43 unique annotated AR proteins identified by functional metagenomics in baboon
expression libraries and the 2165 reference AR protein sequences in the Comprehensive Antibiotic
Resistance Database (CARD)149; this extended our resistome analysis to antibiotics that target
Gram-positive bacteria (e.g., vancomycin, macrolides, lincosamides, streptogramins), and any
other known AR genes that are not detectable in functional selections in our E. coli host. We then
measured the abundance of these markers across the shotgun-sequenced metagenomes of: (i) our
eight pooled baboon fecal communities used in functional selections, (ii) 48 wild yellow baboons
from Amboseli National Park in Kenya280, (iii) 104 USA human metagenomes from the first phase
Human Microbiome Project284, and (iv) 38 metagenomes from a study comparing Hadza huntergatherer groups in northwestern Tanzania (n=27) to healthy Italian adults (n=11)287. See Methods
for details of the ShortBRED analysis and criteria for AR marker selection.
Hits for 114 AR markers were found across all sampled metagenomes. Human samples
had ~5x greater AR gene marker richness compared to baboons (Chao1 index, 19.8 ± 0.5 vs. 4.3
± 0.4, p<0.0001, Fig. 5.4B, Fig. S5.4), and these markers were ~37x more abundant in humans
(246.5 ± 10.8 vs. 6.5 ± 0.9 cumulative ShortBRED RPKM, p<0.0001, Fig. 5.4C, Fig. S5.4). Genes
conferring resistance to aminoglycoside, MLS, β-lactam, and tetracycline antibiotics were
abundant in USA and Italian samples. Although less exposed to clinical antibiotic use, the Hadza
hunter-gatherer microbiota also showed a high abundance of AR gene markers, as originally
reported287. Among baboons, the most common and abundant markers were an OXA-type (class
D) β-lactamase and a novel chloramphenicol acetyltransferase. Notably, the two SNPRC (captive,
high contact) metagenomes had the highest number and highest abundance of ShortBRED hits,
followed by the Chunga School pooled metagenome (wild, medium contact). These contained AR
markers that were not usually present in wild baboon metagenomes and were common and
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abundant in human metagenomes (e.g. CfxA6 β-lactamase and TetW/TetO ribosome protection
factors).
PCoA ordination of Sørensen-Dice index (presence/absence) matrices based on
ShortBRED outputs indicates that baboon and human resistomes are, in general, different from
each other (ANOSIM R=0.96, p=0.001; Fig. 5.4D). However, resistomes from captive baboons
(S1 and S2) were more similar in their composition to Hadza hunter-gatherer resistomes than to
other baboons (mean Sørensen-Dice index 0.49 ± 0.02 vs. 0.69 ± 0.03).
To leverage our much larger 16S dataset, we used PICRUST288 to infer metagenomes from
taxonomic profiles and performed LDA analysis of enriched KEGG Ortholog (KO) categories
between predicted captive and wild baboon metagenomes. Consistent with our shotgun and
functional resistome analysis, we find that the second most discriminatory feature for captive
baboons was KO K12555, which encodes penicillin-binding protein 2A, associated with resistance
to beta-lactam antibiotics. When predicted metagenome features were grouped at the pathway
level, we identified nine differentially enriched features for captive baboons. The fifth most
discriminative pathway was ‘Penicillin and cephalosporin biosynthesis’.
The similarity between the resistomes of captive baboons and humans prompted us to
extend the metagenomic analysis from antibiotic resistance functions to microbiota composition
and metabolic gene pathways. We used MetaPhlAn2241 to assess the microbial species composition
of these metagenomes and observed that (i) human and baboon microbiota are markedly different
in their composition (ANOSIM R=0.75, p=0.01, Fig. S5.4); (ii) Hadza hunter gatherers form a
separate cluster from HMP / Italy metagenomes (ANOSIM R=0.88, p=0.01); (iii) bacteria of the
order Bifidobacteriales and Lactobacillales are enriched in baboon samples, while the order
Bacteroidales is enriched in humans (LEfSe, LDA log-score >4.5, p=0.05); (iv) captive baboons
146

are more similar in their microbiota composition to Hadza humans than to other baboons (mean
Sørensen-Dice index 0.48 ± 0.01 vs. 0.54 ± 0.03, Fig. S5.4). We used HUMAnN2289 to perform
functional profiling of metagenomes by mapping translated DNA reads to the UniRef90 and
MetaCyc databases240 and determine the presence of cataloged gene families. Comparison of
Sørensen-Dice matrices from HUMAnN2 outputs shows that (i) functional profiles of baboon and
human metagenomes also cluster apart strongly (ANOSIM R=0.73, p=0.001), and (ii) baboons
from this study (Kafue, SNPRC) have HUMAnN2 profiles that are more similar to Hadza humans
than to Amboseli baboons (mean Sørensen-Dice index 0.53 ± 0.02 vs. 0.67 ± 0.02, Fig. S5.4). We
used LefSe285 to identify microbial metabolic pathways that were enriched in baboon microbiomes
compared to humans. Among the 20 most discriminant (LDA>3.5, p<0.05), baboons were
enriched in the pyruvate fermentation to acetate and lactate pathway.

5.3 Discussion
5.3.1 Baboon microbiome architectures across different habitats and lifeways
Vertebrate hosts and their microbes have co-existed for millions of years, resulting in the
adaptation of gut commensal populations to diverse host lifestyles across the animal kingdom 278,
290, 291

. This co-adaptation is evident in humans, where marked differences in microbial community

composition occur across a spectrum of diets, cultures, and geography7, 23, 292. Comparison to
published human datasets enabled the analysis of baboon 16S rRNA results in the context of
modern humans. Access to wild baboon populations from Zambia and captive animals from
SNPRC allowed us to study the variation of the baboon microbiota across different habitats,
lifestyles, diets, and levels of human contact. The finding that the baboon gut microbiota is distinct
from that of humans is in line with other studies in primate populations. However, within the
baboon cluster, captive animals formed a separate group represented by a different microbial
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composition, possibly reflecting differences in habitat and lifestyle compared to wild baboons from
Kafue. We observed lower alpha-diversity in baboon microbiota compared to humans (Fig. S5.4),
and in wild baboons compared to captive ones (Fig. S5.1), both in 16S and MetaPhlan2 datasets.
This is in contrast to recent reports describing loss of microbial species diversity in captive
primates compared to wild ones, and in western human populations compared to non-western
groups7, 276, 277. However, captivity is not always associated with reduced diversity in mammals283,
and a more diverse microbiota may not necessarily correlate with increased fitness for the host in
a given environment.
The high relative abundance of bifidobacteria in baboon populations was an unexpected
finding (Fig. S5.1) that was, however, observed in two independent datasets (16S and
MetaPhlAn2) and corroborated in a recent report279. This group comprises some of the most
abundant species in the infant human gut, which decrease substantially as the microbiota reaches
a mature configuration in the first three years of life7, 293, consistent with its proposed role in the
fermentation of milk oligosaccharides294,

295

. We observed high relative abundances of

bifidobacteria despite most sampled baboons being adults or juveniles (only three baboons were
infants, and these did not harbor significantly different gut communities (Fig. S5.2). This finding
suggests that bifidobacteria may play other ecological roles in the baboon microbiota beyond the
digestion of milk oligosaccharides during early life stages, such as protection from enteric
pathogens via production of fermentation end products296. Indeed, using HUMAnN2, we saw an
enrichment of enzymes related to bacterial pyruvate fermentation to acetate and lactate, a feature
commonly associated with bifidobacteria and lactic acid bacteria297. Levels of Actinobacteria in
captive baboons were much lower compared to wild groups, suggesting that conditions that select
for the high abundance of bifidobacteria in the microbiota of wild animals are absent in captivity.
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5.3.2 Resistome profile of human and baboon populations
Previous surveys of human, animal, and environmental resistomes support the view that
antibiotic resistance is a ubiquitous feature of microbial communities even in the most remote
locations268, 276, 298. Genes encoding resistance are presumably maintained in in the absence of
inhibitory concentrations of antibiotics, perhaps by playing alternative roles in these ecosystems266,
272, 299

.
We hypothesized that exposure to humans and their activities result in shifts in microbiota

composition and function, and an expansion of the baboon gut resistome. We used cultureindependent metagenomic methods and bioinformatic tools to survey the resistomes of baboon
populations from different habitats and at varying levels of human contact. While contact may be
partly responsible for the differences observed across baboon metagenomes, it is possible that
differences in habitat, diet, host genotype, and social interactions may also contribute to the
observed differences279-281.
We acknowledge that there is a bias in AR gene databases toward genes found in human
pathogens. This is one of the reasons why we performed functional selections on eight pooled
baboon metagenomes. By surveying functional resistance phenotypes, these selections can identify
novel, unannotated genes conferring resistance. Using this approach, we observed phenotypic
chloramphenicol resistance in metagenomes from baboons with low human contact (Kafue South),
whereas medium and high human contact metagenomes showed resistance to seven other
antibiotics, including newer-generation beta-lactams and cephalosporins. Previously identified AR
genes were only annotated in ~40% of resistance contigs, and ten previously-unknown resistance
proteins were identified in our experiments (Fig. 5.4A), highlighting the novelty of the baboon
resistomes and the need to further characterize non-human and environmental resistomes.
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Metagenome-wide surveys of AR genes identified in functional selections and the CARD
resistance gene database allowed the comparison of Kafue baboon metagenomes to datasets from
previous baboon and human studies and identified resistance genes not captured in functional
selections. This approach identified AR genes in all sampled baboon gut microbiomes. We also
analyzed the metagenomes of 48 yellow baboons from Amboseli National Park in Kenya and
found fewer AR genes compared to baboons in Kafue National Park. However, several Amboseli
baboons contained class A, B and D β-lactamases commonly associated with plasmids and
integrons found in human pathogens149. Like the baboons in Kafue National Park, Amboseli
baboons live in a protected area away from large human settlements. However, these animals have
come into contact with researchers280, tourists, and local pastoralist groups for decades

300287137

,

creating multiple opportunities for the transfer of AR genes between human and baboon gut
microbiota.
Our resistome surveys also showed that microbiota from wild baboons of the Chunga group
(CS, medium contact) and captive baboons from SNPRC (S1 and S2, high contact) had greater
diversity and abundance of AR genes than baboons from low contact groups. Many of these genes
are also found in human gut metagenomes, human bacterial pathogens, and are commonly
associated with mobile genetic elements149. Overall, resistome, taxonomic composition and
functional profiles of captive baboon microbiomes were more similar to Hadza hunter-gatherers
than to wild baboons (Fig 5.4D, Fig. S5.4). Captive baboon microbiota contained genes encoding
class A and D β-lactamases, aminoglycoside nucleotidyltransferases, tetracycline efflux pumps
and ribosome protection factors that were also present in sampled human gut metagenomes in our
analyses. It is plausible that a subset of these AR genes and bacterial taxa were not native to baboon
gut microbiota, but were rather exchanged with caretakers at SNPRC and sympatric humans at
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Chunga in recent times. Our findings support the hypothesis that sharing habitat with human
populations –and the lifestyle and diet changes that result from it may lead to a ‘humanization’ of
the primate gut microbiota281 and its antibiotic resistome, although the consequences of these
population shifts on overall host health remain unknown.

5.4 Material and Methods
5.4.1 Sample collection and study design
We obtained fecal samples from wild baboon populations from Kafue National Park in
Zambia as part of a field-based study of the kinda baboon (Papio kindae) and the grayfoot chacma
baboon (Papio ursinus griseipes). The genus Papio includes six clearly distinguishable,
phylogenetically distinct major taxa, which nevertheless are interfertile and can and do interbreed
in the wild 301288138. Under some species definitions (which we prefer) they are considered separate,
yet closely related, species; others prefer to regard them as subspecies of a single species. Kinda
and chacma baboon populations come into contact in the Kafue National Park, and interbreeding
occurs between them, producing a hybrid zone in which individuals of mixed appearance and
parentage are found302. We collected samples from 55 kinda baboons from three social groups that
live in proximity to humans near the Kafue National Park (North) Headquarters at Chunga (15O 2'
S, 26O 0' E) (Chunga School, Chunga HQ, and Chunga College groups), and 16 hybrids living near
the National Park (South) Headquarters at Ngoma (15O 58' S, 25O 56' E) (n =12) and near the
Dendro safari camp (16O 9' S, 26O 4' E) (n=4) located approximately 100 km south of Chunga (Fig
5.1). Samples from Chunga groups (North Kafue) were collected in May and June 2011, in the
cool, dry season. Samples from Ngoma and Dendro groups (South Kafue) were obtained in May
and June 2012. Diet in all baboons was varied and consisted mostly of fruits, pods, seeds, leaves,
corms and, rarely, animal protein. Chunga School and HQ groups had overlapping ranges and
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supplemented their diet considerably by feeding on discarded human foods at garbage dumps
(Phillips-Conroy, Jolly, and Rogers, personal observations). Baboons were temporarily captured
and tranquilized to allow specimen collection and to determine their sex and age based on dental
eruption patterns. We also obtained samples from nine captive olive baboons (Papio anubis) from
SNPRC in San Antonio, Texas, along with information on their age, diet, and medical history.
Captive baboons were fed a commercial chow preparation (15% protein, 4% fat, 10% crude fiber)
and had received one or more courses of antibiotics (penicillin G, amoxicillin, ceftriaxone,
cefalexin, cefpodoxime, cefazolin, metronidazole, orbifloxacin, enrofloxacin) throughout their
lifetime, as described in individual medical records. We define the baboons sampled from Ngoma
and Dendro (South Kafue) as ‘low human contact’ because they have infrequent contact with only
a few humans. We define the baboons sampled from Chunga (North Kafue) as ‘medium human
contact’ because their range encompasses a village of several hundred humans and they regularly
feed on discarded human foods. We define the baboons sampled from SPNRC as ‘high human
contact’ because these baboons were born and bred in captivity with constant human control of
their diets and environment. Fecal samples were collected in sterile containers immediately upon
and stored in liquid nitrogen until shipment to Washington University in St. Louis, where samples
were kept at -80°C until processing. Baboon sample collection was conducted with the permission
of the Zambian Wildlife Authority and in compliance with institutional animal care and use
committee requirements at Washington University, New York University and Baylor College of
Medicine.

5.4.2 DNA extraction and 16S rRNA phylogenetic analysis
Metagenomic DNA was extracted from 250 mg of each specimen using a standard phenolchloroform bead-beating protocol
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and eluted in Qiagen EB buffer. The 16S rRNA V4 region
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(515-806) was amplified using barcoded primers and PCR protocols described previously 304. Each
reaction contained 12.5 μL of Hot-Start Taq DNA polymerase mix (Takara-Clontech), 1 μL of
forward and reverse primers (10 μM), 1.0 μL of genomic DNA (1 ng/μL), and 12μL of nucleasefree water. Barcoded amplicons were pooled and sequenced on an Illumina MiSeq instrument with
2x250 bp paired-end reads.
Barcoded Illumina reads were demultiplexed in QIIME v.1.8305. Paired reads were quality
filtered (split_libraries_fastq.py -q0 –r 500 –p 0 –n 500) and merged using USEARCH v7

306

.

Operational taxonomic units (OTUs) were generated de novo to uncover novel taxa and were
clustered at 97% sequence identity from all merged and filtered reads with the UPARSE
pipeline307. Representative sequences from each OTU were assigned taxonomy with UCLUST
against the Greengenes database (version 13_8, 97% clusters), aligned, and used to create a
phylogenetic tree in QIIME. The pipeline generated 1109 OTUs across the 80 baboon samples.
Samples were rarefied to 4100 sequences per sample for community diversity analyses.
We compared our baboon 16S data to the GlobalGut human 16S dataset generated from
individuals in urban centers in the USA and rural communities in Malawi and Venezuela 7 (MGRAST accession: qiime:850). We excluded samples from infants younger than three years old
because of the highly variable nature of the gut microbiota during post-natal development7, 292. The
remaining 343 samples (USA=253; Venezuela=60; Malawi=30) were rarefied to 50000 reads
each. Baboon reads were trimmed to 101 bp and combined with the GlobalGut reads. De novo
OTU tables were generated in QIIME and rarefied to 13000 sequences per sample. Unweighted
UniFrac distances308 were calculated and used for principal coordinates analysis. As an internal
control, we analyzed ten human samples from the USA (n=4) and Peru (n=6) from a previous
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study by our group79 to verify that the observed differences between baboons and humans were
not due to artifacts from cross-comparison with published 16S datasets (data not shown).
The analysis of similarity (ANOSIM) test was performed in QIIME to assess clustering of
samples by host genus, sex, age class, social group, and captivity status. Mean UniFrac distances
between sampled groups were calculated to compare microbiota similarity between cohorts.
LEfSe285 was used to identify overrepresented taxa in sampling groups (e.g. Kafue vs. SNPRC
baboons). It runs the nonparametric Kruskal-Wallis sum-rank test to detect features with
significant (p<0.05) differential abundance for the class of interest, followed by Wilcoxon ranksum test to detect biological significance (p<0.05), and Linear Discriminant Analysis (LDA) to
estimate the effect size of each differentially abundant taxa.

5.4.5 Functional metagenomic selections
Due to the limited amount of metagenomic DNA available from individual samples, we
pooled samples from three baboons with similar 16S profiles from each of the six groups at Kafue
and SNPRC (Fig S5.3). Two pools were created from the Chunga College group because it
contained samples with high levels of Actinobacteria, a feature not typically observed in adult
human gut metagenomes. Pool CC1 includes three specimens in which the relative abundance of
Actinobacteria is greater than 60%, while pool CC2 included samples with 20%-40% relative
abundance. Two pools (S1 and S2) were created from the SNPRC animals to increase the
representation of captive baboon metagenomes in our analyses. Functional metagenomic libraries
were prepared and sequenced as described previously208. Briefly, small-insert (3-6 kb) expression
libraries (0.4-3.1 GB, equivalent to ~80-700 E. coli K-12 genomes) were created from 20 µg of
pooled metagenomic DNA in the vector pZE21 in E. coli MegaX DH10B electrocompetent cells13.
Libraries were screened on Mueller-Hinton agar plates containing 12 natural and synthetic
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antibiotics from six different classes at concentrations previously determined to inhibit the growth
of non-transformed MegaX cells. Resistant colonies were pooled and subjected to PCR with
vector-specific primers, barcoded, and sequenced on an Illumina HiSeq 2000 instrument (2x101bp
reads). Reads were filtered, demultiplexed and assembled into contigs with PARFuMS13.
Assembled contigs smaller than 500 bp were removed from further analysis. Predicted ORFs were
annotated with Resfams v1.280. ORFs that could be classified with high confidence as AR genes
specific to the screened antibiotic class were clustered at 99% identity and used for ShortBRED
marker creation. These sequences were compared to NCBI nr (accessed December 2017) with
blastp to identify the top local hits. The global percent identity was calculated as the number of
matches over the length of the shorter sequence. Matches with the highest alignment score and
lowest e-value were used for analysis.

5.4.6 Metagenome-wide measurement of AR gene abundance
Metagenomic DNA (500 ng) from the same eight baboon pools used for functional
metagenomic selections was sheared to ~450 bp, barcoded, and sequenced on an Illumina HiSeq
2500 instrument with 2x150bp paired reads. Reads were demultiplexed with no mismatches and
trimmed with Trimmomatic v0.36
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to remove Illumina adapters and low-quality bases using

following parameters:
trimmomatic-0.36.jar PE -phred33 ILLUMINACLIP:TruSeq3-PE.fa:2:30:10:1:TRUE
LEADING:10 TRAILING:10 SLIDINGWINDOW:4:15 MINLEN:60
Human and baboon sequences were removed with DeconSeq239 by mapping to the human
reference genome (GRCh38) and a published baboon genome (Papio anubis, GCA_000264685.2
Panu_3.0), resulting in 10,141,457 ± 1,200,437 cleaned reads per sample.
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To measure the relative abundance of resistance genes, a set of 923 unique markers were
generated with ShortBRED113 from 2208 antibiotic resistance protein sequences as protein of
interest using shortbred_identify.py with cluster identity of 95% (--clustid 0.95) and Uniref90 (-ref Uniref90.fasta) as a reference database. The protein sequences used for identification of marker
families included 43 AR proteins identified via functional metagenomic selections in baboon
samples and 2165 AR protein sequences from CARD database149. The marker list was manually
curated to reduce the rate of false positives in our surveys. Entries were removed if they were not
associated with resistance phenotypes or had low risk of transmission across environments, based
on the criteria described by Martinez and Baquero

309

. These included (i) genes that confer

resistance via overexpression of resistant target alleles (e.g. resistance to antifolate drugs via
mutated DHPS and DHFR); (ii) global gene regulators, two-component system proteins, and
signaling mediators; (iii) efflux pumps that confer resistance to multiple antibiotics (those known
to confer resistance to single antibiotic classes, such as the TetA family, were retained in the
analysis); (iv) genes modifying cell wall charge (e.g. those conferring resistance to polymixins and
defensins). The final marker list consisted of 687 unique sequences. In order to measure the
abundance of these markers, shortbred_quantify.py script was used in our eight pooled baboon
metagenomes and published metagenomes from yellow baboons (Papio cynocephalus) in
Amboseli National Park in Kenya (n=48)280, healthy adult volunteers from cities in the US
(n=102)284, and from a recent study that compared the microbiota of Hadza hunter-gatherers in
Tanzania (n=27) to Italian volunteers (n=11)287. Relative abundance tables were filtered for
markers with RPKM<0.1, resulting in 114 AR markers with positive hits. Output tables were
converted to BIOM format and QIIME v1.8. was used to calculate beta diversity (-m
binary_sorensen_dice), run ANOSIM tests and principal coordinates analyses.
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The use of pooled baboon metagenomes and their comparison to individual human and
baboon samples could potentially result in bias in measuring marker abundance and low frequency
signals. We addressed this by (i) filtering low-abundance hits (RPKM<0.1) and using a binary
(presence/absence) metric (Sørensen-Dice index) as opposed to a quantitative metric (e.g. BrayCurtis); and (ii) created 15 in silico pooled triplets from Amboseli, HMP and Hadza metagenomes,
rarefied to one third of the reads, and ran these along individual samples in metagenomic surveys.
Abundance tables and principal coordinate analyses show that, using the same analysis parameters,
detection levels and resistome profiles of pooled samples were similar to those of individual
samples (Fig. S5.5).

5.4.7 Prediction of metagenomes from 16S rRNA profiles
We

used

the

Galaxy

implementation

of

PICRUSt

v1.1.1

(http://galaxy.morganlangille.com/) to infer the metagenome composition based on 16S rRNA
profiles. Closed-reference OTU tables were created in QIIME v1.8 using the GreenGenes 13.5
reference database. We performed normalization of 16S copy numbers, followed by metagenome
prediction and grouping into L3 KEGG categories. LEfSe was used to identify KO entries of
pathways that were differentially enriched in captive and wild baboon metagenomes.

5.4.8 Taxonomic composition and functional profiling of baboon and human
metagenomes
MetaPhlAn2241 was used to assess the microbial composition of baboon and human
metagenomes, and expand our analysis beyond 16S to species-level resolution and non-bacterial
microbial taxa. To infer the functional profiles of baboon and human metagenomes, HUMAnN2289
analysis was performed by calculating relative abundances of annotated microbial gene families
and

pathways

in

the

UniRef90240

and
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MetaCyc310

databases.

We

normalized

(humann2_renorm_table.py) merged individual ‘pathway abundance’ and ‘gene family’ output
files (humann2_join_tables.py), converted them to BIOM format, and filtered hits with RPKM <
0.1 relative abundance. QIIME 1.8 was used to calculate Sørensen-Dice distances
(beta_diversity.py –m binary_sorensen_dice), run ANOSIM tests (compare_categories.py), and
perform principal coordinates analysis (principal_coordinates.py). LefSe285 was used to identify
biomarker taxa, AR genes, and metabolic pathways from humans and baboons in metagenomic
datasets.
Raw sequence reads generated for this study have been deposited with accession number
PRJNA430956 in the NCBI BioProject database.
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5.6 Supplementary Figures

Figure S5.1: (A) Relative abundances of the major bacterial phyla identified in human (n=343), wild baboon
(n=71) and captive baboon (n=9) gut communities, determined by 16S rRNA sequencing. Boxplot whiskers indicate
minimum and maximum values. *Non-parametric Student’s T-test, p<0.05. (B,C) α-diversity comparisons between
wild (n=71) and captive (n=9) baboons at a rarefaction depth of 4100 sequences. (B) Mean Faith’s PD index, and
(C) number of observed OTUs. *Non-parametric Student’s T-test
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Figure S5.2: Principal coordinates plot of wild and captive baboon microbiota from Kafue National Park and
SNPRC. Samples colored by (A) sex, (B) Age class, and (C) Social group. ANOSIM R values indicate the strength
of sample grouping by categories.
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Figure S5.3: 16S-based taxonomic profiles of individual samples pooled for functional metagenomic analysis and
whole-metagenome sequencing. (A) Relative abundances of major bacterial phyla. Columns represent individual
baboon samples, grouped by social group. (B) PCoA plot based on unweighted UniFrac distances. White circles
indicate baboon samples that were not used metagenomic analyses.
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Figure S5.4: Whole-metagenome surveys of microbiome composition and function. Comparison of resistomes (A,B)
and microbiota genus diversity (C) between human and baboon metagenomes. PCoA plots of (D) microbiota
composition profiles, calculated from the presence/absence MetaPhlan2 species markers; (E) Microbial functional
profiles, based on the presence of UniRef90 and MetaCyc pathways using HUMAnN2.
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Chapter 6: Environmental remodeling of
human gut microbiota and antibiotic
resistome in livestock farms
Lateral exchange of virulent clones and genes, including antimicrobial resistance genes,
between the human gut microbiota and environmental microbes could crucially impact public
health. Here, we report the extensive interconnection of the microbiome and resistome between a
swine farm environment and visiting students. Metagenomic sequencing indicated that
environmental exposure during the students’ stay at the farm shaped their gut microbiomes,
resulting in enrichment of potentially pathogenic taxa and of antibiotic resistance genes.
Comparative genomics revealed that the students shared bacterial genomes with farm
environments after three months. Notably, antibiotic resistance genes were found in similar genetic
contexts in student samples and farm environmental samples. Dynamic Bayesian network
modeling predicted that the observed changes in human gut microbiota partially reverse over a 46 months period. Our results indicate that acute changes in a human’s living environment can
persistently shape their gut microbiota and antibiotic resistome.

6.1 Introduction
The human gut microbiota is a dynamic ecosystem of commensal microbes which
collectively modulate host health and physiology311, 312. Previous studies have revealed that the
human gut microbiota composition is stable over time313-315 and to some extent resilient to shortterm perturbations316, 317. While the host gut microbiota is generally predicted to recover to pre164

perturbation states318, the exact extent of reversion and stability of different human microbiomes
subjected to different types of environmental perturbations remains underdetermined.
The human gut microbiota composition is generally influenced by both host genetics and
environment319-321; however the effect of environmental factors appears to outweigh host genetics
in shaping the human gut microbiota16. Recent studies have demonstrated that environments where
antibiotics are used indiscriminately serve as hot-spots of resistance gene enrichment and
exchange79. One such environment are swine farms, where antibiotics are administered routinely
for growth promotion and disease prevention152, providing ideal selection pressure for enrichment
of antibiotic resistant bacteria (ARBs) and antibiotic resistance genes (ARGs) in swine gut
microbiota. These ARBs and ARGs can spread to humans via contaminated meat, pig-house dust
and manure, and wastewater discharge322-324. Interacting with swine farms environments, where
antibiotic use is prevalent, has been considered a potential high-risk factor for infection with
multidrug-resistant bacteria325. The influence of antibiotic use on human health is dependent on
the connectivity between the farm and human associated microbiomes. This connectivity refers to
both the transmissibility of ARBs selected in animals to human hosts and the potential of gene
transfer between animal associated and human associated bacteria. It is critical not only to
determine the extent of human microbiota disruption in such environmental exposures, but also
the distribution and enrichment of ARGs to evaluate the potential risks of these environments in
facilitating the global dissemination of antibiotic resistance.
Here, we report on a longitudinal investigation of the impact of confined and controlled
swine farm environments on temporal changes in the gut microbiome and resistome of 14 healthy
students who underwent occupational exposure during 3-month internships at swine farms. We
found that the students’ gut microbiota were consistently changed in correlation with swine farm
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environmental exposure despite geographic separation, that student and swine farm environmental
microbiota and resistome appear extensively interconnected following exposure, and that changes
in student microbial community structure were partially relieved six months after they returned to
their home environment. This study presents new insights on how, and to what extent, temporary
change in living environment shapes the human gut microbiota and resistome.

6.2 Results
6.2.1 Gut microbiota changes correlate with environmental exposure
We performed 16S rRNA gene sequencing of 98 fecal samples collected longitudinally
from 14 male student volunteers (at time points T0, T1-T3 and T4-T6), randomly assigned to
different large-scale farms in China (Fig. S6.1) to characterize temporal patterns in gut microbial
community structure that occur with environmental changes. Multivariate analysis of operational
taxonomic unit (OTU) composition revealed a substantial change (adonis P < 0.001) in the gut
microbial communities of the study participants over the period from swine farm arrival (T0) to
leaving the farm environment (Fig. 6.1a). This change occurred within 1 month (T1) of the students
reaching the swine farms. Three months after leaving the swine farms (T6), the students’ gut
microbiota partially reverted to their original microbial composition. Notably, the student’s gut
microbiota changed in a similar fashion at all three farms, likely reflecting the commonalities of
the farm ecological environment despite geographical separation (Fig. S6.2). The microbial
diversity (alpha diversity) within the subjects’ gut microbiota did not different significantly
(pairwise Student’s t-test with Benjamin-Hochberg correction, q > 0.05; Fig. 1b) during the period
of residence at the swine farms. However, granular analysis of specific microbial taxa showed
marked deviation between students’ arrival at the swine farm and their return home. Specifically,
we observed a moderate decrease in Bacteroidetes (the major symbiont in the human gut that
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contributes to diet carbohydrate metabolism and vitamin biosynthesis326) and an increase in
Proteobacteria (especially Gammaproteobacteria, which includes many human pathogens) (Fig.
S6.3a), as well as significant changes in the relative abundance of several organisms such as
Faecalibacterium, Collinsella, Blautia, and Veillonellaceae (Fig. S6.3b). These results suggest that
swine farm environmental exposure from divergent geographical locations can consistently shape
the human gut microbiota.
To further investigate the extent of alteration in students’ gut microbiota, we performed
whole-metagenome shotgun sequencing (WGS) on 42 fecal samples of students at time points T0,
T3, and T6 and on fecal samples of three full-time workers from each swine farm (representing
336.9 Gb of high-quality data). Distance based redundancy analysis (dbRDA) of microbial taxa
(Fig. S6.4) showed marked deviation of students’ gut microbiota at T3 from the pre-exposure timepoint (T0) and they were similar to the swine farm workers’ microbiota. These results demonstrate
that working in the swine farm environment is correlated with alterations in the visiting students’
gut microbiota to more closely resemble the full-time workers’ gut microbiota. Since many
environmental factors, including diet22, 327, antibiotics328, and geography7, have been associated
with changes to the human gut microbiota, it is difficult to identify specific contributions from
separate factors from the farm environment329. However, we observed the same trends of microbial
community shift in all the students despite individual host and geographical location differences,
mirroring the taxonomic trends from the 16S rRNA gene-based analysis. This implies multiple
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conserved environmental factors on the swine farms participated in shaping the gut microbial
community changes.

Figure 6.1: Change in the human gut microbiota following environmental conversion. a) Overview of the
study design. Fourteen veterinary students’ fecal samples were collected at seven time points: T0, 1–2
weeks before work on the swine farm; T1–T3, while living and working at the swine farm; T4–T6, after
returning to the university. b) Distance-based redundancy analysis (dbRDA) revealed gut microbiota
dysbiosis during the students’ swine farm stays, which partially recovered after leaving the farm. dbRDA
of Bray–Curtis distances between operational taxonomic units (OTUs, based on 16S sequences) in
samples at all-time points is shown at the first two constrained principal coordinates (CAP1 1.8%
variance explained, CAP2 1.3% variance explained). Lines connect samples from the same time point,
and colored circles indicate the samples near the center of gravity for each time point. The results
depicted here are cumulative of the samples from three swine farms. c) Change in the within-sample
microbial diversity (observed number of OTUs and Shannon diversity index) of samples at seven different
time points. Boxes show the distribution of students’ samples (n = 14 biologically independent samples
per timepoint) (boxes show medians/quartiles; error bars extend to the most extreme values within 1.5
interquartile ranges). P > 0.05 by Student’s t-tests (paired two-sided test between the students’ samples
at time points 0, 3, and 6). P-values are multiple hypothesis test corrected using Benjamini–Hochberg
(FDR) correction.
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6.2.2 Antibiotic resistomes structure influenced by changing environment
To evaluate whether AR gene changes accompanied the microbiota changes, we performed
metagenomic analysis of the students’ gut resistomes. We identified 1,924 non-redundant AR
genes in the WGS samples. These genes encoded a range of AR enzymes, with beta-lactamases
(44.4%), aminoglycoside resistance proteins, (17.5%) and chloramphenicol acetyltransferases
(15.2%) representing the most dominant types.
The abundance of AR genes in the students’ samples was quantified using ShortBRED140
based on a custom AR gene database that included unique protein markers created from
Comprehensive Antibiotic Resistance Database (CARD ver. 2.0.0)119 and the ARGs we identified
using metagenomic assembly. Similar to the gut microbiota composition changes, the students’
gut resistome showed minor divergence between the samples taken at the three swine farm-stay
time points (adonis P = 0.63 among three time points; Fig. 6.2a). Procrustes analysis confirmed
that antibiotic resistomes were significantly correlated with community composition (permutated
protest P < 0.001; Fig. 6.2b). There was no significant change in the number and abundance of AR
genes detected in the samples obtained during the swine farm residence period (Fig. 6.2c; Fig.
S6.5a), despite an average 3.7% increase in relative abundance (measured by normalized reads per
kilobases per million reads, RPKM). This increase occurred for several types of AR mechanisms
(Fig. S6.5b) and the most prominent changes were observed in subclass B3 β-lactamase,
aminoglycoside acetyltransferase, and tetracycline-resistant ribosomal protection proteins.
Interestingly, these resistome changes occur after only three months in the swine farm
environment.
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Figure 6.2: Change in the gut antibiotic resistomes following environmental exposure. a) Distance-based
redundancy analysis (dbRDA) plot of the gut antibiotic resistomes of students’ samples at time points 0
(red), 3 (green) and 6 (blue), and workers’ samples. Lines connect samples from the same time point, and
colored circles indicate the samples near the center of gravity for each time point. The first two
constrained principal coordinates are shown (CAP1 2.8% variance explained, CAP2 1.6% variance
explained). b) Procrustes analysis connecting the microbiomes and resistomes of gut microbiota. c) total
abundance of the antibiotic resistance genes in students’ samples at time points 0, 3, and 6, and workers’
samples. Box plots show the distribution of students’ samples (n =14 biologically independent samples
per timepoint) (boxes show medians/quartiles; error bars extend to the most extreme values within 1.5
interquartile ranges). P > 0.05; Student’s t-tests (paired two-sided test between the students’ samples at
time points 0, 3, and 6). P-values are multiple hypothesis test corrected using Benjamini–Hochberg (FDR)
correction.

6.2.3 Microbial transmission from the swine farm environment into students’
gut
To assess whether changes in the students’ gut microbiota and antibiotic resistome were
driven by their swine farm environmental contact, we examined the microbial landscape of the
swine farm ecosystem via four representative environments: ventilation system dust, swine feces,
sewage, and compost soil. Pooled environmental samples (each environment contained 3-5
sampling spots) were collected from each swine farm and analyzed using WGS (representing 133.2
Gb of data). The presence of many non-redundant genes in these habitats revealed the magnitude
of diversity of the swine farm ecosystem (Fig. S6.6). Compared to the human gut microbiome, the
environmental samples exhibited higher phylogenetic and resistance gene diversity (Fig. S6.7).
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Comparison of student samples before and during swine farm residence revealed a high
proportion of genes (average 42%, range 18-61%) emerged after they arrived at the swine farms.
Nearly two-thirds of these genes were also present in the environmental samples (Fig. 6.3a; Fig.
S6.8). This indicated extensive gene exchange between the environment and the human gut. The
SourceTracker algorithm330 was used to validate these results by integrating the taxonomic
assignments and the abundance levels of the newly acquired genes. 142 species transmission
events were identified from various swine farm environments to the students’ gut microbiota (Fig.
6.3b; Fig. S6.9), and swine feces and soil were the main bacterial sources. These transmission
events included diverse groups of Firmicutes and Proteobacteria, some of which (e.g.,
Ruminococcus spp., Escherichia spp. and Pseudomonas putida) are zoonotic pathogens.
Transmission of these commonly pathogenic species indicates that the soil and swine feces may
be underappreciated occupational hazards of industrialized farming. To confirm that the species
and their genes were environmentally acquired, we performed comparative genome analysis on
these putatively transmitted species identified from the student and the environment microbiomes.
Draft genomes of 9 high-abundance species, including the genome of Phascolarctobacterium
succinatutens, which is rarely observed in human gut, were reconstructed from the students’ gut
microbiomes and from the corresponding environmental samples (see the Methods section). These
genomes shared 99.9±0.1% (minimum 99.7%) 16S rRNA gene similarity and 99.5±0.4%
(minimum 98.9%) average nucleotide identity (ANI) with their respective environmentally
derived genomes (Fig. 6.3c), suggesting that belong to the same bacterial clones shared by the
students and their surrounding environments.
To further study microbe transmission between students and farm environment/workers,
we cultured and characterized the genetic relatedness of 82 E. coli strains isolated from students,
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farmer workers, and environment samples collected from one pig farm. We found different events
of clonal spread of E. coli strains between students, farm workers, and farm environment (Fig.
S6.10). Together, the results from culture-independent analysis of fecal metagenomes and from
culture-dependent analysis of environmental bacterial clones revealed extensive transmission
events between the students’ gut microbiome and farm environment occurred for diverse
taxonomic groups, including putatively pathogenic bacteria.
Gene content from the 142 putatively transmitted species was further analyzed to identify
genes with clinical relevance (e.g. chromosome-encoded AR genes and virulence factors), likely
to transfer concomitantly with the microbes. Approximately 27% of species transmission events
between the environment and human gut microbiota carried at least one AR gene on their contigs
(Fig. S6.11a). Specifically, S. marcescens strains carried the largest number of AR genes (average
11 genes), though this may reflect their high assembly completeness in our dataset. Additionally,
many genes encoding virulence factors (observed in 30% of species transmission events),
antibacterial biocide resistance genes (18%), and heavy metal resistance genes (18%) were also
concomitantly transferred along with the microbes (Fig. S6.11b-S6.11d). These results agree with
our earlier Procrustes analysis and demonstrate comprehensive accompanying transfer of clinically
relevant genes with environment-mediated microbial transmission events. Altogether our results
show an extensive exchange of bacteria (including pathogens and ARBs) between humans and
their surrounding environments.
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Figure 6.3: Transmission of microbes and antibiotic resistance genes from swine farm environments. a) Origin of
the genes observed in the students’ gut microbiomes during their stay on the swine farms (time point 3). The
majority of the genes did not change (58%), but a large number of the newly observed genes were also identified
in various swine farm habitats, such as the environment (19%, including dust, pig feces, soil, and sewage) and the
workers’ gut microbiota (7%). b) Species transmission network from the swine farm environment to the human gut.
Larger nodes depict the students (student ID is displayed in the center of each node). Smaller nodes depict
transmitted species, color-coded according to environmental types. Connecting arrows represent the transmission
events. c) Circular representation of the S. marcescens S-e-s draft genome (assembled from a soil sample from
swine farm S) and comparison to other genomes. The inner three circles represent the genome scale, G +C skew
and G +C content of the S-e-s draft genome. The outer three circles show the portions of the S-e-s genomic region
that have close orthologs in other draft genomes: S. marcescens Z (blue, from one student who inherited S-e-s), S.
marcescens D-e-s (yellow, from the soil sample taken from swine farm D) and S. marcescens FGI94 (green, the
most homologous genome from the NCBI database). High ANI (99.9%) between S. marcescens S-e-s and Z
confirmed the inheritance relationship between them.

6.2.4 Horizontal gene transfer of antibiotic resistance genes between the swine
farm environment and human gut
The environment represents an enormous reservoir of AR genes331, and its transmissibility
to humans is concerning79. In our dataset, we found an extensive network of AR gene sharing
between microbial communities of humans and environments (Fig. S6.12a, a similar network is
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found in ref. 13), and further revealed that 25% (477/1,924) of AR genes detected in the students’
microbiota while on the farms co-localized with putative mobile genetic elements, which are often
involved in AR transfer across environments. Using the SourceTracker algorithm, we identified
270 AR genes involved in transfer from swine farm environmental samples to the students’ gut
microbiotas (Fig. S6.12b). Swine feces and sewage were the major AR gene transfer sources; gene
transfer events from these sources included almost all types of AR genes, whereas soil mainly
contributed the transfer of AR genes encoding aminoglycoside inactivating enzymes. Of note,
several studies have confirmed that soil13, sewage332, and even air dust333 are likely significant
reservoirs involved in spreading AR genes persistently found in clinical pathogens.
To further link the emergence of AR genes conferring resistance to medically important
antimicrobials with their acquisition from the pig farm environment, we identified 120 relevant
AR genes. These genes included extended-spectrum β-lactamases (including blaTEM and blaCTXM),

plasmid-mediated quinolone resistance genes (qnrS6, qnrS7), and the tigecycline resistance

gene tetX. These AR genes were enriched in the students’ gut resistome during or after swine farm
stays (Fig. 6.4a; Fig. S6.13). To understand the exchange potential of these AR genes, we
examined the flanking genetic sequences in assembled contigs. 41% (49/120) of genes encoded by
both human gut and environmental microbiota were found in a consistently similar genetic context
in the two habitats, and many of those were associated with mobile genetic elements (including
several extended-spectrum β-lactamases, tetX and qnrS6/7; Fig. 6.4b shows an example of blaCTXM).

This provides evidence for HGT of important AR genes across habitats (human gut microbiota

and environmental microbiota).
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To study the acquisition of AR and AR genes associated with the culture-dependent
bacteria during the students’ stay on the farms, we isolated 1851 E. coli strains from all samples.
Phenotypic resistance testing showed that the resistance rates to nine antibiotics including
cefotaxime, ciprofloxacin, and fosfomycin, increased among E. coli strains from students’ samples
at time points T2, T3, and T4 compared to time point T0. Conversely, these resistance rates
decreased among E. coli strains from students’ samples at time points T4, T5, and T6 (Fig. S6.14).
Notably, relatively high resistance rates to these drugs were found among E. coli strains from farm
samples including farm workers, pigs, and environmental samples. Consistent with these
phenotypic AR results, the detection rate of transferable plasmid-mediated AR genes, blaCTX-M
(conferring resistance to third generation cephalosporin) and fosA3 (conferring resistance to
fosfomycin), also increased among E. coli strains from students during T2-T4 compared to T0.
These rates declined during T4-T6 (Fig. 6.4c-d). fosA3 genes co-existed with blaCTX−M−14 on an
identical genetic structure (blaCTX−M−14-△IS903-261bp-fosA3-orf1-orf2-IS26) among 9 of 15 E.
coli strains co-carrying blaCTX−M−14 and fosA3 from students (n = 4), pigs (n = 5) and farm
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environment (n = 1). These results indicate that the pig farm environment probably contributed to
AR increases in human commensal E. coli isolates through HGT of AR genes.

Figure 6.4: Accumulation of important antibiotic resistance genes in the human gut. a) Occurrence of the important
antibiotic resistance genes in the microbiota of the students, the swine farm workers and the environment. Only
important antibiotic resistance genes that were enriched in students’ gut antibiotic resistomes during their swine
farm stays (time point T3) are shown. The occurrence rates of antibiotic resistance genes in each group are
represented by color shading. b) Representative alignment of three contigs encoding a CTX-M β-lactamase with
99% nucleotide identity. The taxonomic assignments of the contigs are indicated on the right, and source
metagenomic libraries are indicated inside the parenthesis. c, d) Changes in resistance detection rate of the
blaCTX-M gene c and fosA3 gene d among 1851 E. coli strains from students (blue), farm workers, and environment
during the students’ swine farm residence period. The dotted lines for worker and environmental samples are the
average occurrence rate of resistance genes in E. coli strains from farm workers (orange) and environment (gray)
in T1, T2, and T3.
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6.2.5 Predicting the impact of environmentally induced changes on the gut
microbial community structure
To predict the duration of the effect on the gut microbial community structure by
environmental changes, we developed a time series model of relative taxonomic abundance based
on the 16S sequencing data obtained from the students’ fecal samples at seven time points (see
Online Methods). We modeled microbial interactions as a dynamic Bayesian network using

Figure 6.5: Predicting students’ gut microbiotas in the next 3 months using a dynamic Bayesian
network model. DbRDA of the Bray–Curtis PCoA of the unweighted UniFrac distances between the gut
microbiota in samples at the seven time points tested and three predicted future time points. Display is
based on sample scores on the primary constrained axis (CAP1, 2.2% variance explained) and primary
multidimensional scaling (MDS1, 20% variance explained). Lines connect samples taken at the same
time point, and colored circles indicate the samples near the center of gravity for each time point. Below
and left boxplots show the sample scores in CAP1 and MDS1 (boxes show medians/quartiles; error
bars extend to the most extreme values within 1.5 interquartile ranges). Coding: 0, baseline; 1–3,
during the swine farm stay; 4–6, 3 months after leaving the farm; 7–9, predicted time points over 3
months in the future (n =14 biologically independent samples per timepoint for 0–6 and n =14 predicted
points per timepoint for 7–9). *P < 0.05; **P < 0.01; ***P < 0.001; NS, not significant; Student’s ttest (paired two-sided test between the students’ samples at time point T0 versus time points T3, T6, T7,
T8, and T9).

extended local similarity analysis, to capture local and potentially time-delayed co-occurrence and
association patterns between microbial taxa (Fig. S6.15).
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Analysis of the extrapolated community structure showed that the students’ gut microbiotas
are likely to revert to the original status within 4-6 months of returning to their initial environment
(Fig. 6.5). As the gut resistome and gut microbiota phylogenetic composition appeared to be tightly
linked, we also found resistome reversion after terminating the exposure to the swine farm
environment. However, some clinically relevant AR genes were persistently isolated after a threemonth recovery period. To elucidate this phenomenon a more extensive longitudinal study of
environmental shaping of the human gut microbiota and resistome along with subsequent recovery
is required.

6.3 Conclusion
In this study, we used both endpoint and extensive time series analyses to demonstrate that
the human gut microbiota and resistome undergoes extensive taxonomic and functional
remodeling in correlation to exposure to the high-risk swine farm environment. We found
substantial interconnection of microbiomes and resistomes between the swine farm environment
and visiting veterinary students. Our results provide direct evidence that the human gut microbiota
can change in response to environmental conversion. These acute changes may considerably
impact human health and could represent underappreciated occupational hazards. Future studies
should seek to clarify the key roles of reservoirs, carriers, and vectors on the transmission chain
and to identify factors promoting AR gene exchange between environmental microbiota and
human commensal bacteria. Additionally, a quantitative model for assessing resistance gene
transmission risk to humans is urgently needed.
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6.4 Material and Methods
6.4.1 Study design
Fourteen senior class veterinary students (Student ID: H, I, J, K, L, M, N, O, P, Q, W, X,
Y, Z) provided their written informed consent and voluntarily enrolled in the study during
participation in an approximately 3-month-long practical training course in veterinary science at
South China Agricultural University (SCAU) from July to October 2015. The 14 students were
randomly divided into three groups of four to five persons, and each group was assigned to one of
three swine farms in three different Chinese provinces, including (from north to south), Henan
(Farm ID: H farm), Jiangxi (Farm ID: D farm), and Guangdong (Farm ID: S farm) (Fig. S6.1a).
These are typical large-scale swine farms, and all have been in operation for more than 5 years.
Three farms implement self-breeding, and all use the closed-end management model. Among
them, H farm is the largest, with 15,000 sows, D farm (7,400 sows) is the next largest, and S farm
(3,800 sows) is the smallest. In addition, 3 farm workers in each swine farm were also recruited in
this study. All the farm workers had engaged in pig farming for 4-18 years and stayed at the present
farm at least for one year. The volunteers signed an informed consent form and were asked to agree
to fecal swabbing and to complete a short questionnaire related to personal information such as
age and gender, personal hygiene, dietary habits, antibiotic use, hospitalization, previous visits to
farms or factories, and other pertinent factors (Supplementary Questionnaire).
Ethics Statement
The Institutional Review Board of South China Agricultural University (SCAU-IRB)
approved the protocols. All animals were sampled under authorization from Animal Research
Committees of South China Agricultural University (SCAU-IACUC).
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6.4.2 Sample collection
The students’ fecal samples were collected at the following intervals: 1) 1-2 weeks prior to
their entry into the swine farm, 2) monthly for the 3 consecutive months of their stay at the swine
farm; 3) monthly for another 3 consecutive months after their return to the university. At each
swine farm, four to five farm workers who had worked on the farm for at least one year were
recruited, and their fecal samples were collected monthly during the period in which the students
stayed at the swine farm. In addition, 55 environmental samples (around 3-5 samples for each item
per farm) from the swine farms, including pig feces, soil, sewage, and ventilation dust, were
collected (Fig. S6.1). All samples were submitted using an assigned student study ID and date.
Five replicates of each environmental sample type were obtained from each farm. All of the
samples were kept on dry ice during transport and were stored at −80 °C prior to DNA extraction
and chemical analysis.

6.4.3 DNA extraction.
Genomic DNA was extracted from all samples using the HiPure Stool DNA Kit (Magen,
No. D3141) according to the manufacturer’s instructions. Briefly, STL buffer (1 ml) was added to
50 mg of sample in a 2-ml screw-cap tube (Axygen), and the mixture was incubated at 65 °C for
10 min. The samples were then vortexed for 15 s and centrifuged at 13,000 × g for 10 min), and
600 μl of the supernatant was transferred to a fresh 2.0-ml tube. PS buffer (150 µl) and 150 µl of
absorber solution was then added. Following a second centrifugation (13,000 × g, 5 min), the
supernatants were placed in fresh 2.0-ml tubes, and 700 µl of GDP buffer was added. A HiPure
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DNA Mini Column (Magen; No. D3141) was used to absorb the products, which were then eluted
with sterile water.

6.4.4 16S rRNA amplification, sequencing and preprocessing.
The V3 and V4 hypervariable regions of the 16S rRNA gene were sequenced and analyzed
to define the composition of the bacterial community in human fecal samples. The following
amplification primers were used:
primer-F = 5’ TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGCCTACGGGNGGCWGCAG
primer-R = 5’ GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGAC TACHVGGGTATCTAATCC

For amplicon library preparation, 20 ng of each genomic DNA, 1.25 U Taq DNA
polymerase, 5 μl 10× Ex Taq buffer (Mg2+ plus), 10 mM dNTPs (all reagents purchased from
TaKaRa Biotechnology Co., Ltd), and 40 pmol of primer mix was used for each 50-μl
amplification reaction. For each sample, the 16S rRNA gene was amplified under the following
conditions: initial denaturation at 94 °C for 3 min followed by 30 cycles of 94 °C for 45 s, 56 °C
for 1 min, and 72 °C for 1 min and a final extension at 72 °C for 10 min. The PCR products were
quantified by gel electrophoresis, pooled and purified for reactions. Pyrosequencing was
performed on an Illumina MiSeq sequencer with paired-end reads 300 base pairs (bp) in length.
Based on the overlaps between the sequenced paired-end reads, the reads were merged into
long sequences using the FLASH algorithm (min-overlap = 30, max-overlap = 150)334. Lowquality sequences were then trimmed and eliminated from the analysis based on the following
criteria: a) shorter than 400 bp; b) a sequence producing more than 3 ‘N’ bases. Bioinformatic
analysis was implemented using the Quantitative Insights into Microbial Ecology QIIME2
platform (https://qiime2.org/)305. Briefly, raw Illumina amplicon sequence data were performed
quality control process based on DADA2 algorithm335, removing the chimeric sequences and
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truncating the sequences from 5 to 250 bases. Phylogenetic diversity analyses were realized via
the q2-phylogeny plugin, which used the mafft336 program to perform multiple sequence alignment
on the representative sequences (FeatureData in QIIME2) and the FastTree337 program to generate
phylogenetic tree from the alignments. The microbial community structure (i.e., species richness,
evenness and between-sample diversity) of fecal samples was estimated by biodiversity. The
Shannon index was used to evaluate alpha diversity, and the weighted and unweighted UniFrac
distances were used to evaluate beta diversity. All of these indices were calculated by the QIIME2
pipeline (q2-diversity plugin).

6.4.5 Metagenomic sequencing and data quality control
The Illumina HiSeq 3000 platform was used to sequence the samples. We constructed a
150-bp paired-end library with an insert size of 350 bp for every sample. The raw sequencing reads
for each sample were independently processed for quality control using the FASTAX Toolkit
(http://hannonlab.cshl.edu/fastx_toolkit/). The quality control used the following criteria: (1) reads
were removed if they contained more than 3 ‘N’ bases or more than 50 bases with low quality
(<Q20); (2) no more than 10 bases with low quality (<Q20) or assigned as N in the tails of reads
were trimmed. The remaining reads were then mapped to the human and swine genomes using
SOAPalinger2338 to remove host DNA contamination. Overall, an average of 0.9% of low-quality
or host genome reads was removed from the sequenced samples.

6.4.6 De novo assembly, gene calling and gene catalogue construction
To determine the best assembling method for high-quality whole-metagenome sequencing
reads, we compared the performance of two assemblers, SOAPdenovo v2 (previously used in
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human gut microbiomes)323,

339

and MEGAHIT (a de novo assembler for large and complex

metagenomic sequences)93. For SOAPdenovo, we tested the k-mer length ranging from 23 bp to
123 bp by 20-bp steps for each sample and selected the assembled contig set with the longest N50
length. For MEGAHIT parameters “--mink 21 --maxk 119 --step 10 --pre_correction” were used.
For most of the samples, MEGAHIT obtained a better assembled contig set than SOAPdenovo;
this could be due to its improved assembly of bacterial genomes with highly uneven sequencing
depths in metagenomic samples. As a result, we obtained an average of 254.6 ± 72.4 and 754.4 ±
180.4 Mbp (mean ± SD) contig sets for human fecal samples and environmental samples,
respectively. The unassembled reads for each ecosystem were pooled and reassembled for further
analysis.
Genes were predicted by MetaGeneMark340 based on parameter exploration by the
MOCAT pipeline324. A non-redundant gene catalogue was constructed using CD-HIT341; from this
catalogue, genes with >90% overlap and >95% nucleic acid similarity (no gap allowed) were
removed as redundancies. The gene catalogues contained 3,338,109 and 11,374,480 nonredundant genes generated from the human microbiome and the swine farm ecosystem,
respectively.

6.4.7 Quantification of metagenomic genes
The abundance of genes in the non-redundant gene catalogues was quantified as the relative
abundance of reads. First, the high-quality reads from each sample were aligned against the gene
catalogue using SOAP 2.21338 using a threshold that allowed at most two mismatches in the initial
32-bp seed sequence and 90% similarity over the whole read. Then, only two types of alignments
were accepted: (1) those in which the entirety of a paired-end read could be mapped onto a gene
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with the correct insert size; (2) those in which one end of the paired-end read could be mapped
onto the end of a gene only if the other end of the read mapped outside the genic region. The
relative abundance of a given gene in a sample was finally estimated by dividing the number of
reads that uniquely mapped to that gene by the length of the gene region and by the total number
of reads from the sample that uniquely mapped to any gene in the catalogue. The resulting set of
gene relative abundances for all samples was termed a gene profile. The average read mapping
rates (or mean reads usage) were 71.5% and 43.8% for human gut microbiome and swine farm
environmental samples, respectively.

6.4.8 Quantification of taxa in metagenomic data
We performed the taxonomic profiling (including phylum, class, order, family, genus and
species levels) of the metagenomic samples using MetaPhlAn2241, which relies on ~1 million
clade-specific marker genes derived from 17,000 microbial genomes (including bacterial, archaeal
and viral species) to unambiguously classify metagenomic reads to taxonomies and yield relative
abundances of taxa identified in the sample.

6.4.9 Alpha diversity (metagenomic data)
The Shannon index, calculated as previously described342, was used to represent the withinsample diversity (alpha diversity) of the microbiota in the samples.

6.4.10 Identification and quantification of antibiotic resistance genes
The antibiotic resistance (AR) genes from each metagenomic assemblies were identified
by blasting protein sequences against Comprehensive Antibiotic Resistance Database (CARD,
downloaded February 2018)119 database using stringent cutoff (>95%ID and >95 overlap with
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subject sequence). The remaining unannotated sequences were filtered and subsequently annotated
with Resfams core database. This approach resulted in 12,739 unique AR genes from 66
metagenomic assemblies. Together, these 12,739 genes with 2,252 AR sequences from CARD
database were used to create high-precision sequence markers using ShortBRED113 (parameters: -clustid 0.95 and --ref Uniref90.fasta).
The ShortBRED results included 20,514 markers for 5,607 AR gene families. The marker
list was then manually curated to reduce the rate of false positives in our surveys. Following criteria
was used to filter out the false positives:


genes that confer resistance via overexpression of resistant target alleles (e.g. resistance to
antifolate drugs via mutated DHPS and DHFR);



global gene regulators, two-component system proteins, and signaling mediators;



efflux pumps that confer resistance to multiple antibiotics;



genes modifying cell wall charge (e.g. those conferring resistance to polymixins and
defensins).
The final set consisted of 1,924 AR gene families. The abundance of AR gene families was

measured using shortbred_quantify.py script and about 1,018 AR determinants were detected with
RPKM > 0 in at least 2 samples.

6.4.11 Identification of virulence factor genes and antibacterial biocide and
metal resistance genes
We identified the virulence factors based on the Virulence Factors of Pathogenic Bacteria
Database (VFDB, downloaded February 2018)343 and the antibacterial biocide and metal resistance
genes based on the BacMet database344. Amino acid sequences were aligned against the databases
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using BLASTP (e-value ≤ 1e-5) and assigned to genes by the highest-scoring annotated hit with
>80% similarity that covered >70% of the length of the query protein.

6.4.12 Species transmission event identification and SourceTracker
We used a modified SourceTracker algorithm330 to identify species transmission events
from the swine farm environment to human gut microbiota. Briefly, the new genes found in each
sample during swine farm residence were grouped into species-level clusters by consistent
taxonomic assignment and relative abundance (range: average ±5%). The SourceTracker
algorithm was then used to estimate the probability that the species in the fecal sample came from
the source environment (probability >80%). The probable transferred species with less than 100
genes or less than 0.01% relative abundance in the human gut microflora were further filtered.
To identify transfer events involving antibiotic resistance genes, SourceTracker was run
with the default settings using the environmental microbiota as the source.

6.4.13 Microbial genome reconstruction in metagenomes
We established an approach to reconstruct the genomes of the high-abundance (typically,
>3%) species in the human gut metagenomes. Firstly, metagenomic reads were mapped to the
closest reference genomes using SOAP2.21338 (>95% identity). The mapped reads were
independently assembled using Velvet82, an algorithm for de novo short read assembly for single
microbial genomes. The software was run multiple times using different k-mer parameters ranging
from 39 to 131 to generate the best assembly results. Then, the raw assembled genome was
scaffolded by SSPACE345, and gaps were closed by GapFiller346. The short scaffolds were filtered
with a minimum length threshold of 200 bp. A circle plot of the draft genomes was obtained using
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BRIG software347. The average nucleotide identity (ANI) between genomes was calculated using
the ANIb algorithm, which uses BLAST as the underlying alignment method348.

6.4.14 Network visualization
The antibiotic resistance gene co-occurrence network was visualized by Cytoscape 3.3.0349
using an edge-weighted spring-embedded layout.

6.4.15 Mobile genetic elements (MGEs)
Putative MGE genes, including transposase, integrase, recombinase, phage terminase and
endopeptidase genes, and bacterial insertion (IS) sequences were identified from the functional
selection by Pfam (v29.0)350 and KEGG (Kyoto Encyclopedia of Genes and Genomes,
downloaded December 2017)351 annotation. Antibiotic resistance genes were considered to colocalize with an MGE if they shared a contig with an MGE gene in a nearby area (<10 kilobases).

6.4.16 Phylogenetic classification of contigs.
Antibiotic resistance contigs and metagenomic assembly contigs were classified using
BLASTN with parameters “-word_size 16 -evalue 1e-5 -max_target_seqs 5000” based on the
NCBI reference microbial genomes (downloaded December 2017). At least 70% alignment
coverage of each contig reads was required. Based on the parameter exploration of sequence
similarity across phylogenetic ranks352, we used 90% identity as the threshold for species
assignment and 85% identity as the threshold for genus assignment.
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6.4.17 Cultures and E. coli analyses
All samples were cultured on MacConkey agar plates and incubated at 37°C for 24 h. One
suspicious colony with typical E. coli morphology was selected from each sample for
identification. We obtained 1,851 E. coli isolates, including 954 isolates from students’ fecal
samples, 182 isolates from farm workers’ fecal samples, 657 isolates from pig feces and 58 isolates
from other farm environmental samples (soil, sewage and ventilation dust). After identifying E.
coli isolates by MALDI-TOF MS (Biomerieux, France), we characterized 82 E. coli isolates to
determine their genetic relatedness by pulsed-field gel electrophoresis (PFGE) according to a
protocol described previously353. These 82 E. coli strains were randomly selected from one pig
farm and origin from students (n=13), farm workers (n=2), pigs (n=51), and farm environments
(16). The DNA banding patterns were analyzed by BioNumerics software (Applied Maths, SintMartens-Latem, Belgium) using the Dice similarity coefficient and a cut-off value of 85% of the
similarity values was chosen to indicate identical Eric types. Salmonella enterica serotype
Braenderup H9812 standards served as size markers.

6.4.18 Phenotypic and genotypic resistance testing
All 1,851 E. coli isolates were tested for susceptibility to 11 antimicrobials for human
medicine and food animals’ production, including colistin (CS), cefotaxime (CTX), gentamicin
(GEN), amikacin (AMK), tetracycline (TET), fosfomycin (FOS), ciprofloxacin (CIP),
methoxazole/trimethoprim (S/T), chloromycetin (CHL), meropenem (MEM) and tigecycline
(TIG). Antimicrobial susceptibilities of isolates were determined by the agar dilution method and
the results were interpreted according to the Clinical and Laboratory Standards Institute (CLSI)
(M100-S25)

354

. All isolates were further screened for blaCTX-M and fosA3 genes (conferring
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resistance to CTX and FOS, respectively) by PCR amplification using primers published
previously355, 356. As fosA3 was frequently co-transferred with blaCTX-M mediated by a single
plasmid322,

356

, the genetic contexts of the fosA3 and blaCTX-M genes were explored by PCR

mapping using the reference regions surrounding them among 15 fosA3-blaCTX-M-co-harboring E.
coli isolates, which were randomly selected from one pig farm.

6.4.19 Creation of the dynamic Bayesian network (DBN) model
The DBN model was created based on genus composition profiles of students’ faecal
samples at all seven time points. Firstly, we removed 1) two students (H and N) who lacked the
sequencing data for at least 2 time points, and 2) the genera with average relative abundance less
than 0.5% in students, remaining the gut microbial communities of 12 students on 39 highabundant genera for further analysis. These genera covered 86% of total relative abundance of
analyzed samples. Then, we calculated the genus-genus associations based on the extended local
similarity analysis (eLSA) algorithm357, 358 (default parameters), using the students’ genus profiles
at all seven time points. The eLSA tool generated an association network from significant
associations (permutated P < 0.01), including both time-independent (undirected) and timedependent (directed) associations. For each genus, five most significant associations were
remained for simplify the network. Lastly, the partially directed DBN model was created based on
the genus-genus association network and the directed associations for each genus from its previous
time point to current time point.
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6.4.20 Prediction of the microbial composition based on the DBM model
In the DBN model, the current relative abundance (tn) of every genus can be expressed as
a function of the relative abundances of its parent genera at the previous time point (tn-1). The
functions in the resulting DBN were derived using Eureqa v1.24.0316 (default parameters). Eureqa
is a freely downloadable software for deducing equations and hidden mathematical relationships
in numerical data sets without prior knowledge of existing patterns. The operations, including
constant, add, subtract, multiply, divide, sine, cosine and exponential, were permitted in solutions.
Eureqa was allowed to search for best-fitting equations for a maximum of 1 x 1010 formula
evaluations, or until correlations >0.8 were observed. Finally, in our dataset, we predicted the
relative abundance of all genera at an extrapolated time point (T7) based on the formulas, using
their abundances at time point T6. Similarly, the microbial communities at time points T8 and T9
were predicted based on T7 and T8.

6.4.21 Statistical analysis
Statistical analysis was implemented using the R platform. Principal coordinate analysis
(PCoA) was performed using the “ape” package359 based on the UniFrac distances between
samples. Distance-based redundancy analysis (dbRDA) was performed using the “vegan”
package360347184 based on the Bray-Curtis distances on normalized taxa abundance matrices and
visualized using the “ggplot2” package. In analyses of PCoA and dbRDA, the top two principal
components of the samples were shown, and the Mann–Whitney U-test was used to evaluate the
significance of differences in samples obtained at different time points. Procrustes analysis was
performed using the “vegan” package, and the significance of the Procrustes statistic (a
correlation-like statistic derived from the symmetric Procrustes sum of squares) was estimated by
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the protest function with 999 permutations. Rarefaction analysis implemented by in-house Perl
scripts was performed to assess the gene richness of environmental samples. Statistical
significance was set at P < 0.05.
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6.6 Supplementary Figures

Figure S6.1: Location and overview of study sites in China.
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Figure S6.2 dbRDA analysis of the Bray Curtis distances between gut microbiota in samples on three swine farms.
The first and second principal components are shown. The nodes represent the samples, the lines connect samples
obtained at the same time points, and the colored circles indicate the samples near the center of gravity for each
time point.

Figure S6.3: Alteration of gut microbial composition following environmental conversion. (a) Change in the
relative abundance of the top 4 dominant phyla. (b) Relative abundance of the top 30 dominant genera in students’
gut microbiota at time points T0, T3 and T6. The box and scatter plots in a) and b) show the distribution of the
samples (the boxes show medians/quartiles; the error bars extend to the most extreme value within 1.5 interquartile
ranges). For b *P < 0.05, **P < 0.01, paired Student’s t-test..
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Figure S6.4: Alteration of gut microbiota as revealed by whole-metagenome data. (a-b) Distance-based
redundancy analysis (dbRDA) of the microbial species-(a) and genus-level (b) composition of students’ samples at
time points T0 (red), T3 (green) and T6 (blue), and workers’ samples. DbRDA plots are shown the first two principal
components. Lines connect samples from the same time point, and coloured circles indicate the samples near the
center of gravity for each time point. (c) Bray-Curtis dissimilarity between student samples at three collection times.
Each point is a pairwise comparison between two samples from an individual. (d) Bray-Curtis dissimilarity between
student times and control samples. Each point is a pairwise comparison between a student sample and a control
sample. (e) Bray-Curtis dissimilarity between student times and controls samples, students are separated into three
farms of geographical location differences. *P < 0.05, **P < 0.01, *** P < 0.001 Wilcoxon test.
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Figure S6.5: Changes in the number and abundance of AR genes in the antibiotic resistome during the swine farm
residence period. (a) Observed total AR gene abundance in RPKM and (b) Observed number of unique AR genes
with RPKM>0.1 in the students’ gut microbiota at time points T0, T3 and T6, and in the workers’ gut microbiota.
Boxes show medians/quartiles; error bars extend to the most extreme values within 1.5 interquartile ranges. (c)
Heatmap showing the composition of AR types in the students’ and workers’ gut microbiota. (d) Box plot showing
the abundance of three AR types that significantly increased during the students’ residence at the swine farm. Boxes
show medians/quartiles; error bars extend to the most extreme values within 1.5 interquartile ranges. P values are
shown on the respective plots with lines indicating the compared groups. P values are multiple hypothesis test
corrected using Benjamini Hochberg (FDR) correction.
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Figure S6.6: Summary of microbial gene content in the swine farm ecosystem. (a) Comparison of the non-redundant
genes found in the swine farm environmental and worker fecal samples. (b) Rarefaction of genes observed in
environmental and worker fecal samples. The number of genes in each sample was calculated after 30 random
samplings with replacement in different numbers of sequencing reads.
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Figure S6.7: Overview of the environmental microbiome and antibiotic resistome. (a) Comparison of the phylumlevel microbial composition of the swine farm environments and the human feces. (b) Genus-level microbial
composition of the swine farm environmental samples. (c) Comparison of the AR genes in the swine farm
environmental and worker fecal samples. (d) Observed number of AR genes in the human gut microbiota and the
environmental samples. Boxes show medians/quartiles; error bars extend to the most extreme values within 1.5
interquartile ranges. P-values are shown on the plot with lines indicating the compared groups. P-values are
multiple hypothesis test corrected using Benjamini-Hochberg (FDR) correction.
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Figure S6.8: Source of genes found in the students’ swine farm-stay microbiomes. Genes inherited from the original
gut microbiome (T0) and genes that co-existed with the environmental and swine farm worker samples are shown.

Figure S6.9: Detailed information on species transmission events. The number of species transmission events
observed in each of 14 students is shown; different colors indicate the phylum taxonomic assignments of the species.

198

Figure S6.10: Dendrogram illustrates the genetic relatedness of E. coli strains isolates by pulsed-field gel
electrophoresis (PFGE). (a) The genetic relatedness of 82 E. coli strains isolates randomly selected from one pig
farm. (b) The genetic relatedness of 13 E. coli strains showing clonal spread.
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Figure S6.11: Transfer of bacterial functional genes along with species transmission. Co-transfers of antibiotic
resistance genes (a), virulence factors (b), and antibacterial biocide (c) and metal resistance genes (d) via the
species transmission networks are shown. The larger nodes depict the students with their IDs displayed in the
center. The smaller nodes depict the transmitted species; the different colors indicate different environmental types,
and nodes representing high-frequency (>3) species are indicated. The connecting arrows represent transmission
events; the numbers within the arrows indicate the number of transferred functional genes.
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Figure S6.12: Antibiotic resistance networks and AR gene transmission between human gut and environmental
microbiota. (a) Sharing network of AR genes among swine farm environmental and human fecal samples. Lines
represent unique AR genes found in at least one sample; the predicted resistance mechanisms are indicated by
different colors. And the lines connecting the samples with the AR genes represent ShortBRED hits with an RPKM
of ≥10. The large nodes represent individual human gut (hexagon) or environmental (rhombus) samples. (b)
Number of antibiotic resistance genes transmitted from the environments to the students’ gut, as identified by
SourceTracker.
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Figure S6.13: Occurrence of the antibiotic resistance genes in the environmental and human fecal samples. All AR
genes that enriched in the students’ gut antibiotic resistomes during their stay on swine farm (time point T3) are
shown. The occurrence rates of antibiotic resistance genes in each group are represent by color shades in boxes.
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Figure S6.14: Changes in resistance rates of nine antibiotics among isolated E. coli strains. Bar plots show the
resistance rates of 954 E. coli strains isolating from students samples during the students’ swine farm before and
after residence.
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Figure S6.15: Dynamic Bayesian network of the gut microbiota. (a) Network showing the association between
microbial taxa generated by the extended local similarity analysis (eLSA) algorithm. Nodes represent species, and
edges represent correlations between two species. (b) Bray-Curtis similarity (1-Bray-Curtis dissimilarity) between
the predicted interpolated community structure and the actual community structure of the students’ gut microbiota
based on leave-one-out cross-validation for the model. (c) Bray-Curtis dissimilarity between T0 and other time
points. Boxes show medians/quartiles; error bars extend to the most extreme values within 1.5 interquartile ranges.
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